<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 27, 1994
REGISTRATION NO. 33-51702
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------
POST-EFFECTIVE AMENDMENT NO. 3
TO
FORM S-6
FOR REGISTRATION UNDER THE SECURITIES ACT
OF 1933 OF SECURITIES OF UNIT INVESTMENT
TRUSTS REGISTERED ON FORM N-8B-2
-------------------
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
(EXACT NAME OF TRUST)
ML LIFE INSURANCE COMPANY OF NEW YORK
(NAME OF DEPOSITOR)
100 CHURCH STREET
11TH FLOOR
NEW YORK, NEW YORK 10080-6511
(COMPLETE ADDRESS OF DEPOSITOR'S PRINCIPAL EXECUTIVE OFFICES)
------------------------
BARRY G. SKOLNICK, ESQ.
SENIOR VICE PRESIDENT & GENERAL COUNSEL
ML LIFE INSURANCE COMPANY OF NEW YORK
800 SCUDDERS MILL ROAD
PLAINSBORO, NEW JERSEY 08536
(NAME AND COMPLETE ADDRESS OF AGENT FOR SERVICE)
------------------------
COPY TO:
STEPHEN E. ROTH, ESQ.
SUTHERLAND, ASBILL & BRENNAN
1275 PENNSYLVANIA AVENUE, NW
WASHINGTON, D.C. 20004-2404
-------------------
It is proposed that this filing will become effective (check appropriate
box)
/ / immediately upon filing pursuant to paragraph (b) of Rule 486
/X/ on May 1, 1994 pursuant to paragraph (b) of Rule 486
/ / 60 days after filing pursuant to paragraph (a) of Rule 486
/ / on (date) pursuant to paragraph (a) of Rule 486
Check box if it is proposed that the filing will become effective on (date)
at (time) pursuant to Rule 487 / /
Pursuant to Rule 24f-2 of the Investment Company Act of 1940, the Registrant
has registered an indefinite amount of securities under the Securities Act of
1933. The Registrant filed the 24f-2 Notice for the year ended December 31, 1993
on February 28, 1994.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
CROSS REFERENCE TO ITEMS REQUIRED BY FORM N-8B-2
<TABLE>
<CAPTION>
N-8B-2 ITEM CAPTION IN PROSPECTUS
----------- ----------------------------------------------------------------------------
<C> <S>
1 Cover Page
2 Cover Page
3 Summary of the Contract (The Investment Divisions); Facts About the Separate
Account, the Series Fund, the Variable Series Funds, the Zero Trusts and ML
of New York
4 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
5 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About ML Life Insurance Company of New York
6 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Separate Account and its Divisions (Charges to Series Fund
Assets; Charges to Variable Series Funds Assets)
7 Not Applicable
8 Not Applicable
9 More About ML Insurance Company of New York (Legal Proceedings)
10 Summary of the Contract; Facts About the Contract; More About the Contract;
More About the Separate Account and its Divisions
11 Summary of the Contract (The Investment Divisions); Facts About the Separate
Account, the Series Fund, the Variable Series Funds, the Zero Trusts and ML
of New York; More About the Separate Account and its Divisions (About the
Separate Account; The Zero Trusts)
12 Summary of the Contract (The Investment Divisions); Facts About the Separate
Account, the Series Fund, the Variable Series Funds, the Zero Trusts and ML
of New York; More About the Separate Account and its Divisions
13 Summary of the Contract (Loans; Fees and Charges); Facts About the Contract
[Charges Deducted from your Investment Base; Charges to the Separate
Account; Guarantee Period; Net Cash Surrender Value; Loans; Partial
Withdrawals; Death Benefit Proceeds; Payment of Death Benefit Proceeds;
Your Right to Cancel ("Free Look" Period) or Exchange]; More About the
Contract; More About the Separate Account and its Divisions (Charges to
Series Fund Assets; Charges to Variable Series Funds Assets)
14 Facts About the Contract (Purchasing a Contract; Planned Payments); More
About the Contract (Other Contract Provisions)
15 Summary of the Contract (Availability and Payments); Facts About the
Contract (Planned Payments; Payments Which Are Not Under a Periodic Payment
Plan; Effect of a Planned Payment and Other Additional Payments); More
About the Contract (Income Plans)
16 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York; More About the Separate Account
and its Divisions
17 Summary of the Contract [Net Cash Surrender Value and Cash Surrender Value;
Right to Cancel ("Free Look" Period) or Exchange; Partial Withdrawals];
Facts About the Contract [Net Cash Surrender Value; Partial Withdrawals;
Right to Cancel ("Free Look" Period) or Exchange]; More About the Contract
(Some Administrative Procedures)
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
N-8B-2 ITEM CAPTION IN PROSPECTUS
----------- ----------------------------------------------------------------------------
<C> <S>
18 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York; More About the Separate Account
and its Divisions
19 More About ML Life Insurance Company of New York
20 More About the Separate Account and its Divisions (Charges Within the
Account; Charges to Series Fund Assets; Charges to Variable Series Funds
Assets)
21 Summary of the Contract (Loans); Facts About the Contract (Loans)
22 Not Applicable
23 Not Applicable
24 Not Applicable
25 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About ML Life Insurance Company of New York
26 Not Applicable
27 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About ML Life Insurance Company of New York
28 More About ML Life Insurance Company of New York
29 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S)
30 Not Applicable
31 Not Applicable
32 Not Applicable
33 Not Applicable
34 Not Applicable
35 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S)
36 Not Applicable
37 Not Applicable
38 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
39 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
40 Not Applicable
41 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
42 Not Applicable
43 Not Applicable
44 Facts About the Contract; More About the Contract
45 Not Applicable
46 Summary of the Contract; Facts About the Contract (Net Cash Surrender Value;
Partial Withdrawals)
47 Summary of the Contract (The Investment Divisions); Facts About the Separate
Account, the Series Fund, the Variable Series Funds, the Zero Trusts and ML
of New York; More About the Separate Account and its Divisions
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
N-8B-2 ITEM CAPTION IN PROSPECTUS
----------- ----------------------------------------------------------------------------
<C> <S>
48 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
49 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
50 Not Applicable
51 Facts About the Contract; More About the Contract
52 Facts About the Separate Account, the Series Fund, the Variable Series
Funds, the Zero Trusts and ML of New York (ML of New York and MLPF&S); More
About the Contract (Selling the Contracts)
53 More About the Contract (Tax Considerations; ML of New York's Income Taxes)
54 Not Applicable
55 Not Applicable
56 Not Applicable
57 Not Applicable
58 Not Applicable
59 More About ML Life Insurance Company of New York (Financial Statements)
</TABLE>
<PAGE>
PROSPECTUS
MAY 1, 1994
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
ALSO KNOWN AS
MODIFIED FLEXIBLE PREMIUM
VARIABLE LIFE INSURANCE CONTRACT
ISSUED BY
ML LIFE INSURANCE COMPANY OF NEW YORK
HOME OFFICE: 100 CHURCH STREET, 11TH FLOOR, NEW YORK, NEW YORK 10080-6511
SERVICE CENTER: P.O. BOX 9025
SPRINGFIELD, MASSACHUSETTS 01102-9025
1414 MAIN STREET, THIRD FLOOR
SPRINGFIELD, MASSACHUSETTS 01104-1007
PHONE: (800) 831-8172
OFFERED THROUGH
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
This Prospectus is for a flexible premium variable life insurance contract (the
"Contract") offered by ML Life Insurance Company of New York ("ML of New York"),
a subsidiary of Merrill Lynch & Co., Inc. It describes contracts which, at the
time of issue, are designed to meet the 7-pay test under federal tax law. (See
"Tax Treatment of Loans and other Distributions" on page 30.) A prospective
contract owner who wants to purchase a modified endowment contract (that would
not meet the 7-pay test) should consult a Merrill Lynch registered
representative.
The initial payment will be invested only in the investment division of the
Separate Account investing in the Money Reserve Portfolio. After the "free look"
period, the contract owner may select up to any five of the 36 investment
divisions of ML of New York Variable Life Separate Account II (the "Separate
Account"), a ML of New York separate investment account available under the
Contract. The investments available through the investment divisions include 10
mutual fund portfolios of the Merrill Lynch Series Fund, Inc., six mutual fund
portfolios of the Merrill Lynch Variable Series Funds, Inc. and 20 unit
investment trusts in The Merrill Lynch Fund of Stripped ("Zero") U.S. Treasury
Securities. Currently, the contract owner may change his or her investment
allocation as many times as desired.
The Contract provides an estate benefit through life insurance coverage on the
insured. ML of New York guarantees that the coverage will remain in force for
the guarantee period. Each payment will extend the guarantee period until such
time as the guarantee period is established for life. During this guarantee
period, ML of New York will terminate the Contract only if the debt exceeds
certain contract values. After the guarantee period, the Contract will remain in
force as long as there is not excessive debt and as long as the cash surrender
value is sufficient to cover the charges due. While the Contract is in force,
the death benefit may vary to reflect the investment results of the investment
divisions chosen, but will never be less than the current face amount.
Contract owners may also purchase a Contract to provide insurance coverage on
the lives of two insureds with proceeds payable upon the death of the last
surviving insured.
The Contract is designed to allow for planned periodic payments, and contract
owners may make additional unplanned payments subject to certain conditions.
Contract owners may also change the face amount of their Contracts, borrow up to
the loan value of the Contract or turn in the Contract for its net cash
surrender value. The net cash surrender value will vary with the investment
results of the investment divisions chosen. ML of New York doesn't guarantee any
minimum cash surrender value.
It may not be advantageous to replace existing insurance with the Contract. The
Contract may be returned or exchanged for a contract with benefits that do not
vary with the investment results of a separate account.
PLEASE READ THIS PROSPECTUS AND KEEP IT FOR FUTURE REFERENCE. IT MUST BE
ACCOMPANIED BY CURRENT PROSPECTUSES FOR THE MERRILL LYNCH SERIES FUND, INC., THE
MERRILL LYNCH VARIABLE SERIES FUNDS, INC. AND THE MERRILL LYNCH FUND OF STRIPPED
("ZERO") U.S. TREASURY SECURITIES.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
IMPORTANT TERMS.............................................................. 4
SUMMARY OF THE CONTRACT
Purpose of the Contract.................................................... 5
Availability and Payments.................................................. 5
Joint Insureds............................................................. 5
CMA-R- Insurance Service................................................... 5
The Investment Divisions................................................... 5
How the Death Benefit Varies............................................... 6
How the Investment Base Varies............................................. 6
Net Cash Surrender Value and Cash Surrender Value.......................... 6
Illustrations.............................................................. 6
Replacement of Existing Coverage........................................... 6
Right to Cancel ("Free Look" Period) or Exchange........................... 6
How Death Benefit and Cash Surrender Value Increases are Taxed............. 7
Loans...................................................................... 7
Partial Withdrawals........................................................ 7
Fees and Charges........................................................... 7
FACTS ABOUT THE SEPARATE ACCOUNT, THE SERIES FUND, THE VARIABLE SERIES FUNDS,
THE ZERO TRUSTS AND ML OF NEW YORK
The Separate Account....................................................... 8
The Series Fund............................................................ 8
The Variable Series Funds.................................................. 9
Equity Growth Fund -- Exemptive Relief..................................... 10
The Zero Trusts............................................................ 10
ML of New York and MLPF&S.................................................. 11
FACTS ABOUT THE CONTRACT
Who May be Covered......................................................... 11
Purchasing a Contract...................................................... 12
Planned Payments........................................................... 13
Payments Which are Not Under a Periodic Payment Plan....................... 14
Effect of a Planned Payment and Other Additional Payments.................. 15
Changing the Face Amount................................................... 15
Investment Base............................................................ 16
Charges Deducted from the Investment Base.................................. 17
Charges to the Separate Account............................................ 19
Guarantee Period........................................................... 19
Net Cash Surrender Value................................................... 20
Loans...................................................................... 20
Partial Withdrawals........................................................ 21
Death Benefit Proceeds..................................................... 22
Payment of Death Benefit Proceeds.......................................... 23
Right to Cancel ("Free Look" Period) or Exchange........................... 23
Reports to Contract Owners................................................. 24
MORE ABOUT THE CONTRACT
Using the Contract......................................................... 24
Some Administrative Procedures............................................. 26
Other Contract Provisions.................................................. 27
Income Plans............................................................... 27
Group or Sponsored Arrangements............................................ 28
Unisex Legal Considerations for Employers.................................. 28
Selling the Contracts...................................................... 28
</TABLE>
2
<PAGE>
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
Tax Considerations......................................................... 29
ML of New York's Income Taxes.............................................. 32
Reinsurance................................................................ 33
MORE ABOUT THE SEPARATE ACCOUNT AND ITS DIVISIONS
About the Separate Account................................................. 33
Changes Within the Account................................................. 33
Net Rate of Return for an Investment Division.............................. 33
The Series Fund and the Variable Series Funds.............................. 34
Charges to Series Fund Assets.............................................. 35
Charges to Variable Series Funds Assets.................................... 35
The Zero Trusts............................................................ 36
ILLUSTRATIONS
Illustrations of Death Benefits, Investment Base, Cash Surrender Values and
Accumulated Payments...................................................... 37
EXAMPLES
Additional Payments........................................................ 45
Changing the Face Amount................................................... 45
Partial Withdrawals........................................................ 46
JOINT INSUREDS............................................................... 47
MORE ABOUT ML LIFE INSURANCE COMPANY OF NEW YORK
Directors and Executive Officers........................................... 51
Services Arrangement....................................................... 53
State Regulation........................................................... 53
Legal Proceedings.......................................................... 53
Experts.................................................................... 53
Legal Matters.............................................................. 53
Registration Statements.................................................... 53
Financial Statements....................................................... 53
Financial Statements of ML of New York Variable Life Separate Account II... 54
Financial Statements of ML Life Insurance Company of New York.............. 64
</TABLE>
THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFERING IN ANY JURISDICTION IN WHICH
SUCH OFFERING MAY NOT LAWFULLY BE MADE. NO PERSON IS AUTHORIZED TO MAKE ANY
REPRESENTATIONS IN CONNECTION WITH THIS OFFERING OTHER THAN THOSE CONTAINED IN
THIS PROSPECTUS.
3
<PAGE>
IMPORTANT TERMS
ADDITIONAL PAYMENT: is a payment which may be made after the "free look"
period.
ATTAINED AGE: is the issue age of the insured plus the number of full years
since the contract date.
CASH SURRENDER VALUE: is equal to the net cash surrender value plus any debt.
CONTRACT ANNIVERSARY: is the same date of each year as the contract date.
CONTRACT DATE: is used to determine processing dates, contract years and
anniversaries. It is usually the business day next following the receipt of the
initial payment at the Service Center. It is also referred to as the policy
date.
DEATH BENEFIT: is the larger of the face amount and the variable insurance
amount.
DEATH BENEFIT PROCEEDS: are equal to the death benefit less any debt and less
any overdue charges.
DEBT: is the sum of all outstanding loans on a Contract plus accrued interest.
DEFERRED CONTRACT LOADING: is chargeable to all payments for sales load,
federal tax and premium tax charges. ML of New York advances the amount of the
loading to the divisions as part of the investment base. This loading is then
deducted in equal installments on the next ten contract anniversaries following
the date the initial payment is received and accepted. ML of New York deducts
the balance of the deferred contract loading not yet recouped in determining a
Contract's net cash surrender value.
FACE AMOUNT: is the minimum death benefit as long as the Contract remains in
force. The face amount will change if the change in face amount option is
chosen; it may increase as a result of an additional payment; or it may decrease
as a result of a partial withdrawal.
FIXED BASE: is calculated like the cash surrender value except that 4% is
substituted for the net rate of return, the guaranteed maximum cost of insurance
rates are substituted for current rates and loans and repayments are not taken
into account.
GUARANTEE PERIOD: is the time guaranteed that the Contract will remain in force
regardless of investment experience, unless the debt exceeds certain values. It
is the period that a comparable fixed life insurance contract (same face amount,
payments made, guaranteed mortality table and loading) would remain in force if
credited with 4% interest per year.
IN FORCE DATE: is the date when the underwriting process is complete, the
initial payment is received and outstanding contract amendments (if any) are
received.
INITIAL PAYMENT: is the payment required to put the Contract into effect.
INVESTMENT BASE: is the amount available under a Contract for investment in the
Separate Account at any time. A contract owner's investment base is the sum of
the amounts invested in each of the selected investment divisions.
INVESTMENT DIVISION: is any division in the Separate Account.
ISSUE AGE: is the insured's age as of his or her birthday nearest the contract
date.
NET AMOUNT AT RISK: is the excess of the death benefit over the cash surrender
value.
NET CASH SURRENDER VALUE: is equal to the investment base less the balance of
any deferred contract loading and, depending on the date it is calculated, less
all or a portion of certain other charges not yet deducted.
NET SINGLE PREMIUM FACTOR: is used to determine the amount of death benefit
purchased by $1.00 of cash surrender value. ML of New York uses this factor in
the calculation of the variable insurance amount to make sure that the Contract
always meets the guidelines of what constitutes a life insurance contract under
the Internal Revenue Code.
PLANNED PERIODIC PAYMENT: is an additional payment made on a planned basis, the
amount, duration and frequency of which are elected in the application or at a
later date.
PROCESSING DATES: are the contract date and the first day of each contract
quarter thereafter. Processing dates after the contract date are the days when
ML of New York deducts charges from the investment base.
PROCESSING PERIOD: is the period between consecutive processing dates.
VARIABLE INSURANCE AMOUNT: is computed daily by multiplying the cash surrender
value by the net single premium factor.
4
<PAGE>
SUMMARY OF THE CONTRACT
PURPOSE OF THE CONTRACT
This flexible premium variable life insurance contract offers a choice of
investments and an opportunity for the Contract's investment base, net cash
surrender value and death benefit to grow based on investment results.
ML of New York doesn't guarantee that contract values will increase. Depending
on the investment results of selected investment divisions, the investment base,
net cash surrender value and death benefit may increase or decrease on any day.
The contract owner bears the investment risk. ML of New York guarantees to keep
the Contract in force during the guarantee period subject to the effect of any
debt.
Life insurance is not a short term investment. The contract owner should
evaluate the need for insurance and the Contract's long term investment
potential before purchasing a Contract.
AVAILABILITY AND PAYMENTS
The Contract is available in New York. A Contract may be issued for an insured
up to age 75 (or up to age 80 for joint insureds). ML of New York will consider
issuing Contracts for insureds above age 75 on an individual basis. Since the
Contract is designed to comply with the 7-pay test under federal tax law,
contract owners must elect a periodic payment plan providing for payments for at
least seven years when they apply for the Contract. ML of New York will modify
the payment plan, if necessary, to ensure that it does comply with the 7-pay
test. The minimum initial payment is $2,000. For a discussion of the 7-pay test,
see "Tax Considerations" on page 29.
Contract owners may elect to pre-pay periodic payments through a single payment
by adding a single premium immediate annuity rider (SPIAR) which will fund the
Contract. The amount applied to purchase the SPIAR is not allocated to the
Separate Account and is not considered a payment to the Contract. (See "Payments
Under a Combination Periodic Payment Plan" on page 13.) Pledging, assigning or
gifting a Contract with a SPIAR may have tax consequences to the contract owner.
(See "Tax Considerations" on page 29.)
ML of New York will not accept an initial payment that provides a guarantee
period of less than one year.
Subject to certain conditions, contract owners may make additional payments that
are not planned. (See "Payments Which are Not Under a Periodic Payment Plan" on
page 14.)
JOINT INSUREDS
The Contract is also available to provide coverage on the lives of two insureds
with a death benefit payable on the death of the last surviving insured. Most of
the discussions in this Prospectus referencing a single insured may also be read
as though the single insured were the two insureds under a joint Contract. Those
discussions which are different for joint insureds are noted accordingly. (See
"Joint Insureds" on page 47.)
CMA-R- INSURANCE SERVICE
Contract owners who subscribe to the Merrill Lynch Cash Management Account-R-
financial service ("CMA account"), may elect to have their Contract linked to
their CMA account electronically. Certain transactions will be reflected in
monthly CMA account statements. Payments may be transferred to and from the
Contract through a CMA account.
THE INVESTMENT DIVISIONS
The initial payment will be invested only in the investment division of the
Separate Account investing in the Money Reserve Portfolio. After the "free look"
period, the contract owner may select up to five of the 36 investment divisions
in the Separate Account. (See "Changing the Allocation" on page 17.)
- ---------
Cash Management Account and CMA are registered trademarks of Merrill Lynch,
Pierce, Fenner & Smith Incorporated.
5
<PAGE>
Payments are invested in investment divisions of the Separate Account. Ten
investment divisions of the Separate Account invest exclusively in shares of
designated mutual fund portfolios of the Merrill Lynch Series Fund, Inc. (the
"Series Fund"). Six investment divisions of the Separate Account invest
exclusively in shares of designated mutual fund portfolios of the Merrill Lynch
Variable Series Funds, Inc. (the "Variable Series Funds"). Each mutual fund
portfolio has a different investment objective. The other 20 investment
divisions invest in units of designated unit investment trusts in The Merrill
Lynch Fund of Stripped ("Zero") U.S. Treasury Securities (the "Zero Trusts").
The contract owner's payments are not invested directly in the Series Fund, the
Variable Series Funds or the Zero Trusts.
HOW THE DEATH BENEFIT VARIES
The death benefit equals the face amount or variable insurance amount, whichever
is larger. It may increase or decrease on any day depending on the investment
results of the investment divisions chosen by the contract owner. Death benefit
proceeds are reduced by any debt.
HOW THE INVESTMENT BASE VARIES
A Contract's investment base is the amount available for investment at any time.
On the contract date (usually the business day next following receipt of the
initial payment at the Service Center), the investment base is equal to the
initial payment. Afterwards, it varies daily based on investment performance of
the investment divisions chosen. The contract owner bears the risk of poor
investment performance and receives the benefit of favorable investment
performance.
NET CASH SURRENDER VALUE AND CASH SURRENDER VALUE
Contract owners may cancel their Contracts at any time and receive the net cash
surrender value. On a contract anniversary, the net cash surrender value equals
the investment base minus the balance of any deferred contract loading not yet
deducted. The net cash surrender value varies daily based on investment
performance of the investment divisions chosen. ML of New York doesn't guarantee
any minimum cash surrender value.
For purposes of certain computations under the Contract, ML of New York uses the
cash surrender value. It is calculated by adding the amount of any debt to the
net cash surrender value.
ILLUSTRATIONS
Illustrations in this Prospectus or used in connection with the purchase of the
Contract are based on hypothetical investment rates of return. These rates are
not guaranteed. They are illustrative only and should not be deemed a
representation of past or future performance. Actual rates of return may be more
or less than those reflected in the illustrations and, therefore, actual values
will be different than those illustrated.
REPLACEMENT OF EXISTING COVERAGE
Before purchasing a Contract, the contract owner should ask his or her Merrill
Lynch registered representative if changing, or adding to, current insurance
coverage would be advantageous. Generally, it is not advisable to purchase
another contract as a replacement for existing insurance. In particular,
replacement should be carefully considered if the decision to replace existing
coverage is based solely on a comparison of contract illustrations.
RIGHT TO CANCEL ("FREE LOOK" PERIOD) OR EXCHANGE
Once the contract owner receives the Contract, he or she should review it
carefully to make sure it is what he or she intended to purchase. A Contract may
be returned for a refund within ten days after the contract owner receives it.
If the Contract is returned during the "free look" period, ML of New York will
refund the payment without interest.
A contract owner may also exchange his or her Contract at any time for a
contract with benefits that do not vary with the investment results of a
separate account.
6
<PAGE>
HOW DEATH BENEFIT AND CASH SURRENDER VALUE INCREASES ARE TAXED
Under current federal tax law, life insurance contracts receive tax-favored
treatment. The death benefit is fully excludable from the beneficiary's gross
income for federal income tax purposes, according to Section 101(a)(1) of the
Internal Revenue Code. A contract owner is not taxed on any increase in the cash
surrender value while a life insurance contract remains in force. For a
discussion of the tax issues associated with this Contract, including taxation
of loans and partial withdrawals from, and collateral assignments of, the
Contract and the possible 10% penalty tax on such distributions, see "Tax
Considerations" on page 29. Contracts that comply with the 7-pay test receive
preferential tax treatment with respect to certain distributions.
LOANS
Contract owners may borrow up to the loan value of their Contracts, which is 90%
of the cash surrender value. (See "Loans" on page 20.)
Loans are deducted from the amount payable on surrender of the Contract and are
also deducted from any death benefit payable. Loan interest of 6% accrues daily
and, if it is not repaid each year, it is capitalized and added to the debt.
Depending upon investment performance of the divisions and the amounts borrowed,
loans may cause a Contract to lapse. If the Contract is not a modified endowment
contract, lapse of the Contract with loans outstanding may result in adverse tax
consequences. (See "Tax Considerations" on page 29.)
PARTIAL WITHDRAWALS
Contract owners may make partial withdrawals after the fifteenth contract year,
subject to certain conditions. (See "Partial Withdrawals" on page 21.)
FEES AND CHARGES
INVESTMENT BASE CHARGES. ML of New York invests the entire amount of all
premium payments in the Separate Account. It then deducts certain charges from
the investment base on processing dates. The charges deducted are as follows:
- deferred contract loading equals 9% of each payment. It consists of a
sales load of 5%, a charge for federal taxes of 2% and a state and local
premium tax charge of 2%. For joint insureds the deferred contract loading
equals 11% of each payment and consists of a sales load of 7%, a charge
for federal taxes of 2% and a state and local premium tax charge of 2%.
Deferred contract loading is deducted in equal installments of .90% (1.1%
for joint insureds) of each payment. The deduction is taken on the ten
contract anniversaries following the date ML of New York receives and
accepts the payment. However, ML of New York subtracts the balance of the
deferred contract loading not yet deducted in determining a Contract's net
cash surrender value. Thus, this balance is deducted in determining the
amount payable on surrender of the Contract;
- on all processing dates after the contract date, ML of New York makes
deductions for mortality cost (see "Mortality Cost" on page 18); and
- on each contract anniversary, ML of New York makes deductions for the net
loan cost if there has been any debt during the prior year. Currently,
there is no net loan cost for amounts borrowed up to the target loan
amount (see "Charges Deducted From the Investment Base" on page 17).
SEPARATE ACCOUNT CHARGES. There are certain charges deducted daily from the
investment results of the investment divisions in the Separate Account. These
charges are:
- an asset charge designed to cover mortality and expense risks deducted
from all investment divisions which is equivalent to .90% annually at the
beginning of the year; and
- a trust charge deducted from only those investment divisions investing in
the Zero Trusts, which is currently equivalent to .34% annually at the
beginning of the year and will never exceed .50% annually.
7
<PAGE>
ADVISORY FEES. The portfolios in the Series Fund and the Variable Series Funds
pay monthly advisory fees and other expenses. (See "Charges to Series Fund
Assets" and "Charges to Variable Series Funds Assets on page 35.)
OTHER CHARGES. If periodic payments are prepaid by purchasing a single premium
immediate annuity rider, ML of New York deducts 5% of the single payment as a
charge for the rider. Any applicable premium taxes will also be deducted. (See
"Payments Under a Combination Periodic Payment Plan" on page 13.)
THIS SUMMARY IS INTENDED TO PROVIDE ONLY A VERY BRIEF OVERVIEW OF THE MORE
SIGNIFICANT ASPECTS OF THE CONTRACT. FURTHER DETAIL IS PROVIDED IN THIS
PROSPECTUS AND IN THE CONTRACT. THE CONTRACT TOGETHER WITH ITS ATTACHED
APPLICATIONS, MEDICAL EXAM(S), AMENDMENTS, RIDERS AND ENDORSEMENTS CONSTITUTES
THE ENTIRE AGREEMENT BETWEEN THE CONTRACT OWNER AND ML OF NEW YORK AND SHOULD BE
RETAINED.
FOR THE DEFINITION OF CERTAIN TERMS USED IN THIS PROSPECTUS, SEE "IMPORTANT
TERMS" ON PAGE 4.
FACTS ABOUT THE SEPARATE ACCOUNT,
THE SERIES FUND, THE VARIABLE SERIES FUNDS, THE ZERO TRUSTS AND ML OF NEW YORK
THE SEPARATE ACCOUNT
The Separate Account is a separate investment account established by ML of New
York on December 4, 1991. It is registered with the Securities and Exchange
Commission as a unit investment trust pursuant to the Investment Company Act of
1940. This registration does not involve any supervision by the Securities and
Exchange Commission over the investment policies or practices of the Separate
Account. It meets the definition of a separate account under the federal
securities laws. The Separate Account is used to support the Contract as well as
to support other variable life insurance contracts issued by ML of New York.
ML of New York owns all of the assets in the Separate Account. The assets of the
Separate Account are kept separate from ML of New York's general account and any
other separate accounts it may have and, to the extent of its reserves and
liabilities, may not be charged with liabilities arising out of any other
business ML of New York conducts.
Obligations to contract owners and beneficiaries that arise under the Contract
are obligations of ML of New York. Income, gains, and losses, whether or not
realized, from assets allocated are, in accordance with the Contracts, credited
to or charged against the Separate Account without regard to other income, gains
or losses of ML of New York. As required, the assets in the Separate Account
will always be at least equal to the reserves and other liabilities of the
Separate Account. If the assets exceed the required reserves and other Contract
liabilities, (which will always be at least equal to the aggregate contract
value allocated to the Separate Account under the Contracts), ML of New York may
transfer the excess to its general account.
There are currently 36 investment divisions in the Separate Account. Ten invest
in shares of a specific portfolio of the Series Fund. Six invest in shares of a
specific portfolio of the Variable Series Funds. Twenty invest in units of a
specific Zero Trust. Complete information about the Series Fund, the Variable
Series Funds and the Zero Trusts, including the risks associated with each
portfolio (including any risks associated with investment in the High Yield
Portfolio of the Series Fund) can be found in the accompanying prospectuses.
They should be read in conjunction with this Prospectus.
THE SERIES FUND
The Merrill Lynch Series Fund, Inc. is registered with the Securities and
Exchange Commission as an open-end management investment company. All of its ten
separate investment mutual fund portfolios are currently available through the
Separate Account. The investment objectives of the Series Fund portfolios are
described below. There is no guarantee that any portfolio will meet its
investment objective. Meeting the objectives depends on how well Series Fund
management anticipates changing economic conditions.
MONEY RESERVE PORTFOLIO seeks to preserve capital and liquidity. It also seeks
the highest possible current income consistent with those objectives. It invests
in short-term money market securities.
8
<PAGE>
INTERMEDIATE GOVERNMENT BOND PORTFOLIO seeks the highest possible current income
consistent with the protection of capital. It invests in intermediate-term debt
securities issued or guaranteed by the U.S. Government or its agencies.
LONG-TERM CORPORATE BOND PORTFOLIO seeks as high a level of current income as is
consistent with prudent investment risk. It invests primarily in fixed-income,
high quality corporate bonds.
HIGH YIELD PORTFOLIO seeks high current income, consistent with prudent
management, by investing principally in fixed-income securities rated in the
lower categories of the established rating services or in unrated securities of
comparable quality (commonly known as "junk bonds").
CAPITAL STOCK PORTFOLIO seeks long-term growth of capital and income, plus
moderate current income. It invests in common stocks considered to be of good or
improving quality or considered to be undervalued based on criteria such as
historical price/book value and price/earnings ratios.
GROWTH STOCK PORTFOLIO seeks above average long-term growth of capital. It
invests primarily in common stocks of aggressive growth companies considered to
have special growth potential.
MULTIPLE STRATEGY PORTFOLIO seeks the highest total investment return consistent
with prudent risk. It does this through a fully managed investment policy
utilizing equity securities, primarily common stocks of large-capitalization
companies, as well as investment grade intermediate-and long-term debt
securities and money market securities.
NATURAL RESOURCES PORTFOLIO seeks long-term growth of capital and protection of
the purchasing power of shareholders' capital by investing primarily in equity
securities of domestic and foreign companies with substantial natural resource
assets.
GLOBAL STRATEGY PORTFOLIO seeks high total investment return by investing
primarily in a portfolio of equity and fixed-income securities of U.S. and
foreign issuers.
BALANCED PORTFOLIO seeks a level of current income and a degree of stability of
principal not normally available from an investment solely in equity securities
and the opportunity for capital appreciation greater than that normally
available from an investment solely in debt securities by investing in a
balanced portfolio of fixed-income and equity securities.
The investment adviser for the Series Fund is Merrill Lynch Asset Management,
L.P. ("MLAM"), a subsidiary of Merrill Lynch & Co., Inc. and a registered
adviser under the Investment Advisers Act of 1940. The Series Fund, as part of
its operating expenses, pays an investment advisory fee to MLAM. (See "Charges
to Series Fund Assets" on page 35.)
THE VARIABLE SERIES FUNDS
The Merrill Lynch Variable Series Funds, Inc. is registered with the Securities
and Exchange Commission as an open-end management investment company. Six of its
18 mutual fund portfolios are currently available through the Separate Account.
The investment objectives of the six available Variable Series Funds portfolios
are described below. There is no guarantee that any portfolio will meet its
investment objective. Meeting the objectives depends on how well Variable Series
Funds management anticipates changing economic conditions.
BASIC VALUE FOCUS FUND seeks to attain capital appreciation, and secondarily,
income by investing in securities, primarily equities, that management of the
Fund believes are undervalued and therefore represent basic investment value.
Particular emphasis is placed on securities which provide an above-average
dividend return and sell at a below-average price/earnings ratio.
WORLD INCOME FOCUS FUND seeks to achieve high current income by investing in a
global portfolio of fixed-income securities denominated in various currencies,
including multinational currency units. The Fund may invest in United States and
foreign government and corporate fixed-income securities, including high yield,
high risk, lower rated and unrated securities. The Fund will allocate its
investments among different types of fixed-income securities denominated in
various currencies.
9
<PAGE>
GLOBAL UTILITY FOCUS FUND seeks to obtain capital appreciation and current
income through investment of at least 65% of its total assets in equity and debt
securities issued by domestic and foreign companies which are, in the opinion of
management of the Fund, primarily engaged in the ownership or operation of
facilities used to generate, transmit or distribute electricity,
telecommunications, gas or water.
INTERNATIONAL EQUITY FOCUS FUND seeks to obtain capital appreciation through
investment in securities, principally equities, of issuers in countries other
than the United States. Under normal conditions, at least 65% of the Fund's net
assets will be invested in such equity securities.
INTERNATIONAL BOND FUND seeks to achieve a high total investment return by
investing in a non-U.S. international portfolio of debt instruments denominated
in various currencies and multi-national currency units.
DEVELOPING CAPITAL MARKETS FOCUS FUND seeks to achieve long-term capital
appreciation by investing in securities, principally equities, of issuers in
countries having smaller capital markets. For purposes of its investment
objective, the Fund considers countries having smaller capital markets to be all
countries other than the four countries having the largest equity market
capitalizations. Currently, these four countries are Japan, the United Kingdom,
the United States, and Germany.
MLAM is the investment adviser for the Variable Series Funds. The Variable
Series Funds, as part of its operating expenses, pays an investment advisory fee
to MLAM. (See "Charges to Variable Series Funds Assets" on page 35.)
EQUITY GROWTH FUND -- EXEMPTIVE RELIEF
An application for exemptive relief has been filed with the Securities and
Exchange Commission on behalf of the Variable Series Funds, the Separate Account
and other affiliated parties. This relief is required under current rules of the
Securities and Exchange Commission in order for the Equity Growth Fund of the
Variable Series Funds to be made available through the Separate Account. (See
"Resolving Material Conflicts" on page 34.) Contract owners will be notified
when the necessary relief is obtained and the Equity Growth Fund is available.
EQUITY GROWTH FUND seeks to attain long-term growth of capital by investing
primarily in common stocks of relatively small companies that management of the
Fund believes have special investment value and emerging growth companies
regardless of size. Such companies are selected by management on the basis of
their long-term potential for expanding their size and profitability or for
gaining increased market recognition for their securities. Current income is not
a factor in such selection. MLAM receives from the Fund an advisory fee at the
annual rate of .75% of the average daily net assets of the Fund. This is a
higher fee than that of many other mutual funds, but management of the Fund
believes it is justified by the high degree of care that must be given to the
initial selection and continuous supervision of the types of portfolio
securities in which the Fund invests.
THE ZERO TRUSTS
The Merrill Lynch Fund of Stripped ("Zero") U.S. Treasury Securities was formed
to provide safety of capital and a high yield to maturity. It seeks this through
U.S. Government-backed investments which make no periodic interest payments and,
therefore, are purchased at a deep discount. When held to maturity the
investments should receive approximately a fixed yield. The value of Zero Trust
units before maturity varies more than it would if the Zero Trusts contained
interest-bearing U.S. Treasury securities of comparable maturities.
The Zero Trust portfolios consist mainly of:
- bearer debt obligations issued by the U.S. Government stripped of their
unmatured interest coupons;
- coupons stripped from U.S. debt obligations; and
- receipts and certificates for such stripped debt obligations and coupons.
10
<PAGE>
The Zero Trusts currently available have maturity dates in years 1994 through
2011, 2013 and 2014.
Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S"), a subsidiary of
Merrill Lynch & Co., Inc., is the sponsor for the Zero Trusts. The sponsor will
sell units of the Zero Trusts to the Separate Account and has agreed to
repurchase units when ML of New York needs to sell them to pay benefits and make
reallocations. ML of New York pays the sponsor a fee for these transactions and
is reimbursed through the trust charge assessed to the divisions investing in
the Zero Trusts. (See "Charges to Divisions Investing in the Zero Trusts" on
page 19.)
ML OF NEW YORK AND MLPF&S
ML of New York is a stock life insurance company organized under the laws of the
State of New York in 1973. It is an indirect wholly owned subsidiary of Merrill
Lynch & Co., Inc. ML of New York is authorized to sell life insurance and
annuities in 9 states. It is also authorized to offer variable life insurance
and variable annuities in certain of those jurisdictions.
MLPF&S is a wholly owned subsidiary of Merrill Lynch & Co., Inc. and provides a
broad range of securities brokerage and investment banking services in the
United States. It provides marketing services for ML of New York and is the
principal underwriter of the Contracts issued through the Separate Account. ML
of New York retains MLPF&S to provide services relating to the Contracts under a
distribution agreement. (See "Selling the Contracts" on page 28.)
FACTS ABOUT THE CONTRACT
WHO MAY BE COVERED
The Contract is available in New York. A Contract may be issued for an insured
up to issue age 75. ML of New York will consider issuing Contracts for insureds
above age 75 on an individual basis. The insured's issue age is his or her age
as of the birthday nearest the contract date. The insured must also meet ML of
New York's medical and other underwriting requirements.
ML of New York uses two methods of underwriting:
- simplified underwriting, with no physical exam; and
- para-medical or medical underwriting with a physical exam.
The initial payment plus the planned periodic payments elected and the age and
sex of the insured determine whether ML of New York will do underwriting on a
simplified or medical basis. The maximum initial payment where a periodic
payment plan is selected, or the maximum initial payment plus the SPIAR payment
where a combination periodic plan is selected, that will be underwritten on a
simplified basis is set out in the charts below.
<TABLE>
<CAPTION>
COMBINATION PERIODIC
PLAN (SPIAR)
------------------------------------
MAXIMUM
PERIODIC PLAN INITIAL
------------------------------------ PAYMENT
MAXIMUM PLUS
INITIAL SPIAR
AGE PAYMENT AGE PAYMENT
--------------------------- ------- --------------------------- -------
<S> <C> <C> <C>
0-29...................... $2,500 0-29....................... $20,000
30-39...................... 3,500 30-39...................... 25,000
40-49...................... 5,000 40-49...................... 35,000
50-59...................... 7,500 50-59...................... 55,000
60-75...................... 10,000 60-75...................... 75,000
</TABLE>
However, if the face amount is above the minimum face amount required for an
initial payment (see "Selecting the Initial Face Amount" on page 12), ML of New
York will also take the net amount at risk into account in determining the
method of underwriting.
11
<PAGE>
ML of New York assigns insureds to underwriting classes which determine the
current cost of insurance rates used in calculating mortality cost deductions.
In assigning insureds to underwriting classes, ML of New York distinguishes
between those insureds underwritten on a simplified basis and those on a para-
medical or medical basis. Under both the simplified and medical underwriting
methods, Contracts may be issued on insureds either in the standard or
non-smoker underwriting class. Contracts may also be issued on insureds in a
substandard underwriting class. For a discussion of the effect of underwriting
classification on mortality cost deductions, see "Mortality Cost" on page 18.
For joint insureds, see modifications to this section on page 47.
PURCHASING A CONTRACT
To purchase a Contract the contract owner must complete an application and make
a payment. A periodic payment plan and the initial face amount are selected at
that time. The amount of the initial payment depends in part on the periodic
payment plan selected. ML of New York will not accept an initial payment for a
specified face amount that will provide a guarantee period of less than one
year. (See "Selecting the Initial Face Amount" and "Initial Guarantee Period" on
page 12.)
Insurance coverage generally begins on the contract date, which is usually the
next business day following receipt of the initial premium payment at ML of New
York's Service Center. Temporary life insurance coverage may be provided under
the terms of a temporary insurance agreement. In accordance with ML of New
York's underwriting rules, temporary life insurance coverage may not exceed
$250,000 and may not be in effect for more than 60 days. As provided for under
state insurance law, the contract owner, to preserve insurance age, may be
permitted to backdate the Contract. In no case may the contract date be more
than six months prior to the date the application was completed. Charges for
cost of insurance for the backdated period are deducted on the first processing
date after the contract date.
For joint insureds, see modifications to this section on page 48.
SELECTING A PERIODIC PAYMENT PLAN. Contract owners select a periodic payment
plan in the application, subject to the rules discussed below. The amount,
duration and frequency of planned payments must be specified, but the minimum
duration is seven contract years, the minimum amount of planned payments is
$2,000 per contract year, the amounts selected must be level, and, in each
contract year under the plan, the amount of planned payments selected must equal
the initial payment. In addition, the plan must comply with the 7-pay test. ML
of New York will modify the periodic payment plan selected, if necessary, to
ensure compliance with the 7-pay test. (See "Planned Payments" on page 13.)
SELECTING THE INITIAL FACE AMOUNT. Contract owners can specify the initial face
amount, within limits. These limits are based in part on the initial payment and
the periodic payment plan selected. The minimum initial face amount is the
amount that would satisfy the 7-pay test or, if greater, the face amount that
would provide a guarantee period for the whole of life assuming all payments are
made as planned under the periodic payment plan selected. (See "Initial
Guarantee Period" below.) If the contract owner elects to make planned payments
for a period shorter than the first nine contract years (or the first ten
contract years if the issue age of the insured is 71 or older), he or she will
not have a guarantee period for the whole of life at the end of the periodic
payment plan assuming all payments are made as planned. The maximum face amount
that may be specified is the amount which will provide a minimum guarantee
period of one year. The initial face amount and initial payment determine the
guarantee period. If the initial face amount is in excess of the minimum, the
guarantee period will be shorter.
INITIAL GUARANTEE PERIOD. The initial guarantee period for a Contract will be
determined by the initial payment and face amount. It will not take the planned
payments into account. Instead, the guarantee period will be adjusted as each
planned payment is made.
The guarantee period is the period of time ML of New York guarantees that the
Contract will remain in force regardless of investment experience unless the
debt exceeds certain values. The guarantee period is based on the guaranteed
maximum cost of insurance rates in the Contract, the deferred contract loading
and a 4% interest assumption. This means that for a given initial payment and
face amount different
12
<PAGE>
insureds will have different guarantee periods depending on their age, sex and
underwriting class. For example, an older insured will have a shorter guarantee
period than a younger insured of the same sex and in the same underwriting
class.
The maximum guarantee period is for the whole of the insured's life and the
minimum guarantee period is one year.
PLANNED PAYMENTS
In the application, contract owners select a periodic payment plan. This plan
must comply with ML of New York's rules. (See "Selecting a Periodic Payment
Plan" on page 12.) The amount and duration of the planned payments selected, as
well as other factors (such as the face amount specified and the insured's age
and sex), will affect whether ML of New York will do underwriting on a
simplified or medical basis. Once the selected plan is approved, a planned
payment may be made without any additional evidence of insurability.
Contract owners may elect another periodic payment plan at a date later than in
the application. The amount and duration of the payments elected, as well as
other factors (such as the current death benefit and the insured's age and sex),
will affect whether ML of New York will require additional evidence of
insurability. Currently, ML of New York will not allow the later election of a
periodic payment plan where additional evidence of insurability would put the
insured in a different underwriting class with different guaranteed or higher
current cost of insurance rates.
Contract owners may elect to make planned payments annually, semiannually or
quarterly, although no planned payments may be made until after the "free look"
period. Payments under a periodic payment plan may not be made until after the
first contract year. Payments may also be made on a monthly basis if the
contract owner authorizes ML of New York to deduct the payment from his or her
checking account (pre-authorized checking) or to withdraw the payment from his
or her CMA account. ML of New York reserves the right to change or discontinue
payment deduction procedures. If a contract owner has the CMA Insurance Service,
planned payments under any of the above frequencies may be withdrawn
automatically from his or her CMA account and transferred to his or her
Contract. The withdrawals will continue under the selected plan until ML of New
York is notified otherwise. For planned payments not being made under
pre-authorized checking or withdrawn from a CMA account, ML of New York will
send the contract owner reminder notices.
ML of New York may require satisfactory evidence of insurability before the
contract owner will be permitted to make any additional payments under a
periodic payment plan if the payment increases the face amount of the Contract.
Failure to make a planned payment will affect the guarantee period. Making a
planned payment before the date specified for payment may affect the contract's
compliance with the 7-pay test. (See "Tax Considerations" on page 29.)
Contract owners may change the frequency, duration and the amount of planned
payments by sending a written request to the Service Center. They may request
one change in the amount, one change in the duration and one change in the
frequency of payments each contract year. Satisfactory evidence of insurability
may be required before the duration or the amount of payments can be increased.
The evidence requirements will be based on the amount of the increase in payment
and the duration, as well as other factors such as the current death benefit and
the insured's age and sex.
For Contracts that otherwise comply with the 7-pay test, changing the frequency,
duration or the amount of planned payments may impact upon such compliance. (See
"Tax Considerations" on page 29.)
PAYMENTS UNDER A COMBINATION PERIODIC PAYMENT PLAN. Contract owners may add a
single premium immediate annuity rider (SPIAR) to their Contract. This rider can
be used as a convenient means to pre-pay planned payments through a single
deposit. It does so by providing a fixed income for six years or more which can
be used to fund the Contract.
The charge for this rider equals 5% of the rider's single payment amount and is
deducted directly from the single payment. Of this charge, 4.5% is attributable
to distribution expenses and 0.5% is attributable
13
<PAGE>
to issuance and administrative expenses relating to the rider. This charge is in
addition to the deferred contract loading chargeable to payments made to the
Contract from SPIAR income payments. A charge for state premium taxes is also
deducted directly from the single payment.
The deposit applied to purchase the SPIAR is not allocated to the Separate
Account and is not considered a payment to the Contract. Each amount paid under
the SPIAR and applied to the Contract is considered a payment to the Contract
when applied. Under this funding plan, a Contract should receive the favorable
tax treatment accorded to contracts which comply with the 7-pay test under
current federal tax law.
If the insured dies before the income period ends, ML of New York will pay the
rider value in a lump sum to the beneficiary under the Contract. For tax
purposes, this payment won't be considered part of the life insurance death
benefit.
If the contract owner surrenders the rider before the end of the income period,
ML of New York will pay the rider value over five years or apply it to a
lifetime income, as selected.
If the contract owner changes ownership of the Contract, ML of New York will
change the owner of the SPIAR to the new owner of the contract.
If the contract owner dies before the income period ends, ML of New York will
pay the remaining income payments to the new owner.
If the Contract ends because the insured dies (where the contract owner is not
the insured), because ML of New York terminates the Contract, or because the
Contract is cancelled for its net cash surrender value, ML of New York will
continue the annuity rider under the same terms. Alternatively, the contract
owner may choose one of the options available upon surrender of the rider.
The rider won't have any effect on the Contract's loan value. The reserves for
this rider will be held in ML of New York's general account.
Pledging, assigning or gifting a Contract with the SPIAR may have tax
consequences to the contract owner. Contract owners are advised to consult their
tax advisor prior to effecting an assignment, pledge or gift of such a Contract.
For a discussion of the tax issues associated with use of a SPIAR, see "Tax
Considerations" on page 29.
The combination periodic plan is not available under a joint insureds Contract.
PAYMENTS WHICH ARE NOT UNDER A PERIODIC PAYMENT PLAN
After the "free look" period, contract owners may make additional payments which
are not under a periodic payment plan provided the attained age of the insured
is not over 80. Additional payments may be made at any time up to four times
each contract year. The minimum ML of New York will accept for these payments is
$200. They may be made whether or not the contract owner is making planned
payments. For Contracts that otherwise comply with the 7-pay test, making an
additional payment that is not under the periodic payment plan selected when the
Contract was issued may impact upon such compliance. (See "Tax Considerations"
on page 29.)
ML of New York may require satisfactory evidence of insurability before a
payment is accepted if the payment immediately increases the net amount at risk
under the Contract, if the contract owner is otherwise making planned payments
or if the guarantee period at the time of the payment is one year or less.
Currently, ML of New York will not accept an additional payment which is not
under a periodic payment plan where the evidence of insurability would put the
insured in a different underwriting class with different guaranteed or higher
current cost of insurance rates.
If an additional payment requires evidence of insurability, ML of New York will
invest that payment in the division investing in the Money Reserve Portfolio.
The additional payment will be invested in this division on the business day
next following receipt at the Service Center. Once the underwriting is completed
and
14
<PAGE>
the payment is accepted, the payment invested in the Money Reserve Portfolio
will automatically be allocated either according to instructions or, if no
instructions have been received, proportionately to the investment base in the
Contract's investment divisions.
EFFECT OF A PLANNED PAYMENT AND OTHER ADDITIONAL PAYMENTS
Currently, any additional payments (including planned payments) not requiring
evidence of insurability will be accepted the day they are received at the
Service Center. However, if acceptance of the payment would affect a Contract's
compliance with the 7-pay test, to the extent feasible ML of New York will not
accept that payment until the contract owner confirms his or her intent to make
that payment under those circumstances. If ML of New York holds the payment
pending receipt of instructions, it will deposit the payment in its general
account and credit it with interest until the payment is returned or accepted.
On the date ML of New York receives and accepts an additional payment, whether
under a periodic payment plan or not, ML of New York will:
- increase the Contract's investment base by the amount of the payment;
- increase the deferred contract loading (see "Deferred Contract Loading" on
page 17);
- reflect the payment in the calculation of the variable insurance amount
(see "Variable Insurance Amount" on page 22); and
- increase the fixed base by the amount of the payment less the deferred
contract loading applicable to the payment (see "The Contract's Fixed
Base" on page 20).
If an additional payment requires evidence of insurability, once underwriting is
completed and the payment is accepted, acceptance will be effective, and the
additional payment will be reflected in contract values as described above, as
of the next business day after the payment is received at the Service Center.
As of the processing date on or next following receipt and acceptance of an
additional payment, ML of New York will increase either the guarantee period or
face amount or both. If the guarantee period prior to receipt and acceptance of
an additional payment is less than for life, payments will first be used to
extend the guarantee period. Any amount in excess of that required to extend the
guarantee period to the whole of life or any subsequent additional payment will
be used to increase the Contract's face amount.
ML of New York will determine the increase in face amount by taking any excess
amount or subsequent additional payment, deducting the applicable deferred
contract loading, bringing the result up at an annual rate of 4% interest from
the date the additional payment is received and accepted to the next processing
date, and then multiplying by the applicable net single premium factor. If the
additional payment is received and accepted on a processing date, the payment
minus the deferred contract loading is multiplied by the applicable net single
premium factor. For a further discussion of the effect of additional payments on
a Contract's face amount, see "Additional Payments" in the Examples on page 45.
Unless specified otherwise, if there is any debt, any payment made, other than
planned payments, will be used first as a loan repayment with any excess applied
as an additional payment. (See "Loans" on page 20.)
For joint insureds, see the modifications to this section on page 48.
CHANGING THE FACE AMOUNT
After the first contract year, if the insured is in a standard or non-smoker
underwriting class, a contract owner may request a change in the face amount of
his or her Contract without making an additional payment subject to the rules
and conditions discussed below. A change in face amount is not permitted if the
attained age of the insured is over 80. The minimum change in face amount is
$10,000 and only one change may be made each contract year. A change in face
amount may affect the mortality cost deduction. (See "Mortality Cost" on page
18.)
15
<PAGE>
The effective date of the change will be the next processing date following the
receipt and acceptance of a written request, provided it is received at the
Service Center at least seven days before the processing date.
Changing the face amount may have tax consequences. (See "Tax Considerations" on
page 29.)
INCREASING THE FACE AMOUNT. To increase the face amount of a Contract, ML of
New York may require satisfactory evidence of insurability. When the face amount
is increased, the guarantee period is decreased. The maximum increase in face
amount is the amount which will provide the minimum guarantee period for which
ML of New York would issue a Contract at the time of the request based on the
insured's attained age. Currently, ML of New York will not permit an increase in
face amount where evidence of insurability, if required, would put the insured
in a different underwriting class with different guaranteed or higher current
cost of insurance rates.
DECREASING THE FACE AMOUNT. When the face amount of a Contract is decreased,
the guarantee period is increased. The maximum decrease in face amount is that
decrease which would provide the minimum face amount for which ML of New York
would issue a Contract at the time of the request based on the insured's
attained age, sex and underwriting class. ML of New York won't permit a decrease
in face amount below the amount required to keep the Contract qualified as life
insurance under federal income tax laws.
DETERMINING THE NEW GUARANTEE PERIOD. As of the effective date of any change in
face amount, ML of New York takes the fixed base on that date and, based on the
attained age and sex of the insured and the new face amount of the Contract, it
redetermines the guarantee period. A 4% interest assumption and the guaranteed
maximum cost of insurance rates is used in these calculations. For a discussion
of the effect of changes in the face amount on a Contract's guarantee period,
see "Changing the Face Amount" in the Examples on page 48.
For joint insureds, see the modifications to this section on page 48.
INVESTMENT BASE
A Contract's investment base is the amount available for investment at any time.
It is the sum of the amounts invested in each of the investment divisions. On
the contract date, the investment base equals the initial payment. ML of New
York adjusts the investment base daily to reflect the investment performance of
the investment divisions the contract owner has selected. (See "Net Rate of
Return for an Investment Division" on page 33.) The investment performance
reflects the deduction of Separate Account charges. (See "Charges to the
Separate Account" on page 19.)
Deductions for deferred contract loading, mortality cost and net loan cost, as
well as partial withdrawals and loans, decrease the investment base. (See
"Charges Deducted from the Investment Base" on page 17, "Partial Withdrawals" on
page 21 and "Loans" on page 20.) Loan repayments and additional payments
increase it. Contract owners may elect from which investment divisions loans and
partial withdrawals are taken and to which investment divisions repayments and
additional payments are added. If an election is not made, ML of New York will
allocate increases and decreases proportionately to the investment base in the
investment divisions the contract owner has selected. (For special rules on
allocation of additional payments which require evidence of insurability, see
"Payments Which are Not Under a Periodic Payment Plan" on page 14.)
INVESTMENT ALLOCATION DURING THE "FREE LOOK" PERIOD AND PREALLOCATION. The
initial payment will be invested only in the investment division of the Separate
Account investing in the Money Reserve Portfolio. Through the first 14 days
following the in force date, the initial payment will remain in that investment
division. Thereafter, the investment base will be reallocated to the investment
divisions selected by the contract owner on the application, if different. The
contract owner may invest in up to five of the 36 investment divisions of the
Separate Account.
16
<PAGE>
CHANGING THE ALLOCATION. After the "free look" period, a contract owner's
investment base may be invested in up to any five investment divisions at any
one time. Currently, investment allocations may be changed as often as desired.
However, ML of New York may limit the number of changes permitted but not to
less than five each contract year. Contract owners will be notified if
limitations are imposed.
In order to change their investment base allocation, contract owners must call
or write to the Service Center. (See "Some Administrative Procedures" on page
26.) If the "free look" period has expired, ML of New York will make the change
as soon as the request is received. Contract owners may give allocation requests
during the "free look" period and the allocation will be made immediately
following the end of the "free look" period.
ZERO TRUST ALLOCATIONS. ML of New York will notify contract owners 30 days
before a Zero Trust in which they have invested matures. Contract owners must
tell ML of New York in writing at least seven days before the maturity date how
to reinvest their funds in the division investing in that Zero Trust. If ML of
New York is not notified, it will move the contract owner's investment base in
that division to the investment division investing in the Money Reserve
Portfolio.
Units of a specific Zero Trust may no longer be available when a request for
allocation is received. Should this occur, ML of New York will attempt to notify
the contract owner immediately so that the request can be changed.
ALLOCATION TO THE DIVISION INVESTING IN THE NATURAL RESOURCES PORTFOLIO. ML of
New York and the Separate Account reserve the right to suspend the sale of units
of the investment division investing in the Natural Resources Portfolio in
response to conditions in the securities markets or otherwise.
CHARGES DEDUCTED FROM THE INVESTMENT BASE
The charges described below are deducted pro-rata from the investment base on
processing dates. ML of New York also deducts certain asset and trust charges
daily from the investment results of each investment division in the Separate
Account in determining its net rate of return. Currently the asset and trust
charges are equivalent to .90% and .34% annually at the beginning of the year.
(See "Charges to the Separate Account" on page 19.) The portfolios in the Series
Fund and the Variable Series Funds also pay monthly advisory fees and other
expenses. (See "Charges to Series Fund Assets" and "Charges to Variable Series
Funds Assets" on page 35.) For a discussion of the charges applicable to the
SPIAR issued under a combination periodic plan, see page 14.
DEFERRED CONTRACT LOADING. 100% of all premium payments are invested in the
Separate Account. Chargeable to each payment is an amount called the deferred
contract loading. The deferred contract loading equals 9% of each payment. This
charge consists of a sales load, a charge for federal taxes and a state and
local premium tax charge.
The sales load, equal to 5% of each payment, compensates ML of New York for
sales expenses. The sales load may be reduced if cumulative payments are
sufficiently high to reach certain breakpoints (2% of payments in excess of $1.5
million and 0% of payments in excess of $4 million) and in certain group or
sponsored arrangements as described on page 28. ML of New York anticipates that
the sales load charge may be insufficient to cover distribution expenses. Any
shortfall will be made up from ML of New York's general account which may
include amounts derived from mortality gains and asset charges.
The charge for federal taxes equal to 2% of each payment, compensates ML of New
York for a significantly higher corporate income tax liability resulting from
changes made to the Internal Revenue Code by the Omnibus Budget Reconciliation
Act of 1990. (See "ML of New York's Income Taxes" on page 32.) This charge is
treated as a sales load for purposes of determining compliance with the
limitations on sales loads imposed by the Investment Company Act of 1940 and
applicable regulations thereunder.
The state and local premium tax charge, equal to 2% of each payment, compensates
ML of New York for state and local premium taxes ML of New York must pay when a
payment is accepted.
17
<PAGE>
Although chargeable to each payment, ML of New York advances the amount of the
deferred contract loading to the investment divisions as part of a contract
owner's investment base. It then takes back these funds in equal installments on
the ten contract anniversaries following the date a payment is received and
accepted. This means that an amount equal to .90% of each payment is deducted
from the investment base on each of the ten contract anniversaries following the
payment. However, in determining a Contract's net cash surrender value, ML of
New York subtracts from the investment base the balance of the deferred contract
loading which is chargeable to any payment made but which has not yet been
deducted. Thus, this balance is deducted in determining the amount payable on
surrender of the Contract.
During the period that the deferred contract loading is included in the
investment base, a positive net rate of return will give greater increases in
net cash surrender value and a negative net rate of return will give greater
decreases in net cash surrender value than if the loading had not been included
in the investment base.
For joint insureds, see the modifications to this subsection on page 48.
MORTALITY COST. ML of New York deducts a mortality cost from the investment
base on each processing date after the contract date. This charge compensates ML
of New York for the cost of providing life insurance coverage for the insured.
It is based on the underwriting class assigned to the insured, the insured's sex
and attained age and the Contract's net amount at risk.
To determine the mortality cost, ML of New York multiplies the current cost of
insurance rate by the Contract's net amount at risk (adjusted for interest at an
annual rate of 4%). The net amount at risk is the difference, as of the previous
processing date, between the death benefit and the cash surrender value.
Current cost of insurance rates may be equal to or less than the guaranteed cost
of insurance rates depending on the insured's underwriting class, sex and
attained age. For all insureds, current cost of insurance rates distinguish
between insureds in the simplified underwriting class and medical underwriting
class. For insureds age 20 and over, current cost of insurance rates also
distinguish between insureds in a smoker (standard) underwriting class and
insureds in a non-smoker underwriting class. For Contracts issued on insureds
under the same underwriting method, current cost of insurance rates are lower
for an insured in a non-smoker underwriting class than for an insured of the
same age and sex in a smoker (standard) underwriting class. Also, current cost
of insurance rates are lower for an insured in a medical underwriting class than
for a similarly situated insured in a simplified underwriting class. The
simplified current cost of insurance rates are higher because less underwriting
is performed and therefore more risk is incurred.
ML of New York guarantees that the current cost of insurance rates will never
exceed the maximum guaranteed rates shown in the Contract. The maximum
guaranteed rates for Contracts (other than those issued on a substandard basis)
do not exceed the rates based on the 1980 Commissioners Standard Ordinary
Mortality Table (CSO Table). ML of New York may use rates that are equal to or
less than these rates, but never greater. The maximum rates for Contracts issued
on a substandard basis are based on a multiple of the 1980 CSO Table. Any change
in the cost of insurance rates will apply to all insureds of the same age, sex
and underwriting class whose Contracts have been in force for the same length of
time.
During the period between processing dates, the net cash surrender value takes
the mortality cost into account on a pro-rated basis. Thus, a pro-rata portion
of the mortality cost is deducted in determining the amount payable on surrender
of the Contract if the date of surrender is not a processing date.
For joint insureds, see the modifications to this subsection on page 48.
MAXIMUM MORTALITY COST. During the guarantee period, ML of New York limits the
deduction for mortality cost if investment results are unfavorable. This is done
by substituting the fixed base for the cash surrender value in determining the
net amount at risk and by multiplying by the guaranteed cost of insurance rate.
ML of New York will deduct this alternate amount from the investment base when
it is less than the mortality cost that would have otherwise been deducted. In
effect, during the guarantee period,
18
<PAGE>
a contract owner will not be charged for mortality costs that are greater than
those for a comparable fixed contract, based on 4% interest and the same
guaranteed cost of insurance rates. (See "The Contract's Fixed Base" on page
20.)
NET LOAN COST. The net loan cost is explained under "Loans" on page 20.
CHARGES TO THE SEPARATE ACCOUNT
Each day ML of New York deducts an asset charge from each division of the
Separate Account. The total amount of this charge is computed at .90% annually
at the beginning of the year. Of this amount, .75% is for
- the risk assumed by ML of New York that insureds as a group will live for
a shorter time than actuarial tables predict. As a result, ML of New York
would be paying more in death benefits than planned; and
- the risk assumed by ML of New York that it will cost more to issue and
administer the Contracts than expected.
The remaining amount, .15%, is for
- the risks assumed by ML of New York with respect to potentially
unfavorable investment results. One risk is that the Contract's cash
surrender value cannot cover the charges due during the guarantee period.
The other risk is that ML of New York may have to limit the deduction for
mortality cost (see "Maximum Mortality Cost" on page 18).
The total charge may not be increased. ML of New York will realize a gain from
this charge to the extent it is not needed to provide for benefits and expenses
under the Contracts.
CHARGES TO DIVISIONS INVESTING IN THE ZERO TRUSTS. ML of New York assesses a
daily trust charge against the assets of each division investing in the Zero
Trusts. This charge reimburses ML of New York for the transaction charge paid to
MLPF&S when units are sold to the Separate Account.
The trust charge is currently equivalent to .34% annually at the beginning of
the year. It may be increased, but will not exceed .50% annually at the
beginning of the year. The charge is based on cost (taking into account our loss
of interest) with no expected profit.
TAX CHARGES. ML of New York has the right under the Contract to impose a charge
against Separate Account assets for its taxes, if any. Such a charge is not
currently imposed, but it may be in the future. However, see page 17 for a
discussion of tax charges included in deferred contract loading.
GUARANTEE PERIOD
ML of New York guarantees that the Contract will stay in force for the guarantee
period. The guarantee period will be affected by a requested change in the face
amount and may also be affected by additional payments. Each payment will extend
the guarantee period until such time as it is guaranteed for the insured's life.
A partial withdrawal may affect the guarantee period in certain circumstances.
ML of New York will not cancel the Contract during the guarantee period unless
the debt exceeds certain contract values. (See "Loans" on page 20.) A reserve is
held in ML of New York's general account to support this guarantee.
WHEN THE GUARANTEE PERIOD IS LESS THAN FOR LIFE. After the end of the guarantee
period, ML of New York will cancel the Contract if the cash surrender value on a
processing date is negative. This negative cash surrender value will be
considered an overdue charge. (See "Charges Deducted from the Investment Base"
on page 17.)
ML of New York will notify the contract owner before cancelling the Contract. He
or she will then have 61 days to pay the charges due on the processing date when
the cash surrender value became negative. ML of New York will cancel the
Contract at the end of this grace period if payment has not yet been received.
19
<PAGE>
If ML of New York cancels a Contract, it may be reinstated while the insured is
still living if:
-the reinstatement is requested within three years after the end of the
grace period;
-ML of New York receives satisfactory evidence of insurability; and
-the reinstatement payment is paid. The reinstatement payment is the minimum
payment for which ML of New York would then issue a Contract for the
minimum guarantee period with the same face amount as the original
Contract, based on the insured's attained age and underwriting class as of
the effective date of the reinstated Contract.
A reinstated Contract will be effective on the processing date on or next
following the date the reinstatement application is approved.
For joint insureds, see the modifications to this section on page 49.
THE CONTRACT'S FIXED BASE. On the contract date, the fixed base equals the cash
surrender value. From then on, the fixed base is calculated like the cash
surrender value except that the calculation substitutes 4% for the net rate of
return, the guaranteed maximum cost of insurance rates are substituted for the
current rates and it is calculated as though there had been no loans or
repayments. The fixed base is equivalent to the cash surrender value for a
comparable fixed benefit contract with the same face amount and guarantee
period. After the guarantee period, the fixed base is zero. The fixed base is
used to limit the mortality cost deduction and ML of New York's right to cancel
the Contract during the guarantee period.
NET CASH SURRENDER VALUE
A Contract's net cash surrender value fluctuates daily with the investment
results of the investment divisions selected. ML of New York doesn't guarantee
any minimum net cash surrender value. On a processing date which is also a
contract anniversary, the net cash surrender value equals:
-the Contract's investment base on that date;
-minus the balance of the deferred contract loading which has not yet been
deducted from the investment base (see "Deferred Contract Loading" on page
17).
If the date of calculation is not a processing date, the net cash surrender
value is calculated in a similar manner but ML of New York also subtracts a
pro-rata portion of the mortality cost which would otherwise be deducted on the
next processing date. And, if there is any existing debt, ML of New York will
also subtract a pro-rata net loan cost on dates other than the contract
anniversary.
CANCELLING TO RECEIVE NET CASH SURRENDER VALUE. A contract owner may cancel the
Contract at any time while the insured is living. The request must be in writing
in a form satisfactory to ML of New York. All rights to death benefits will end
on the date the written request is sent to ML of New York.
The contract owner will then receive the net cash surrender value. The contract
owner may elect to receive this amount either in a single payment or under one
or more income plans described on page 27. The net cash surrender value will be
determined upon receipt of the written request at the Service Center.
For joint insureds, see the modifications to this subsection on page 49.
LOANS
Contract owners may use the Contract as collateral to borrow funds from ML of
New York. The minimum loan is $200 unless the contract owner is borrowing to
make a payment on another ML of New York variable life insurance contract. In
that case, the contract owner may borrow the exact amount required even if it's
less than $200. Contract owners may repay all or part of the loan any time
during the insured's lifetime. Each repayment must be for at least $200 or the
amount of the debt, if less. Loan repayments will first be allocated to loans
above the target loan amount and then to loans from the target loan amount. (See
"Target Loan Amount" on page 21.)
When a loan is taken, ML of New York transfers a portion of the contract owner's
investment base equal to the amount borrowed out of the investment divisions and
holds it as collateral in its general account.
20
<PAGE>
When a loan repayment is made, ML of New York transfers an amount equal to the
repayment from the general account to the investment divisions. The contract
owner may select from which divisions borrowed amounts should be taken and which
divisions should receive repayments (including interest payments). Otherwise, ML
of New York will take the borrowed amounts proportionately from and make
repayments proportionately to the contract owner's investment base as then
allocated in the investment divisions.
If a contract owner has the CMA Insurance Service, loans may be transferred to
and loan repayments transferred from his or her CMA account.
EFFECT ON DEATH BENEFIT AND CASH SURRENDER VALUE. Whether or not a loan is
repaid, taking a loan will have a permanent effect on a Contract's cash
surrender value and may have a permanent effect on its death benefit. This is
because the collateral for a loan does not participate in the performance of the
investment divisions while the loan is outstanding. If the amount credited to
the collateral is more than what is earned in the investment divisions, the cash
surrender value will be higher as a result of the loan, as may be the death
benefit. Conversely, if the amount credited is less, the cash surrender value
will be lower, as may be the death benefit. In that case, the lower cash
surrender value may cause the Contract to lapse sooner than if no loan had been
taken.
LOAN VALUE. The loan value of a Contract equals 90% of its cash surrender
value. The sum of all outstanding loan amounts plus accrued interest is called
debt. The maximum amount that can be borrowed at any time is the difference
between the loan value and the debt. The cash surrender value is the net cash
surrender value plus any debt.
TARGET LOAN AMOUNT. A loan is deemed to first be taken from the target loan
amount, if any, and then from amounts above the target loan amount. The target
loan amount is equal to the investment base at the time a loan is made, plus
prior loans not repaid, plus prior withdrawals made, less the initial and any
additional payments made.
INTEREST. While a loan is outstanding, ML of New York charges interest of 6%
annually. Interest accrues each day and payments are due at the end of each
contract year. If the interest isn't paid when due, it is added to the
outstanding loan amount. Interest paid on a loan may not be tax-deductible.
The amount held in ML of New York's general account as collateral for a loan
earns interest at a minimum of 4% annually. The amount held in ML of New York's
general account as collateral for loans taken up to the target loan amount
currently earns interest at 6% annually.
NET LOAN COST. On each contract anniversary, ML of New York reduces the
investment base by the net loan cost (the difference between the interest
charged and the earnings on the amount held as collateral in the general
account) and adds that amount to the amount held in the general account as
collateral for the loan. Since the interest charged and the collateral earnings
on the target loan amount currently are both 6% annually, there is no net loan
cost on loaned amounts up to the target loan amount. Since the interest charged
on amounts above the target loan amount is 6% and the collateral earnings on
such amounts are 4%, the net loan cost on loaned amounts above the target loan
amount is 2%. The net loan cost is taken into account in determining the net
cash surrender value of the Contract if the date of surrender is not a contract
anniversary.
CANCELLATION DUE TO EXCESS DEBT. If the debt exceeds the larger of the cash
surrender value and the fixed base on a processing date, ML of New York will
cancel the Contract 61 days after a notice of intent to terminate the Contract
is mailed to the contract owner unless ML of New York has received at least the
minimum repayment amount specified in the notice. If the Contract lapses with a
loan outstanding, adverse tax consequences may result. (See "Tax Considerations"
on page 29.)
PARTIAL WITHDRAWALS
Currently, after a Contract is in force for fifteen years, a contract owner may
make partial withdrawals by submitting a request in a form satisfactory to ML of
New York. The effective date of the withdrawal is the
21
<PAGE>
date a withdrawal request is received at the Service Center. Contract owners may
elect to receive the withdrawal amount either in a single payment or, subject to
ML of New York's rules, under one or more income plans.
Contract owners may make one partial withdrawal each contract year. The minimum
amount for each partial withdrawal is $500. The maximum amount of each partial
withdrawal is set forth below.
<TABLE>
<CAPTION>
CONTRACT YEAR MAXIMUM
- ------------------- -----------
<S> <C>
16................. 25% of payments made
17................. 50%
18................. 75%
19+................ 100%
</TABLE>
The amount of any partial withdrawal may not exceed the loan value less any
debt. The total amount of partial withdrawals may not exceed the amount of the
initial payment plus any additional payments made under the Contract. A partial
withdrawal may not be repaid.
EFFECT ON INVESTMENT BASE, FIXED BASE AND DEATH BENEFIT. As of the effective
date of the withdrawal, the investment base and fixed base will be reduced by
the amount of the partial withdrawal. ML of New York allocates this reduction
proportionately to the investment base in the contract owner's investment
divisions unless notified otherwise. The variable insurance amount will also
reflect the partial withdrawal as of the effective date.
EFFECT ON GUARANTEED BENEFITS. As of the processing date on or next following a
partial withdrawal, ML of New York reduces the Contract's face amount. This is
done by taking the fixed base as of that processing date and determining what
face amount that fixed base would support for the Contract's guarantee period.
If this produces a face amount below the minimum face amount for the Contract,
ML of New York will reduce the face amount to that minimum and reduce the
guarantee period, based on the reduced face amount, the fixed base and the
insured's sex, attained age and underwriting class. The minimum face amount for
a Contract is the greater of the minimum face amount for which ML of New York
would then issue the Contract, based on the insured's sex, attained age and
underwriting class, and the minimum amount required to keep the Contract
qualified as life insurance under applicable tax law. For a discussion of the
effect of partial withdrawals on a Contract's guaranteed benefits, see "Partial
Withdrawals" in the Examples on page 46.
A partial withdrawal may affect compliance with the 7-pay test. For a discussion
of the tax issues associated with a partial withdrawal, see "Tax Considerations"
on page 29.
Partial withdrawals are not available under a joint insureds Contract.
DEATH BENEFIT PROCEEDS
ML of New York will pay the death benefit proceeds to the beneficiary upon
receipt of all information needed to process the payment, including due proof of
the insured's death.
AMOUNT OF DEATH BENEFIT PROCEEDS. The death benefit proceeds are equal to the
death benefit, which is the larger of the current face amount and the variable
insurance amount, less any debt. The death benefit proceeds will also include
any amounts payable under any riders.
The values used in calculating the death benefit proceeds are as of the date of
death. The death benefit will never be less than the amount required to keep the
Contract qualified as life insurance under federal income tax laws. If the
insured dies during the grace period, the death benefit proceeds equal the death
benefit proceeds in effect immediately prior to the grace period reduced by any
overdue charges. (See "When the Guarantee Period is Less Than for Life" on page
19.)
VARIABLE INSURANCE AMOUNT. ML of New York determines the variable insurance
amount daily by:
-calculating the cash surrender value; and
-multiplying by the net single premium factor (explained below).
The variable insurance amount will never be less than required by federal tax
law.
22
<PAGE>
NET SINGLE PREMIUM FACTOR. The net single premium factor is used to determine
the amount of death benefit purchased by $1.00 of cash surrender value. It is
based on the insured's sex, underwriting class and attained age on the date of
calculation. It decreases daily as the insured's age increases. As a result, the
variable insurance amount as a multiple of the cash surrender value will
decrease over time. Also, net single premium factors may be higher for a woman
than for a man of the same age. A table of net single premium factors as of each
anniversary is included in the Contract.
TABLE OF ILLUSTRATIVE NET SINGLE PREMIUM FACTORS
ON ANNIVERSARIES
STANDARD UNDERWRITING CLASS
<TABLE>
<CAPTION>
ATTAINED
AGE MALE FEMALE
-------- -------- --------
<S> <C> <C>
5 10.26605 12.37298
15 7.41158 8.96292
25 5.50384 6.48170
35 3.97197 4.64894
45 2.87749 3.36465
55 2.14058 2.48940
65 1.65786 1.87562
75 1.35394 1.45952
85 1.18029 1.21265
</TABLE>
For joint insureds, see the modifications to this section on page 47.
PAYMENT OF DEATH BENEFIT PROCEEDS
ML of New York will generally pay the death benefit proceeds to the beneficiary
within seven days after all the information needed to process the payment is
received at its Service Center.
ML of New York will add interest from the date of the insured's death to the
date of payment at an annual rate of at least 4%. The beneficiary may elect to
receive the proceeds either in a single payment or under one or more income
plans described on page 27. Payment may be delayed if the Contract is being
contested or under the circumstances described in "Using the Contract" on page
24 and "Other Contract Provisions" on page 26.
For joint insureds, see the modifications to this section on page 49.
RIGHT TO CANCEL ("FREE LOOK" PERIOD) OR EXCHANGE
A contract owner may cancel his or her Contract during the "free look" period by
returning it for a refund. The "free look" period ends ten days after the
Contract is received. To cancel the Contract during the "free look" period, the
contract owner must mail or deliver the Contract to ML of New York's Service
Center or to the registered representative who sold it. ML of New York will
refund the payment made without interest. If cancelled, ML of New York may
require the contract owner to wait six months before applying again.
EXCHANGING THE CONTRACT. Contract owners may exchange their Contracts at any
time for a contract with benefits that do not vary with the investment results
of a separate account. A request to exchange must be in writing. Also, the
original Contract must be returned to ML of New York's Service Center.
The new contract will have the same owner, insured, and beneficiary as those of
the original Contract on the date of the exchange. It will have the same issue
age, issue date, face amount, cash surrender value, benefit riders and
underwriting class as the original Contract on the date of the exchange. Any
debt will be carried over to the new contract.
ML of New York will not require evidence of insurability to exchange for a new
contract.
For joint insureds, see the modifications to this section on page 49.
23
<PAGE>
REPORTS TO CONTRACT OWNERS
After the end of each processing period, contract owners will be sent a
statement of the allocation of their investment base, death benefit, cash
surrender value, any debt and, if there has been a change, the new face amount
and guarantee period. All figures will be as of the end of the immediately
preceding processing period. The statement will show the amounts deducted from
or added to the investment base during the processing period. The statement will
also include any other information that may be currently required by a contract
owner's state.
Contract owners will receive confirmation of all financial transactions. Such
confirmations will show the price per unit of each of the contract owner's
investment divisions, the number of units a contract owner has in the investment
division and the value of the investment division computed by multiplying the
quantity of units by the price per unit. (See "Net Rate of Return for an
Investment Division" on page 33.) The sum of the values in each investment
division is a contract owner's investment base.
Contract owners will also be sent an annual and a semi-annual report containing
financial statements and a list of portfolio securities of the Series Fund and
the Variable Series Funds, as required by the Investment Company Act of 1940.
CMA ACCOUNT REPORTING. Contract owners who have the CMA Insurance Service will
have certain Contract information included as part of their regular monthly CMA
account statement. It will list the investment base allocation, death benefit,
net cash surrender value, debt and any CMA account activity affecting the
Contract during the month.
MORE ABOUT THE CONTRACT
USING THE CONTRACT
OWNERSHIP. The contract owner is usually the insured, unless another owner has
been named in the application. The contract owner has all rights and options
described in the Contract.
The contract owner may want to name a contingent owner. If the contract owner
dies before the insured, the contingent owner will own the contract owner's
interest in the Contract and have all the contract owner's rights. If the
contract owner does not name a contingent owner, the contract owner's estate
will own the contract owner's interest in the Contract upon the owner's death.
If there is more than one contract owner, Merrill Lynch Life will treat the
owners as joint tenants with rights of survivorship unless the ownership
designation provides otherwise. The owners must exercise their rights and
options jointly, except that any one of the owners may reallocate the Contract's
investment base by phone if the owner provides the personal identification
number as well as the Contract number. One contract owner must be designated, in
writing, to receive all notices, correspondence and tax reporting to which
contract owners are entitled under the Contract.
CHANGING THE OWNER. During the insured's lifetime, the contract owner has the
right to transfer ownership of the Contract. The new owner will have all rights
and options described in the Contract. The change will be effective as of the
day the notice is signed, but will not affect any payment made or action taken
by ML of New York before receipt of the notice of the change at the Service
Center. Changing the owner may have tax consequences. (See "Tax Considerations"
on page 29.)
ASSIGNING THE CONTRACT AS COLLATERAL. Contract owners may assign the Contract
as collateral security for a loan or other obligation. This does not change the
ownership. However, the contract owner's rights and any beneficiary's rights are
subject to the terms of the assignment. Contract owners must give satisfactory
written notice at the Service Center in order to make or release an assignment.
ML of New York is not responsible for the validity of any assignment.
For a discussion of the tax issues associated with a collateral assignment, see
"Tax Considerations" on page 29.
24
<PAGE>
NAMING BENEFICIARIES. ML of New York will pay the primary beneficiary the death
benefit proceeds of the Contract on the insured's death. If the primary
beneficiary has died, ML of New York will pay the contingent beneficiary. If no
contingent beneficiary is living, ML of New York will pay the insured's estate.
A contract owner may name more than one person as primary or contingent
beneficiaries. ML of New York will pay proceeds in equal shares to the surviving
beneficiary unless the beneficiary designation provides otherwise.
A contract owner has the right to change beneficiaries during the insured's
lifetime, unless the primary beneficiary designation has been made irrevocable.
If the designation is irrevocable, the primary beneficiary must consent when
certain rights and options are exercised under this Contract. If the beneficiary
is changed, the change will take effect as of the day the notice is signed, but
will not affect any payment made or action taken by ML of New York before
receipt of the notice of the change at the Service Center.
CHANGING THE INSURED. If permitted by state regulation, and subject to certain
requirements, contract owners may request a change of insured once each contract
year. ML of New York must receive a written request from the contract owner and
the proposed new insured. Neither the original nor the new insured can have
attained ages as of the effective date of the change less than 21 or more than
75. ML of New York will also require evidence of insurability for the proposed
new insured. If the request for change is approved, insurance coverage on the
new insured will take effect on the processing date on or next following the
date of approval, provided the new insured is still living.
The Contract will be changed as follows on the effective date:
- the issue age will be the new insured's issue age (the new insured's age
as of the birthday nearest the contract date);
- the guaranteed maximum cost of insurance rates will be those in effect on
the contract date for the new insured's issue age, sex and underwriting
class;
- a charge for changing the insured will be deducted from the Contract's
investment base on the effective date. This charge will also be reflected
in the Contract's fixed base.The charge will equal $1.50 per $1,000 of
face amount with a minimum charge of $200 and a maximum of $1,500. This
charge may be reduced in certain group or sponsored arrangements as
described on page 28;
- the variable insurance amount will reflect the change of insured; and
- the Contract's issue date will be the effective date of the change.
The face amount or guarantee period may also change on the effective date
depending on the new insured's age, sex and underwriting class. The new
guarantee period cannot be less than the minimum guarantee period for which ML
of New York would then issue a Contract based on the new insured's attained age
as of the effective date of the change.
This option is not available for joint insureds.
For a discussion of the tax issues associated with changing the insured, see
"Tax Considerations" on page 29.
MATURITY PROCEEDS. The maturity date is the anniversary nearest the insured's
100th birthday. On the maturity date, ML of New York will pay the net cash
surrender value to the contract owner, provided the insured is still living and
the Contract is in effect at that time.
HOW ML OF NEW YORK MAKES PAYMENTS. ML of New York generally pays death benefit
proceeds, partial withdrawals, loans and net cash surrender value on
cancellation from the Separate Account within seven days after the Service
Center receives all the information needed to process the payment.
However, it may delay payment from the Separate Account if it isn't practical
for ML of New York to value or dispose of Trust units, Series Fund shares or
Variable Series Funds shares because:
- the New York Stock Exchange is closed, other than for a customary weekend
or holiday; or
25
<PAGE>
- trading on the New York Stock Exchange is restricted by the Securities and
Exchange Commission; or
- the Securities and Exchange Commission declares that an emergency exists
such that it is not reasonably practical to dispose of securities held in
the Separate Account or to determine the value of their assets.
For joint insureds, see the modifications to this section on page 49.
SOME ADMINISTRATIVE PROCEDURES
Described below are certain administrative procedures. ML of New York reserves
the right to modify them or to eliminate them. For administrative and tax
purposes, ML of New York may from time to time require that specific forms be
completed in order to accomplish certain transactions, including surrenders.
PERSONAL IDENTIFICATION NUMBER. ML of New York will send each contract owner a
four-digit personal identification number ("PIN") shortly after the Contract is
placed in force and before the end of the "free look" period. This number must
be given when a contract owner calls the Service Center to get information about
the Contract, to make a loan (if an authorization is on file), or to make other
requests. Unless the contract owner has preallocated the Contract's investment
base, the personal identification number will be accompanied by a notice
reminding the contract owner that all of the investment base is in the division
investing in the Money Reserve Portfolio and that this allocation may be changed
by calling or writing to the Service Center. (See "Changing the Allocation" on
page 17.)
REALLOCATING THE INVESTMENT BASE. Contract owners can reallocate their
investment base either in writing in a form satisfactory to ML of New York or by
phone. If the reallocation is requested by phone, contract owners must give
their personal identification number as well as their Contract number. ML of New
York will give a confirmation number over the phone and then follow up in
writing.
REQUESTING A LOAN. A loan may be requested in writing in a form satisfactory to
ML of New York or, if all required authorization forms are on file, by phone.
Once the authorization has been received at the Service Center, contract owners
can call the Service Center, give their Contract number, name and personal
identification number, and tell ML of New York the loan amount and from which
divisions the loan should be taken.
Upon request, ML of New York will wire the funds to the account at the financial
institution named on the contract owner's authorization. ML of New York will
generally wire the funds within two working days of the receipt of the request.
If the contract owner has the CMA Insurance Service, funds may be transferred
directly to that CMA account.
REQUESTING PARTIAL WITHDRAWALS. Partial withdrawals may be requested in writing
in a form satisfactory to ML of New York. A contract owner may request a partial
withdrawal by phone if all required phone authorization forms are on file. Once
the authorization has been received at the Service Center, contract owners can
call the Service Center, give their Contract number, name and personal
identification number, and tell ML of New York how much to withdraw and from
which investment divisions.
Upon request, ML of New York will wire the funds to the account at the financial
institution named on the contract owner's authorization. ML of New York will
generally wire the funds within two working days of receipt of the request. If
the contract owner has the CMA Insurance Service, funds may be transferred
directly to that CMA account.
TELEPHONE REQUESTS. A telephone request for a loan, partial withdrawal or a
reallocation received before 4 p.m. (ET) generally will be processed the same
day. A request received at or after 4 p.m. (ET) will be processed the following
business day. ML of New York reserves the right to change or discontinue
telephone transfer procedures.
26
<PAGE>
OTHER CONTRACT PROVISIONS
IN CASE OF ERRORS IN THE APPLICATION. If an age or sex given in the application
is wrong, it could mean that the face amount or any other Contract benefit is
wrong. ML of New York will pay what the payments made would have bought for the
guarantee period at the true age or sex.
INCONTESTABILITY. ML of New York will rely on statements made in the
applications. Legally, they are considered representations, not warranties. ML
of New York can contest the validity of a Contract if any material misstatements
are made in the initial application. ML of New York can also contest the
validity of any change in face amount requested if any material misstatements
are made in any application required for that change. ML of New York can also
contest any amount of death benefit which would not be payable except for the
fact that an additional payment which requires evidence of insurability was made
if any material misstatements are made in the application required with the
additional payment.
ML of New York will not contest the validity of a Contract after it has been in
effect during the insured's lifetime for two years from the date of issue. Any
change in face amount will not be contested after the change has been in effect
during the insured's lifetime for two years from the date of the change. Nor
will ML of New York contest any amount of death benefit attributable to an
additional payment which requires evidence of insurability after the death
benefit has been in effect during the insured's lifetime for two years from the
date the payment was received and accepted.
PAYMENT IN CASE OF SUICIDE. If the insured commits suicide within two years
from the Contract's issue date, ML of New York will pay only a limited death
benefit. The benefit will be equal to the amount of the payments made.
If the insured commits suicide within two years of the effective date of any
increase in face amount requested, any amount of death benefit which would not
be payable except for the fact that the face amount was increased will be
limited to the amount of mortality cost deductions made for the increase.
If the insured commits suicide within two years of any date an additional
payment is received and accepted, any amount of death benefit which would not be
payable except for the fact that the additional payment was made will be limited
to the amount of the payment.
The death benefit will be reduced by any debt.
CONTRACT CHANGES - APPLICABLE FEDERAL TAX LAW. To receive the tax treatment
accorded to life insurance under federal income tax law, the Contract must
qualify initially and continue to qualify as life insurance under the Internal
Revenue Code or successor law. Therefore, to maintain this qualification to the
maximum extent of the law, ML of New York reserves the right to return any
additional payments that would cause the Contract to fail to qualify as life
insurance under applicable tax law as interpreted by ML of New York. Further, ML
of New York reserves the right to make changes in the Contract or its riders or
to make distributions from the Contract to the extent it is necessary to
continue to qualify the Contract as life insurance. Any changes will apply
uniformly to all Contracts that are affected and contract owners will be given
advance written notice of such changes.
For joint insureds, see the modifications to this section on page 50.
INCOME PLANS
ML of New York offers several income plans to provide for payment of the death
benefit proceeds to the beneficiary. The contract owner may choose one or more
income plans at any time during the insured's lifetime. If no plan has been
chosen when the insured dies, the beneficiary has one year to apply the death
benefit proceeds either paid or payable to that beneficiary to one or more of
the plans. The contract owner may also choose one or more income plans if the
Contract is cancelled for its net cash surrender value or a partial withdrawal
is taken. ML of New York's approval is needed for any plan where any income
payment would be less than $100. Payments under these plans do not depend on the
investment results of a separate account.
For joint insureds, see the modifications to this section on page 51.
27
<PAGE>
Income plans include:
ANNUITY PLAN. An amount can be used to purchase a single premium
immediate certain annuity. (Annuity purchase rates will be 3% less than for
new annuitants.)
INTEREST PAYMENT. Amounts can be left with ML of New York to earn
interest at an annual rate of at least 3%. Interest payments can be made
annually, semi-annually, quarterly or monthly.
INCOME FOR A FIXED PERIOD. Payments are made in equal installments for
a fixed number of years.
INCOME FOR LIFE. Payments are made in equal monthly installments until
death of a named person or end of a designated period, whichever is later.
The designated period may be for 10 or 20 years.
INCOME OF A FIXED AMOUNT. Payments are made in equal installments until
proceeds applied under the option and interest on unpaid balance at not less
than 3% per year are exhausted.
JOINT LIFE INCOME. Payments are made in monthly installments as long as
at least one of two named persons is living. While both are living, full
payments are made. If one dies, payments at two-thirds of the full amount
are made. Payments end completely when both named persons die.
Once in effect, some of the plans may not provide any surrender rights.
GROUP OR SPONSORED ARRANGEMENTS
For certain group or sponsored arrangements, ML of New York may reduce the sales
load, cost of insurance rates and the minimum payment and may modify
underwriting classifications and requirements.
Group arrangements include those in which a trustee or an employer, for example,
purchases Contracts covering a group of individuals on a group basis. Sponsored
arrangements include those in which an employer allows ML of New York to sell
Contracts to its employees on an individual basis.
Costs for sales, administration, and mortality generally vary with the size and
stability of the group and the reasons the Contracts are purchased, among other
factors. ML of New York takes all these factors into account when reducing
charges. To qualify for reduced charges, a group or sponsored arrangement must
meet certain requirements, including requirements for size and number of years
in existence. Group or sponsored arrangements that have been set up solely to
buy Contracts or that have been in existence less than six months will not
qualify for reduced charges.
ML of New York makes any reductions according to rules in effect when an
application for a Contract or additional payment is approved. It may change
these rules from time to time. However, reductions in charges will not
discriminate unfairly against any person.
UNISEX LEGAL CONSIDERATIONS FOR EMPLOYERS
In 1983 the Supreme Court held in ARIZONA GOVERNING COMMITTEE V. NORRIS that
optional annuity benefits provided under an employee's deferred compensation
plan could not, under Title VII of the Civil Rights Act of 1964, vary between
men and women. In addition, legislative, regulatory or decisional authority of
some states may prohibit use of sex-distinct mortality tables under certain
circumstances.
The Contracts offered by this Prospectus are based on mortality tables that
distinguish between men and women. As a result, the Contract pays different
benefits to men and women of the same age. Employers and employee organizations
should check with their legal advisers before purchasing these Contracts.
SELLING THE CONTRACTS
Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S") is the principal
underwriter of the Contract. It was organized in 1958 under the laws of the
state of Delaware and is registered as a broker-dealer under the Securities
Exchange Act of 1934. It is a member of the National Association of Securities
Dealers, Inc. ("NASD"). The principal business address of MLPF&S is World
Financial Center, 250 Vesey
28
<PAGE>
Street, New York, New York 10281. MLPF&S also acts as principal underwriter of
other variable life insurance and variable annuity contracts issued by ML of New
York, as well as variable life insurance and variable annuity contracts issued
by Merrill Lynch Life Insurance Company, an affiliate of ML of New York. MLPF&S
also acts as principal underwriter of certain mutual funds managed by MLAM, the
investment adviser for the Series Fund and the Variable Series Funds.
Contracts are sold by registered representatives of MLPF&S who are also licensed
through Merrill Lynch Life Agency, Inc. as insurance agents for ML of New York.
ML of New York has entered into a distribution agreement with MLPF&S and a
companion sales agreement with Merrill Lynch Life Agency, Inc. through which
agreements the Contracts and other variable life insurance contracts issued
through the Separate Account are sold and the registered representatives are
compensated by Merrill Lynch Life Agency, Inc. and/or MLPF&S.
The maximum commission ML of New York will pay to Merrill Lynch Life Agency,
Inc. to be used to pay Contract commissions to registered representatives is
9.5% of each Contract premium. Additional annual compensation of no more than
0.10% of the Contract's investment base may also be paid to the registered
representatives. Commissions may be paid in the form of non-cash compensation.
If the contract owner has also purchased the single premium immediate annuity
certain rider (SPIAR) to fund his or her Contract the maximum commission ML of
New York will pay to Merrill Lynch Life Agency, Inc. to be used to pay SPIAR
commissions to registered representatives is 3.5% of each SPIAR premium.
The amounts paid under the distribution and sales agreements related to
Contracts invested in the Separate Account for the years ended December 31, 1993
and December 31, 1992 were $143,207 and $226, respectively.
MLPF&S may arrange for sales of the Contract by other broker-dealers who are
registered under the Securities Exchange Act of 1934 and are members of the
NASD. Registered representatives of these other broker-dealers may be
compensated on a different basis than MLPF&S registered representatives.
TAX CONSIDERATIONS
DEFINITION OF LIFE INSURANCE. In order to qualify as a life insurance contract
for federal tax purposes, the Contract must meet the definition of a life
insurance contract which is set forth in Section 7702 of the Internal Revenue
Code of 1986, as amended (the "Code"). The Section 7702 definition can be met if
a life insurance contract satisfies either one of two tests that are contained
in that section. The manner in which these tests should be applied to certain
innovative features of the Contract offered in this Prospectus is not directly
addressed by Section 7702 or the proposed regulations issued thereunder. The
presence of these innovative Contract features, and the absence of final
regulations or any other pertinent interpretations of the tests, thus creates
some uncertainty about the application of the tests to the Contract.
ML of New York believes that the Contract qualifies as a life insurance contract
for federal tax purposes. This means that:
- the death benefit should be fully excludable from the gross income of the
beneficiary under Section 101(a)(1) of the Code; and
- the contract owner should not be considered in constructive receipt of the
cash surrender value, including any increases, until actual cancellation
of the Contract (see "Tax Treatment of Loans and Other Distributions" on
page 30).
Because of the absence of final regulations or any other pertinent
interpretations of the Section 7702 tests, it, however, is unclear whether
substandard risk Contracts or Contracts insuring more than one person will, in
all cases, meet the statutory life insurance contract definition. If a contract
were determined not to be a life insurance contract for purposes of Section
7702, such contract would not provide most of the tax advantages normally
provided by a life insurance contracts.
29
<PAGE>
ML of New York thus reserves the right to make changes in the Contract if such
changes are deemed necessary to attempt to assure its qualification as a life
insurance contract for tax purposes. (See "Contract Changes -- Applicable
Federal Tax Law" on page 27.)
DIVERSIFICATION. Section 817(h) of the Code provides that separate account
investments (or the investments of a mutual fund, the shares of which are owned
by separate accounts of insurance companies) underlying the Contract must be
"adequately diversified" in accordance with Treasury regulations in order for
the Contract to qualify as life insurance. The Treasury Department has issued
regulations prescribing the diversification requirements in connection with
variable contracts. The Separate Account, through the Series Fund and the
Variable Series Funds, intends to comply with these requirements. Although ML of
New York doesn't control the Series Fund or the Variable Series Funds, it
intends to monitor the investments of the Series Fund and the Variable Series
Funds to ensure compliance with the requirements prescribed by the Treasury
Department.
In connection with the issuance of the temporary diversification regulations,
the Treasury Department stated that it anticipates the issuance of regulations
or rulings prescribing the circumstances in which an owner's control of the
investments of a separate account may cause the owner, rather than the insurance
company, to be treated as the owner of the assets in the account. If the
contract owner is considered the owner of the assets of the Separate Account,
income and gains from the account would be included in the owner's gross income.
The ownership rights under the Contract offered in this Prospectus are similar
to, but different in certain respects from, those described by the Internal
Revenue Service in rulings in which it determined that the owners were not
owners of separate account assets. For example, the owner of the Contract has
additional flexibility in allocating payments and cash values. These differences
could result in the owner being treated as the owner of the assets of the
Separate Account. In addition, ML of New York does not know what standards will
be set forth in the regulations or rulings which the Treasury has stated it
expects to be issued. ML of New York therefore reserves the right to modify the
Contract as necessary to attempt to prevent the contract owner from being
considered the owner of the assets of the Separate Account.
TAX TREATMENT OF LOANS AND OTHER DISTRIBUTIONS. Federal tax law establishes a
class of life insurance contracts referred to as modified endowment contracts. A
modified endowment contract is any contract which satisfies the definition of
life insurance set forth in Section 7702 of the Code but fails to meet the 7-pay
test. This test applies a cumulative limit on the amount of payments that can be
made into a contract each year in the first seven contract years in order to
avoid modified endowment treatment. In effect, compliance with the 7-pay test
requires that contracts be purchased with a higher face amount for a given
initial payment than would otherwise be required, at a minimum, to meet the
definition of life insurance.
Pre-death distributions from contracts that comply with the 7-pay test will
generally not be included in gross income to the extent that the amount received
does not exceed the owner's investment in the contract. Loans from these
contracts will be considered indebtedness of an owner and no part of a loan will
constitute income to an owner. However, a lapse of a contract with an
outstanding loan will result in the treatment of the loan cancellation
(including the accrued interest) as a distribution under the contract and may be
taxable.
Any contract received in an exchange for a modified endowment contract will be
considered a modified endowment contract and will be subject to the tax
treatment accorded to modified endowment contracts that is described in the
Prospectus. A contract that is not originally classified as a modified endowment
contract can become so classified if there is a reduction in benefits during the
first seven contract years (including, for example, by a decrease in face
amount) or if a material change is made in the contract at any time. A material
change includes, but is not limited to, a change in the benefits that was not
reflected in a prior 7-pay test computation. This could result from additional
payments made after 7-pay test
30
<PAGE>
calculations done at the time of the contract exchange. Contract owners may
choose not to exercise their right to make additional payments (whether planned
or unplanned) in order to preserve their Contract's current tax treatment.
Contracts that do not satisfy the 7-pay test, including contracts which
initially satisfied the 7-pay test but later failed the test, will be considered
modified endowment contracts subject to the following distribution rules. Loans
from, as well as collateral assignments of, modified endowment contracts will be
treated as distributions to the contract owner. Furthermore, if the loan
interest is capitalized by adding the amount due to the balance of the loan, the
amount of the capitalized interest will be treated as a distribution which may
be subject to income tax, to the extent of the income in the contract. All
pre-death distributions (including loans and collateral assignments) from these
contracts will be included in gross income on an income-first basis to the
extent of any income in the contract (the cash surrender value less the contract
owner's investment in the contract) immediately before the distribution.
The law also imposes a 10% penalty tax on pre-death distributions (including
loans, capitalized interest, collateral assignments, partial withdrawals and
complete surrenders) from modified endowment contracts to the extent they are
included in income, unless such amounts are distributed on or after the taxpayer
attains age 59 1/2, because the taxpayer is disabled, or as substantially equal
periodic payments over the taxpayer's life (or life expectancy) or over the
joint lives (or joint life expectancies) of the taxpayer and his or her
beneficiary.
Compliance with the 7-pay test does not imply or guarantee that only seven
payments will be required for the initial death benefit to be guaranteed for
life. Although this Contract is specifically designed to comply with the 7-pay
test and ML of New York will modify the payment plan selected, if necessary, to
ensure that it complies with the test, certain actions by the contract owner
will affect the ability of ML of New York to provide such a plan. Following the
payment plan as originally established will ensure that the Contract will not be
treated as a modified endowment contract. However, making payments in addition
to the planned periodic payments established at the onset of the Contract
(including payments made in connection with an increase in face amount),
accelerating the payment schedules or reducing the benefits during the first
seven contract years, may violate the 7-pay test or, at a minimum, reduce the
amount that may be paid in the future under the 7-pay test. Further, in the case
of a Contract with joint insureds, reducing the death benefit below the lowest
death benefit provided by the Contract during the first seven years will require
retroactive retesting and will probably result in a failure of the 7-pay test
regardless of any efforts by ML of New York to provide a payment schedule that
will not violate the 7-pay test.
SPECIAL TREATMENT OF LOANS ON THE CONTRACT. If there is any borrowing against
the Contract, whether a modified endowment contract or not, the interest paid on
loans may not be tax deductible. There is a possibility that the part of the
loan equal to the target loan amount may be treated as subject to the rules of
Section 7872 of the Code. If so, the contract owner would be deemed to receive
imputed income. Futhermore, the contract owner would then be deemed to pay ML of
New York additional interest accrued on the loan, which interest may not be tax
deductible. While the application of the Section 7872 imputed interest rules to
these loans is far from certain, some possibility of their application does
exist.
AGGREGATION OF MODIFIED ENDOWMENT CONTRACTS. In the case of a pre-death
distribution (including a loan, partial withdrawal, collateral assignment or
complete surrender) from a contract that is treated as a modified endowment
contract under the rules described above, a special aggregation requirement may
apply for purposes of determining the amount of the income on the contract.
Specifically, if ML of New York or any of its affiliates issues to the same
contract owner more than one modified endowment contract within a calendar year,
then for purposes of measuring the income on the contract with respect to a
distribution from any of those contracts, the income on the contract for all
those contracts will be aggregated and attributed to that distribution.
TAXATION OF SINGLE PREMIUM IMMEDIATE ANNUITY RIDER. If a SPIAR is used to make
the payments on the Contract, a portion of each payment from the annuity will be
includible in income for federal tax purposes when distributed. The amount of
taxable income consists of the excess of the payment amount
31
<PAGE>
over the exclusion amount. The exclusion amount is defined as the payment amount
multiplied by the ratio of the investment in the annuity rider to the total
amount expected to be paid by ML of New York under the annuity.
If payments cease because of death before the investment in the annuity rider
has been fully recovered, a deduction is allowed for the unrecovered amount.
Moreover, if the payments continue beyond the time at which the investment in
the annuity rider has been fully recovered, the full amount of each payment will
be includible in income. If the SPIAR is surrendered before all of the scheduled
payments have been made by ML of New York, the remaining income in the annuity
rider will be taxed just as in the case of life insurance contracts.
Payments under an immediate annuity rider are not subject to the 10% penalty tax
that is generally applicable to distributions from annuities made before the
recipient attains age 59 1/2.
Other than the tax consequences described above, and assuming that the SPIAR is
not subjected to a pledge, loan or partial withdrawal, no income will be
recognized to the contract owner or beneficiary.
The SPIAR does not exist independently of a contract. Accordingly, there are tax
consequences if a contract with a SPIAR is assigned, transferred by gift, or
pledged. Owners of contracts with a SPIAR are advised to consult a tax advisor
prior to effecting an assignment, gift or pledge of the contract.
OTHER TRANSACTIONS. Changing the contract owner or the insured may have tax
consequences. Exchanging this Contract for another involving the same insured(s)
will have no tax consequences if there is no debt and no cash or other property
is received, according to Section 1035(a)(1) of the Code. The new contract would
have to satisfy the 7-pay test from the date of the exchange to avoid
characterization as a modified endowment contract. Changing the insured under
this Contract may not be treated as an exchange under Section 1035 but rather as
a taxable exchange.
OTHER TAXES. Federal estate and state and local estate, inheritance and other
taxes depend upon the contract owner's or the beneficiary's specific situation.
OWNERSHIP OF THIS CONTRACT BY NON-NATURAL PERSONS. The above discussion of the
tax consequences arising from the purchase, ownership and transfer of the
Contract has assumed that the owner of the Contract consists of one or more
individuals. Organizations exempt from taxation under Section 501(a) of the Code
may be subject to additional or different tax consequences with respect to
transactions such as contract loans. Further, organizations purchasing Contracts
covering the life of an individual who is an officer or employee, or is
financially interested in, the taxpayer's trade or business, may be unable to
deduct all or a portion of the interest or payments made with respect to the
Contract. Such organizations should obtain tax advice prior to the acquisition
of this Contract and also before entering into any subsequent changes to or
transactions under this Contract.
ML OF NEW YORK DOES NOT MAKE ANY GUARANTEE REGARDING THE TAX STATUS OF THE
CONTRACT OR ANY TRANSACTION REGARDING THE CONTRACT.
THE ABOVE DISCUSSION IS NOT INTENDED AS TAX ADVICE. FOR TAX ADVICE CONTRACT
OWNERS SHOULD CONSULT A COMPETENT TAX ADVISER. ALTHOUGH THIS TAX DISCUSSION IS
BASED ON ML OF NEW YORK'S UNDERSTANDING OF FEDERAL INCOME TAX LAWS AS THEY ARE
CURRENTLY INTERPRETED, IT CAN'T GUARANTEE THAT THOSE LAWS OR INTERPRETATIONS
WILL REMAIN UNCHANGED.
ML OF NEW YORK'S INCOME TAXES
As a result of the Omnibus Budget Reconciliation Act of 1990, insurance
companies are generally required to capitalize and amortize certain policy
acquisition expenses over a ten year period rather than currently deducting such
expenses. This treatment applies to the deferred acquisition expenses of a
Contract and will result in a significantly higher corporate income tax
liability for ML of New York in early contract years. ML of New York makes a
charge, which is included in the Contract's deferred contract loading, to
compensate ML of New York for the anticipated higher corporate income taxes that
result from the sale of a Contract. (See "Deferred Contract Loading" on page
17.)
32
<PAGE>
ML of New York makes no other charges to the Separate Account for any federal,
state or local taxes that it incurs that may be attributable to the Separate
Account or to the Contracts. ML of New York, however, reserves the right to make
a charge for any tax or other economic burden resulting from the application of
tax laws that it determines to be properly attributable to the Separate Account
or to the Contracts.
REINSURANCE
ML of New York intends to reinsure some of the risks assumed under the
Contracts.
MORE ABOUT THE SEPARATE ACCOUNT AND ITS DIVISIONS
ABOUT THE SEPARATE ACCOUNT
The Separate Account is registered with the Securities and Exchange Commission
under the Investment Company Act of 1940 as a unit investment trust. This
registration does not involve any supervision by the Securities and Exchange
Commission of ML of New York's management or the management of the Separate
Account. The Separate Account is also governed by the laws of the State of New
York, ML of New York's state of domicile.
ML of New York owns all of the assets of the Separate Account. These assets are
held separate and apart from all of ML of New York's other assets. ML of New
York maintains records of all purchases and redemptions of Series Fund, Variable
Series Funds and Zero Trust shares by each of the investment divisions.
CHANGES WITHIN THE ACCOUNT
ML of New York may from time to time make additional investment divisions
available to contract owners. These divisions will invest in investment
portfolios ML of New York finds suitable for the Contracts. ML of New York also
has the right to eliminate investment divisions from the Separate Account, to
combine two or more investment divisions, or to substitute a new portfolio for
the portfolio in which an investment division invests. A substitution may become
necessary if, in ML of New York's judgment, a portfolio no longer suits the
purposes of the Contracts. This may happen due to a change in laws or
regulations or in a portfolio's investment objectives or restrictions, or
because the portfolio is no longer available for investment, or for some other
reason. ML of New York would get prior approval from the New York State
Insurance Department and the Securities and Exchange Commission before making
such a substitution. It would also get any other required approvals before
making such a substitution.
Subject to any required regulatory approvals, ML of New York reserves the right
to transfer assets of the Separate Account or of any of the investment divisions
to another separate account or investment division.
When permitted by law, ML of New York reserves the right to:
- deregister the Separate Account under the Investment Company Act of 1940;
- operate the Separate Account as a management company under the Investment
Company Act of 1940;
- restrict or eliminate any voting rights of contract owners, or other
persons who have voting rights as to the Separate Account; and
- combine the Separate Account with other separate accounts.
NET RATE OF RETURN FOR AN INVESTMENT DIVISION
Each investment division has a distinct unit value (also referred to as "price"
or "separate account index" in reports furnished to the contract owner by ML of
New York). When payments or other amounts are allocated to an investment
division, a number of units are purchased based on the value of a unit of the
investment division as of the end of the valuation period during which the
allocation is made. When amounts are transferred out of, or deducted from, an
investment division, units are redeemed in a similar manner. A valuation period
is each business day together with any non-business days before it. A business
day is any day the New York Stock Exchange is open or there's enough trading in
portfolio securities to materially affect the net asset value of an investment
division.
33
<PAGE>
For each investment division, the separate account index was initially set at
$10.00. The separate account index for each subsequent valuation period
fluctuates based upon the net rate of return for that period. The net rate of
return reflects the investment performance of the division for the valuation
period and is net of the charges to the Separate Account described above.
For divisions investing in the Series Fund or the Variable Series Funds, shares
are valued at net asset value and reflect reinvestment of any dividends or
capital gains distributions declared by the Series Fund or the Variable Series
Funds.
For divisions investing in the Zero Trusts, units of each Zero Trust are valued
at the sponsor's repurchase price, as explained in the prospectus for the Zero
Trusts.
THE SERIES FUND AND THE VARIABLE SERIES FUNDS
BUYING AND REDEEMING SHARES. The Series Fund and the Variable Series Funds sell
and redeem their shares at net asset value. Any dividend or capital gain
distribution will be reinvested at net asset value in shares of the same
portfolio.
VOTING RIGHTS. ML of New York is the legal owner of all Series Fund and
Variable Series Funds shares held in the Separate Account. As the owner, ML of
New York has the right to vote on any matter put to vote at the Series Fund's
and Variable Series Funds' shareholder meetings. However, ML of New York will
vote all Series Fund and Variable Series Funds shares attributable to Contracts
according to instructions received from contract owners. Shares attributable to
Contracts for which no voting instructions are received will be voted in the
same proportion as shares in the respective investment divisions for which
instructions are received. Shares not attributable to Contracts will also be
voted in the same proportion as shares in the respective divisions for which
instructions are received. If any federal securities laws or regulations, or
their present interpretation, change to permit ML of New York to vote Series
Fund or Variable Series Funds shares in its own right, it may elect to do so.
ML of New York determines the number of shares that contract owners have in an
investment division by dividing their Contract's investment base in that
division by the net asset value of one share of the portfolio. Fractional votes
will be counted. ML of New York will determine the number of shares for which a
contract owner may give voting instructions 90 days or less before each Series
Fund or Variable Series Funds meeting. ML of New York will request voting
instruction by mail at least 14 days before the meeting.
Under certain circumstances, ML of New York may be required by state regulatory
authorities to disregard voting instructions. This may happen if following the
instructions would mean voting to change the sub-classification or investment
objectives of the portfolios, or to approve or disapprove an investment advisory
contract.
ML of New York may also disregard instructions to vote for changes in the
investment policy or the investment adviser if it disapproves of the proposed
changes. ML of New York would disapprove a proposed change only if it was:
- contrary to state law;
- prohibited by state regulatory authorities; or
- decided by management that the change would result in overly speculative
or unsound investments.
If ML of New York disregards voting instructions, it will include a summary of
its actions in the next semi-annual report.
RESOLVING MATERIAL CONFLICTS. Shares of the Series Fund are available for
investment by ML of New York, Merrill Lynch Life Insurance Company (an indirect
wholly owned subsidiary of Merrill Lynch & Co., Inc.) and Monarch Life Insurance
Company (an insurance company not affiliated with ML of New York or Merrill
Lynch & Co., Inc.). Shares of the Variable Series Funds are currently sold only
to separate accounts of ML of New York, Merrill Lynch Life Insurance Company and
Family Life Insurance Company (an insurance company not affiliated with ML of
New York or Merrill Lynch & Co., Inc.) to fund benefits under certain variable
life insurance and variable annuity contracts. The Basic Value Focus Fund, World
34
<PAGE>
Income Focus Fund, Global Utility Focus Fund, International Equity Focus Fund,
International Bond Fund and Developing Capital Markets Focus Fund are only
offered to separate accounts of ML of New York and Merrill Lynch Life Insurance
Company. The Equity Growth Fund is also offered to Family Life Insurance
Company.
It is possible that differences might arise between ML of New York's Separate
Account and one or more of the other separate accounts which invest in the
Series Fund or the Variable Series Funds. In some cases, it is possible that the
differences could be considered "material conflicts". Such a "material conflict"
could also arise due to changes in the law (such as state insurance law or
federal tax law) which affect these different variable life insurance and
variable annuity separate accounts. It could also arise by reason of difference
in voting instructions from ML of New York's contract owners and those of the
other insurance companies, or for other reasons. ML of New York will monitor
events to determine how to respond to such conflicts. If a conflict occurs, ML
of New York may be required to eliminate one or more investment divisions of the
Separate Account which invest in the Series Fund or the Variable Series Funds
substitute a new portfolio for a portfolio in which a division invests. In
responding to any conflict, ML of New York will take the action which it
believes necessary to protect its contract owners.
CHARGES TO SERIES FUND ASSETS
The Series Fund incurs operating expenses and pays a monthly advisory fee to
MLAM. This fee equals an annual rate of:
- .50% of the first $250 million of the aggregate average daily net assets
of the Series Fund;
- .45% of the next $50 million of such assets;
- .40% of the next $100 million of such assets;
- .35% of the next $400 million of such assets; and
- .30% of such assets over $800 million.
One or more of the insurance companies investing in the Series Fund has agreed
to reimburse the Series Fund so that the ordinary expenses of each portfolio
(which include the monthly advisory fee) do not exceed .50% of the portfolio's
average daily net assets. These companies have also agreed to reimburse MLAM for
any amounts it pays under the investment advisory agreement, as described below.
These reimbursement obligations will remain in effect so long as the advisory
agreement remains in effect and cannot be amended or terminated without Series
Fund approval.
Under its investment advisory agreement, MLAM has agreed that if any portfolio's
aggregate ordinary expenses (excluding interest, taxes, brokerage commissions
and extraordinary expenses) exceed the expense limitations for investment
companies in effect under any state securities law or regulation, it will reduce
its fee for that portfolio by the amount of the excess. If required, it will
reimburse the Series Fund for the excess. This reimbursement agreement will
remain in effect so long as the advisory agreement remains in effect and cannot
be amended without Series Fund approval.
CHARGES TO VARIABLE SERIES FUNDS ASSETS
The Variable Series Funds incurs operating expenses and pays a monthly advisory
fee to MLAM. This fee equals an annual rate of .60% of the average daily net
assets of the Basic Value Focus Fund, World Income Focus Fund and Global Utility
Focus Fund. This fee equals an annual rate of .75%, .60% and 1.00% of the
average daily net assets of the International Equity Focus Fund the
International Bond Fund and the Developing Capital Markets Focus Fund,
respectively.
Under its investment advisory agreement, MLAM has agreed to reimburse the
Variable Series Funds if and to the extent that in any fiscal year the operating
expenses of any Fund exceeds the most restrictive expense limitations then in
effect under any state securities laws or published regulations thereunder.
Expenses for this purpose include MLAM's fee but exclude interest, taxes,
brokerage commissions and extraordinary expenses, such as litigation. No fee
payments will be made to MLAM with respect to any Fund during any fiscal year
which would cause the expenses of such Fund to exceed the pro rata expense
35
<PAGE>
limitation applicable to such Fund at the time of such payment. This
reimbursement agreement will remain in effect so long as the advisory agreement
remains in effect and cannot be amended without Variable Series Funds approval.
MLAM and Merrill Lynch Life Agency, Inc. have entered into two agreements which
limit the operating expenses paid by each Fund in a given year to 1.25% of its
average daily net assets, which is less than the expense limitations imposed by
state securities laws or published regulations thereunder. These reimbursement
agreements provide that any expenses in excess of 1.25% of average daily net
assets will be reimbursed to the Fund by MLAM which, in turn, will be reimbursed
by Merrill Lynch Life Agency, Inc.
THE ZERO TRUSTS
THE 20 ZERO TRUSTS:
<TABLE>
<CAPTION>
Targeted Rate of Return to
Maturity as
Zero Trust Maturity Date of April 25, 1994
- ---------- ------------------ -------------------------------
<C> <S> <C>
1994 August 15, 1994 2.65
1995 November 15, 1995 3.94
1996 February 15, 1996 4.26
1997 February 15, 1997 4.67
1998 February 15, 1998 4.99
1999 February 15, 1999 5.28
2000 February 15, 2000 5.38
2001 February 15, 2001 5.48
2002 February 15, 2002 5.64
2003 August 15, 2003 5.85
2004 February 15, 2004 5.88
2005 February 15, 2005 5.92
2006 February 15, 2006 5.84
2007 February 15, 2007 5.94
2008 February 15, 2008 6.15
2009 February 15, 2009 6.19
2010 February 15, 2010 6.26
2011 February 15, 2011 6.26
2013 February 15, 2013 6.32
2014 February 15, 2014 6.30
</TABLE>
TARGETED RATE OF RETURN TO MATURITY
Because the underlying securities in the Zero Trusts will grow to their face
value on the maturity date, it is possible to estimate a compound rate of growth
to maturity for the Zero Trust units.
But because the units are held in the Separate Account, the asset charge and the
trust charge (described in "Charges to the Separate Account" on page 19) must be
taken into account in estimating a net rate of return for the Separate Account.
The net rate of return to maturity for the Separate Account depends on the
compound rate of growth adjusted for these charges. It does not, however,
represent the actual return on a payment ML of New York might receive under the
Contract on that date, since it does not reflect the charges for deferred
contract loading, mortality costs and any net loan cost deducted from a
Contract's investment base (described in "Charges Deducted from the Investment
Base" on page 17).
Since the value of the Zero Trust units will vary daily to reflect the market
value of the underlying securities, the compound rate of growth to maturity for
the Zero Trust units and the net rate of return to maturity for the Separate
Account will vary correspondingly.
36
<PAGE>
ILLUSTRATIONS
ILLUSTRATIONS OF DEATH BENEFITS, INVESTMENT BASE, CASH SURRENDER VALUES AND
ACCUMULATED PAYMENTS
The tables on pages 39 through 44 demonstrate the way in which the Contract
works. The tables are based on the following ages, face amounts, payments and
guarantee periods and assume maximum mortality charges.
1. The illustration on page 39 is for a Contract issued to a male age 5
in the standard-simplified underwriting class with an initial payment of
$2,000, a face amount of $144,039 and an initial guarantee period of 15.50
years with planned periodic payments of $2,000 for six contract years.
2. The illustration on page 40 is for a Contract issued to a male age
35 in the standard-simplified underwriting class with an initial payment of
$3,500, a face amount of $96,919 and an initial guarantee period of 12.75
years with planned periodic payments of $3,500 for six contract years.
3. The illustration on page 41 is for a Contract issued to a female age
45 in the standard-simplified underwriting class with an initial payment of
$5,000, a face amount of $116,558 and an initial guarantee period of 10
years with planned periodic payments of $5,000 for six contract years.
4. The illustration on page 42 is for a Contract issued to a male age
55 in the standard-simplified underwriting class with an initial payment of
$7,500, a face amount of $107,681 and an initial guarantee period of 5.50
years with planned periodic payments of $7,500 for six contract years.
5. The illustration on page 43 is for a Contract issued to a male age
65 in the standard-simplified underwriting class with an initial payment of
$10,000, a face amount of $103,905 and an initial guarantee period of 3.25
years with planned periodic payments of $10,000 for six contract years.
6. The illustration on page 44 is for a Contract issued to a male age
55 and a female age 55 in the medical underwriting class with an initial
payment of $10,000, a face amount of $205,818 and an initial guarantee
period of 17 years with planned periodic payments of $10,000 for six
contract years.
The tables show how the death benefit, investment base and cash surrender value
may vary over an extended period of time assuming hypothetical rates of return
(i.e., investment income and capital gains and losses, realized or unrealized)
equivalent to constant gross annual rates of 0%, 6% and 12%.
The death benefit, investment base and cash surrender value for a Contract would
be different from those shown if the actual rates of return averaged 0%, 6% and
12% over a period of years, but also fluctuated above or below those averages
for individual contract years.
The amounts shown for the death benefit, investment base and cash surrender
value as of the end of each contract year take into account the daily asset
charge in the Separate Account equivalent to .90% (annually at the beginning of
the year) of assets attributable to the Contracts at the beginning of the year.
The amounts shown in the tables also assume an additional charge of .490%. This
charge assumes that investment base is allocated equally among all investment
divisions and is based on the 1993 expenses (including monthly advisory fees)
for the Series Fund and the Variable Series Funds, anticipated 1994 expenses for
the International Bond Fund and the Developing Capital Markets Focus Fund, and
the current trust charge. This charge does not reflect expenses incurred by the
Global Strategy Portfolio and the Natural Resources Portfolio of the Series Fund
in 1993, which were reimbursed to the Series Fund by MLAM. The reimbursements
amounted to .01% and .09%, respectively, of the average daily net assets of
these portfolios. (See "Charges to Series Fund Assets" on page 35.) The actual
charge under a Contract for Series Fund and Variable Series Funds expenses and
the trust charge will depend on the actual allocation of the investment base and
may be higher or lower depending on how the investment base is allocated.
37
<PAGE>
Taking into account the .90% asset charge in the Separate Account and the .490%
charge described above, the gross annual rates of investment return of 0%, 6%
and 12% correspond to net annual rates of -1.39%, 4.56%, and 10.51%,
respectively. The gross returns are before any deductions and should not be
compared to rates which are after deduction of charges.
The hypothetical returns shown on the tables are without any income tax charges
that may be attributable to the Separate Account in the future (although they do
reflect the charge for federal income taxes included in the deferred contract
loading, see "Deferred Contract Loading" on page 17). In order to produce after
tax returns of 0%, 6% and 12%, the Series Fund and the Variable Series Funds
would have to earn a sufficient amount in excess of 0% or 6% or 12% to cover any
tax charges attributable to the Separate Account.
The second column of the tables shows the amount which would accumulate if an
amount equal to the payments were invested to earn interest (after taxes) at 5%
compounded annually.
ML of New York will furnish upon request a personalized illustration reflecting
the proposed insured's age, face amount and the payment amounts requested. The
illustration will also use current cost of insurance rates and will assume that
the proposed insured is in a standard underwriting class.
38
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
MALE ISSUE AGE 5
$2,000 INITIAL PAYMENT FOR STANDARD-SIMPLIFIED UNDERWRITING CLASS
FACE AMOUNT: $144,039 INITIAL GUARANTEE PERIOD (1): 15.50 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
TOTAL DEATH BENEFIT (3)
PAYMENTS ASSUMING HYPOTHETICAL GROSS
MADE PLUS ANNUAL INVESTMENT RETURN OF
INTEREST AT 5% AS ------------------------------
CONTRACT YEAR PAYMENTS (2) OF END OF YEAR 0% 6% 12%
--------------- ----------------- -------- -------- ----------
<S> <C> <C> <C> <C> <C>
1................... $2,000 $ 2,100 $144,039 $144,039 $ 144,039
2................... 2,000 4,305 144,039 144,039 144,039
3................... 2,000 6,620 144,039 144,039 144,039
4................... 2,000 9,051 144,039 144,039 144,039
5................... 2,000 11,604 144,039 144,039 144,039
6................... 2,000 14,284 144,039 144,039 144,039
7................... 2,000 17,098 144,039 144,039 153,558
8................... 0 17,953 144,039 144,039 163,806
9................... 0 18,851 144,039 144,039 174,577
10................... 0 19,793 144,039 144,039 185,911
15................... 0 25,262 144,039 144,039 252,852
20 (age 25) ......... 0 32,241 144,039 144,039 342,738
30 (age 35) ......... 0 52,518 144,039 144,039 629,412
60 (age 65) ......... 0 226,977 144,039 153,011 3,904,396
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR
CASH SURRENDER VALUE (3)
END OF YEAR ASSUMING HYPOTHETICAL
INVESTMENT BASE (3) GROSS
ASSUMING HYPOTHETICAL GROSS ANNUAL INVESTMENT RETURN
ANNUAL INVESTMENT RETURN OF OF
---------------------------- --------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- ------- ---------- ------- -----------------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 1,823 $ 1,939 $ 2,056 $ 1,661 $ 1,777 $ 1,894
2................... 3,611 3,956 4,317 3,305 3,650 4,011
3................... 5,368 6,061 6,811 4,936 5,629 6,379
4................... 7,089 8,250 9,556 6,549 7,710 9,016
5................... 8,771 10,522 12,575 8,141 9,892 11,945
6................... 10,418 12,888 15,900 9,716 12,186 15,198
7................... 12,021 15,340 19,552 11,265 14,584 18,796
8................... 11,619 15,803 21,359 10,989 15,173 20,729
9................... 11,203 16,266 23,325 10,699 15,762 22,821
10................... 10,772 16,730 25,462 10,394 16,352 25,084
15................... 8,680 19,356 39,582 8,662 19,338 39,564
20 (age 25) ......... 6,929 22,868 62,273 6,929 22,868 62,273
30 (age 35) ......... 3,995 33,100 158,463 3,995 33,100 158,463
60 (age 65) ......... 0 92,294 2,355,082 0 92,294 2,355,082
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 72.25 years
at the end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
39
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
MALE ISSUE AGE 35
$3,500 INITIAL PAYMENT FOR STANDARD-SIMPLIFIED UNDERWRITING CLASS
FACE AMOUNT: $96,919 INITIAL GUARANTEE PERIOD (1): 12.75 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
DEATH BENEFIT (3)
ASSUMING HYPOTHETICAL
GROSS
TOTAL ANNUAL INVESTMENT RETURN
PAYMENTS OF
END OF MADE PLUS --------------------------
CONTRACT YEAR PAYMENTS (2) INTEREST AT 5% 0% 6% 12%
------------ ----------------- ------- ------- --------
<S> <C> <C> <C> <C> <C>
1................... $3,500 $ 3,675 $96,919 $96,919 $ 96,919
2................... 3,500 7,534 96,919 96,919 96,919
3................... 3,500 11,585 96,919 96,919 96,919
4................... 3,500 15,840 96,919 96,919 96,919
5................... 3,500 20,307 96,919 96,919 96,919
6................... 3,500 24,997 96,919 96,919 96,919
7................... 3,500 29,922 96,919 96,919 103,476
8................... 0 31,418 96,919 96,919 110,386
9................... 0 32,989 96,919 96,919 117,649
10................... 0 34,638 96,919 96,919 125,290
15................... 0 44,208 96,919 96,919 170,399
20................... 0 56,422 96,919 96,919 230,992
30 (age 65) ......... 0 91,906 96,919 96,919 424,652
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR END OF YEAR
INVESTMENT BASE (3) CASH SURRENDER VALUE (3)
ASSUMING HYPOTHETICAL ASSUMING HYPOTHETICAL
GROSS GROSS
ANNUAL INVESTMENT RETURN ANNUAL INVESTMENT RETURN
OF OF
END OF -------------------------- --------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- ------- -------- ------- ------- --------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 3,221 $ 3,425 $ 3,629 $ 2,938 $ 3,142 $ 3,345
2................... 6,361 6,969 7,602 5,825 6,433 7,067
3................... 9,418 10,636 11,956 8,662 9,880 11,200
4................... 12,393 14,430 16,729 11,448 13,485 15,784
5................... 15,288 18,359 21,969 14,186 17,257 20,867
6................... 18,104 22,428 27,725 16,875 21,200 26,497
7................... 20,842 26,646 34,049 19,519 25,323 32,726
8................... 20,076 27,382 37,138 18,974 26,279 36,036
9................... 19,301 28,132 40,514 18,419 27,250 39,632
10................... 18,516 28,897 44,203 17,854 28,236 43,542
15................... 14,876 33,442 68,954 14,844 33,411 68,922
20................... 11,303 39,039 107,911 11,303 39,039 107,911
30 (age 65) ......... 712 50,836 256,145 712 50,836 256,145
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 44.75 years
at the end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
40
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
FEMALE ISSUE AGE 45
$5,000 INITIAL PAYMENT FOR STANDARD-SIMPLIFIED UNDERWRITING CLASS
FACE AMOUNT: $116,558 INITIAL GUARANTEE PERIOD (1): 10 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
TOTAL DEATH BENEFIT (3)
PAYMENTS ASSUMING HYPOTHETICAL GROSS
MADE PLUS ANNUAL INVESTMENT RETURN OF
INTEREST AT 5% AS ----------------------------
CONTRACT YEAR PAYMENTS (2) OF END OF YEAR 0% 6% 12%
------------ ----------------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
1................... $5,000 $ 5,250 $116,558 $116,558 $116,558
2................... 5,000 10,762 116,558 116,558 116,558
3................... 5,000 16,551 116,558 116,558 116,558
4................... 5,000 22,628 116,558 116,558 116,558
5................... 5,000 29,010 116,558 116,558 116,558
6................... 5,000 35,710 116,558 116,558 116,558
7................... 5,000 42,746 116,558 116,558 124,114
8................... 0 44,883 116,558 116,558 132,420
9................... 0 47,127 116,558 116,558 141,147
10................... 0 49,483 116,558 116,558 150,329
15................... 0 63,155 116,558 116,558 204,502
20 (age 65) ......... 0 80,603 116,558 116,558 277,241
30................... 0 131,294 116,558 116,558 509,712
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR END OF YEAR
INVESTMENT BASE (3) CASH SURRENDER VALUE (3)
ASSUMING HYPOTHETICAL ASSUMING HYPOTHETICAL
GROSS GROSS
ANNUAL INVESTMENT RETURN ANNUAL INVESTMENT RETURN
OF OF
-------------------------- --------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- ------- -------- ------- ------- --------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 4,487 $ 4,775 $ 5,064 $ 4,082 $ 4,370 $ 4,659
2................... 8,852 9,709 10,602 8,087 8,944 9,837
3................... 13,104 14,815 16,673 12,024 13,735 15,593
4................... 17,244 20,101 23,333 15,894 18,751 21,983
5................... 21,272 25,574 30,649 19,697 23,999 29,074
6................... 25,194 31,249 38,696 23,439 29,494 36,941
7................... 29,013 37,136 47,543 27,123 35,246 45,653
8................... 27,827 38,043 51,748 26,252 36,468 50,173
9................... 26,626 38,962 56,333 25,366 37,702 55,073
10................... 25,409 39,894 61,333 24,464 38,949 60,388
15................... 19,782 45,513 94,850 19,737 45,468 94,805
20 (age 65) ......... 14,407 52,618 147,813 14,407 52,618 147,813
30................... 0 66,634 349,233 0 66,634 349,233
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 40.25 years
at the end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
41
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
MALE ISSUE AGE 55
$7,500 INITIAL PAYMENT FOR STANDARD-SIMPLIFIED UNDERWRITING CLASS
FACE AMOUNT: $107,681 INITIAL GUARANTEE PERIOD (1): 5.50 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
TOTAL DEATH BENEFIT (3)
PAYMENTS ASSUMING HYPOTHETICAL GROSS
MADE PLUS ANNUAL INVESTMENT RETURN OF
INTEREST AT 5% AS ----------------------------
CONTRACT YEAR PAYMENTS (2) OF END OF YEAR 0% 6% 12%
------------ ----------------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
1................... $7,500 $ 7,875 $107,681 $107,681 $107,681
2................... 7,500 16,144 107,681 107,681 107,681
3................... 7,500 24,826 107,681 107,681 107,681
4................... 7,500 33,942 107,681 107,681 107,681
5................... 7,500 43,514 107,681 107,681 107,681
6................... 7,500 53,565 107,681 107,681 107,681
7................... 7,500 64,118 107,681 107,681 114,119
8................... 0 67,324 107,681 107,681 121,800
9................... 0 70,690 107,681 107,681 129,868
10 (age 65) ......... 0 74,225 107,681 107,681 138,353
15................... 0 94,732 107,681 107,681 188,374
20................... 0 120,905 107,681 107,681 255,555
30................... 0 196,941 0 107,681 470,652
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR END OF YEAR
INVESTMENT BASE (3) CASH SURRENDER VALUE (3)
ASSUMING HYPOTHETICAL ASSUMING HYPOTHETICAL
GROSS GROSS
ANNUAL INVESTMENT RETURN ANNUAL INVESTMENT RETURN
OF OF
-------------------------- --------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- ------- -------- ------- ------- --------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 6,265 $ 6,688 $ 7,112 $ 5,658 $ 6,080 $ 6,505
2................... 12,322 13,558 14,855 11,174 12,410 13,707
3................... 18,206 20,655 23,339 16,586 19,035 21,719
4................... 23,929 27,999 32,663 21,904 25,974 30,638
5................... 29,507 35,617 42,944 27,144 33,255 40,581
6................... 34,953 43,536 54,317 32,320 40,903 51,684
7................... 40,283 51,786 66,902 37,448 48,951 64,067
8................... 38,083 52,521 72,437 35,720 50,159 70,074
9................... 35,812 53,203 78,416 33,922 51,313 76,526
10 (age 65) ......... 33,459 53,820 84,870 32,042 52,403 83,453
15................... 21,080 56,599 126,710 21,012 56,532 126,642
20................... 5,005 56,771 188,749 5,005 56,771 188,749
30................... 0 2,468 398,759 0 2,468 398,759
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 27 years at
the end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
42
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
MALE ISSUE AGE 65
$10,000 INITIAL PAYMENT FOR STANDARD-SIMPLIFIED UNDERWRITING CLASS
FACE AMOUNT: $103,905 INITIAL GUARANTEE PERIOD (1): 3.25 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
TOTAL DEATH BENEFIT (3)
PAYMENTS ASSUMING HYPOTHETICAL GROSS
MADE PLUS ANNUAL INVESTMENT RETURN OF
INTEREST AT 5% AS ----------------------------
CONTRACT YEAR PAYMENTS (2) OF END OF YEAR 0% 6% 12%
------------ ----------------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
1................... $10,000 $ 10,500 $103,905 $103,905 $103,905
2................... 10,000 21,525 103,905 103,905 103,905
3................... 10,000 33,101 103,905 103,905 103,905
4................... 10,000 45,256 103,905 103,905 103,905
5................... 10,000 58,019 103,905 103,905 103,905
6................... 10,000 71,420 103,905 103,905 103,905
7................... 10,000 85,491 103,905 103,905 109,390
8................... 0 89,766 103,905 103,905 116,823
9................... 0 94,254 103,905 103,905 124,623
10................... 0 98,967 103,905 103,905 132,819
15................... 0 126,309 103,905 103,905 181,031
20................... 0 161,206 0 103,905 245,717
30................... 0 262,588 0 0 452,818
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR END OF YEAR
INVESTMENT BASE (3) CASH SURRENDER VALUE (3)
ASSUMING HYPOTHETICAL ASSUMING HYPOTHETICAL
GROSS GROSS
ANNUAL INVESTMENT RETURN ANNUAL INVESTMENT RETURN
OF OF
-------------------------- --------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- ------- -------- ------- ------- --------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 7,303 $ 7,844 $ 8,390 $ 6,493 $ 7,034 $ 7,580
2................... 14,308 15,848 17,485 12,778 14,318 15,955
3................... 21,108 24,116 27,477 18,948 21,956 25,317
4................... 27,742 32,700 38,537 25,042 30,000 35,837
5................... 34,247 41,657 50,863 31,097 38,057 47,713
6................... 40,666 51,053 64,702 37,156 47,543 61,192
7................... 47,054 60,971 80,303 43,274 57,191 76,523
8................... 43,360 60,799 86,432 40,210 57,649 83,282
9................... 39,435 60,388 92,987 36,915 57,868 90,467
10................... 35,226 59,687 99,988 33,336 57,797 98,098
15................... 8,758 50,789 144,307 8,668 50,699 144,217
20................... 0 16,419 208,183 0 16,419 208,183
30................... 0 0 421,956 0 0 421,956
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 19.25 years
at the end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
43
<PAGE>
FLEXIBLE PREMIUM VARIABLE LIFE INSURANCE CONTRACT
JOINT INSUREDS: FEMALE ISSUE AGE 55/MALE ISSUE AGE 55
$10,000 INITIAL PAYMENT FOR MEDICAL UNDERWRITING CLASS
FACE AMOUNT: $205,818 INITIAL GUARANTEE PERIOD (1): 17 YEARS
BASED ON MAXIMUM MORTALITY CHARGES
<TABLE>
<CAPTION>
END OF YEAR
TOTAL DEATH BENEFIT (3)
PAYMENTS ASSUMING HYPOTHETICAL GROSS
MADE PLUS ANNUAL INVESTMENT RETURN OF
INTEREST AT 5% AS ----------------------------
CONTRACT YEAR PAYMENTS (2) OF END OF YEAR 0% 6% 12%
------------ ----------------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
1................... $10,000 $ 10,500 $205,818 $205,818 $205,818
2................... 10,000 21,525 205,818 205,818 205,818
3................... 10,000 33,101 205,818 205,818 205,818
4................... 10,000 45,256 205,818 205,818 205,818
5................... 10,000 58,019 205,818 205,818 205,818
6................... 10,000 71,420 205,818 205,818 205,818
7................... 10,000 85,491 205,818 205,818 222,827
8................... 0 89,766 205,818 205,818 237,851
9................... 0 94,254 205,818 205,818 253,606
10................... 0 98,967 205,818 205,818 270,153
15................... 0 126,309 205,818 205,818 367,524
20................... 0 161,206 205,818 205,818 498,189
30................... 0 262,588 205,818 205,818 916,453
</TABLE>
<TABLE>
<CAPTION>
END OF YEAR END OF YEAR
INVESTMENT BASE (3) CASH SURRENDER VALUE (3)
ASSUMING HYPOTHETICAL GROSS ASSUMING HYPOTHETICAL GROSS
ANNUAL INVESTMENT RETURN OF ANNUAL INVESTMENT RETURN OF
--------------------------- ---------------------------
CONTRACT YEAR 0% 6% 12% 0% 6% 12%
------- -------- -------- ------- -------- --------
<S> <C> <C> <C> <C> <C> <C>
1................... $ 9,737 $ 10,331 $ 10,925 $ 8,747 $ 9,341 $ 9,935
2................... 19,197 20,991 22,856 17,327 19,121 20,986
3................... 28,382 31,992 35,895 25,742 29,352 33,255
4................... 37,293 43,348 50,159 33,993 40,048 46,859
5................... 45,934 55,075 65,778 42,084 51,225 61,928
6................... 54,307 67,189 82,899 50,017 62,899 78,609
7................... 62,415 79,707 101,671 57,795 75,087 97,051
8................... 60,494 82,286 111,296 56,644 78,436 107,446
9................... 58,529 84,915 121,842 55,449 81,835 118,762
10................... 56,508 87,585 133,382 54,198 85,275 131,072
15................... 46,765 102,968 210,901 46,655 102,858 210,791
20................... 35,205 120,316 331,291 35,205 120,316 331,291
30................... 0 138,296 754,114 0 138,296 754,114
<FN>
- --------------------------
(1) The initial guarantee period will increase with each additional payment
and, assuming all planned periodic payments are made, will be 33.75 at the
end of contract year 7.
(2) All payments are illustrated as if made at the beginning of the contract
year.
(3) Assumes no loan has been made.
</TABLE>
IT IS EMPHASIZED THAT THE HYPOTHETICAL INVESTMENT RATES OF RETURN SHOWN ABOVE
AND ELSEWHERE IN THIS PROSPECTUS ARE ILLUSTRATIVE ONLY AND SHOULD NOT BE
CONSIDERED A REPRESENTATION OF PAST OR FUTURE PERFORMANCE. ACTUAL RATES OF
RETURN MAY BE MORE OR LESS THAN THOSE ILLUSTRATED AND WILL DEPEND ON A NUMBER OF
FACTORS, INCLUDING THE INVESTMENT ALLOCATIONS SELECTED, PREVAILING INTEREST
RATES AND RATES OF INFLATION. THE DEATH BENEFIT, INVESTMENT BASE AND CASH
SURRENDER VALUE WOULD BE DIFFERENT FROM THOSE SHOWN IF THE ACTUAL GROSS RATES OF
RETURN AVERAGED 0%, 6% AND 12% OVER A PERIOD OF YEARS, BUT ALSO FLUCTUATED ABOVE
OR BELOW THOSE AVERAGES FOR INDIVIDUAL CONTRACT YEARS. NO REPRESENTATIONS CAN BE
MADE BY ML OF NEW YORK OR THE SERIES FUND OR THE VARIABLE SERIES FUNDS OR THE
ZERO TRUSTS THAT THESE HYPOTHETICAL RATES OF RETURN CAN BE ACHIEVED FOR ANY ONE
YEAR OR SUSTAINED OVER ANY PERIOD OF TIME.
44
<PAGE>
EXAMPLES
ADDITIONAL PAYMENTS
If the guarantee period is for the whole of life at the time an additional
payment is received and accepted (which means that planned periodic payments
have been made through contract year 9), as of the processing date on or next
following the date of the additional payment, ML of New York will increase the
face amount to the amount that the Contract's fixed base, as of such processing
date, would support for the life of the insured.
Under these circumstances the amount of the increase in face amount will depend
on the amount of the additional payment and the contract year in which it is
received and accepted. If additional payments of different amounts were made at
the same time to equivalent Contracts, the Contract to which the larger payment
is applied would have a proportionately larger increase in face amount. And if
additional payments of the same amounts were made in earlier and later years,
those made in the later years would result in smaller increases to the face
amount.
Example 1 shows the effect on face amount of a $2,000 additional payment
received and accepted at the beginning of contract year ten. Example 2 shows the
effect of a $4,000 additional payment received and accepted at the beginning of
contract year ten. Example 3 shows the effect of a $2,000 additional payment
received and accepted at the beginning of contract year eleven. All three
examples assume that the guarantee period at the time of the additional payment
is for life and assume no other contract transactions have been made.
MALE ISSUE AGE: 55
PAYMENTS: INITIAL PAYMENT PLUS 8 PERIODIC PAYMENTS OF $7,500
FACE AMOUNT: $107,681
<TABLE>
<CAPTION>
EXAMPLE 1
---------------------------------------------
CONTRACT ADDITIONAL CHANGE IN NEW FACE
YEAR PAYMENT FACE AMOUNT AMOUNT
-------- ---------- ----------- --------
<S> <C> <C> <C>
10 $2,000 $2,629 $110,310
<CAPTION>
EXAMPLE 2
---------------------------------------------
CONTRACT ADDITIONAL CHANGE IN NEW FACE
YEAR PAYMENT FACE AMOUNT AMOUNT
-------- ---------- ----------- --------
<S> <C> <C> <C>
10 $4,000 $5,730 $113,411
<CAPTION>
EXAMPLE 3
---------------------------------------------
CONTRACT ADDITIONAL CHANGE IN NEW FACE
YEAR PAYMENT FACE AMOUNT AMOUNT
-------- ---------- ----------- --------
<S> <C> <C> <C>
11 $2,000 $2,538 $110,219
</TABLE>
CHANGING THE FACE AMOUNT
As of the processing date on or next following receipt and acceptance of a
request for a change in face amount, ML of New York will make the requested
change and adjust the guarantee period. For an increase in face amount, ML of
New York will decrease the guarantee period and for a decrease in face amount,
ML of New York will increase the guarantee period. To decrease the face amount,
the guarantee period must be less than for the whole of life at the time of the
request. A new guarantee period is established by taking the Contract's fixed
base as of the processing date and determining how long that fixed base would
support the face amount.
The amount of the increase or decrease in the guarantee period will depend on
the amount of increase or decrease in the face amount and the contract year in
which the change is made. If made at the same time to equivalent Contracts, a
larger increase in face amount would result in a greater decrease in the
guarantee period than a smaller increase in face amount. The same increase made
in two different years would result in a smaller decrease in the guarantee
period for the increase in face amount made in the later year.
45
<PAGE>
Examples 1 and 2 show the effect on the guarantee period of an increase in face
amount of $10,000 and $20,000 made at the beginning of contract year eight.
Example 3 shows the effect on the guarantee period of an increase in face amount
of $10,000 made at the beginning of contract year ten. All three examples assume
no other contract transactions have been made.
MALE ISSUE AGE: 55
PAYMENTS: INITIAL PAYMENT PLUS 6 PERIODIC PAYMENTS OF $7,500
FACE AMOUNT: $107,681
<TABLE>
<CAPTION>
EXAMPLE 1
----------------------------------------
CONTRACT INCREASE IN DECREASE IN
YEAR FACE AMOUNT GUARANTEE PERIOD
-------- ----------- ----------------
<S> <C> <C>
8 $10,000 2.00 years
<CAPTION>
EXAMPLE 2
----------------------------------------
CONTRACT INCREASE IN DECREASE IN
YEAR FACE AMOUNT GUARANTEE PERIOD
-------- ----------- ----------------
<S> <C> <C>
8 $20,000 3.50 years
<CAPTION>
EXAMPLE 3
----------------------------------------
CONTRACT INCREASE IN DECREASE IN
YEAR FACE AMOUNT GUARANTEE PERIOD
-------- ----------- ----------------
<S> <C> <C>
10 $10,000 1.75 years
</TABLE>
PARTIAL WITHDRAWALS
As of the processing date on or next following any partial withdrawal, ML of New
York will reduce the Contract's face amount. The new face amount is established
by taking the Contract's fixed base as of the processing date and determining
what face amount that fixed base would support for the Contract's guarantee
period.
The amount of the reduction in the face amount will depend on the amount of the
partial withdrawal, the guarantee period at the time of the withdrawal and the
contract year in which the withdrawal is made. If made at the same time to
equivalent Contracts, a larger withdrawal would result in a greater reduction in
the face amount than a smaller withdrawal. The same partial withdrawal made at
the same time from Contracts with the same face amounts but with different
guarantee periods would result in a greater reduction in the face amount for the
Contract with the longer guarantee period. A partial withdrawal made in a later
contract year would result in a smaller decrease in the face amount than if the
same amount was withdrawn in an earlier year.
46
<PAGE>
Examples 1 and 2 show the effect on the face amount of partial withdrawals for
$5,000 and $10,000 taken at the beginning of contract year sixteen. Example 3
shows the effect on the face amount of a $10,000 partial withdrawal taken at the
beginning of contract year eighteen. All three examples assume no other contract
transactions have been made.
MALE ISSUE AGE: 55
PAYMENTS: INITIAL PAYMENT PLUS 6 PERIODIC PAYMENTS OF $7,500
FACE AMOUNT: $107,681
<TABLE>
<CAPTION>
EXAMPLE 1
----------------------------------
CONTRACT PARTIAL
YEAR WITHDRAWAL FACE AMOUNT
-------- ---------- -----------
<S> <C> <C>
16 $5,000 $100,208
<CAPTION>
EXAMPLE 2
----------------------------------
CONTRACT PARTIAL
YEAR WITHDRAWAL FACE AMOUNT
-------- ---------- -----------
<S> <C> <C>
16 $10,000 $ 92,734
<CAPTION>
EXAMPLE 3
----------------------------------
CONTRACT PARTIAL
YEAR WITHDRAWAL FACE AMOUNT
-------- ---------- -----------
<S> <C> <C>
18 $10,000 $ 93,312
</TABLE>
If the reduction in face amount would be below the minimum face amount for a
Contract, ML of New York will reduce the face amount to the minimum face amount,
and then reduce the guarantee period by taking the Contract's fixed base as of
the processing date and determining how long that fixed base would support the
reduced face amount.
JOINT INSUREDS
Contract owners may purchase a Contract on the lives of two insureds. Some of
the discussions in this Prospectus applicable to the Contract apply only to a
Contract on a single insured. Set out below are the modifications to the
designated sections of this Prospectus for joint insureds. Except in the
sections noted below, the discussions in this Prospectus referencing a single
insured, can be read as though the single insured were the two insureds under a
joint contract.
AVAILABILITY AND PAYMENTS (REFERENCE PAGE 5)
A Contract may be issued for insureds up to age 80.
ML of New York will not accept an initial payment that will provide a guarantee
period of less than the minimum guarantee period for which it would then issue a
Contract based on the age of the younger insured. Such minimum will range from
10 to 40 years depending on the age of the younger insured.
WHO MAY BE COVERED (REFERENCE PAGE 11)
ML of New York will issue a Contract on the lives of two insureds provided the
relationship among the applicant and the insureds meets its insurable interest
requirements and provided neither insured is over age 80 and no more than one
insured is under age 20. The insureds' issue ages will be determined using their
ages as of their birthdays nearest the contract date.
The initial payment plus any planned periodic payments elected and the average
age of the insureds determine whether underwriting will be done on a simplified
or medical basis. The maximum amount underwritten on a simplified basis for
joint insureds depends on ML of New York's administrative rules in effect at the
time of underwriting.
Under both simplified and medical underwriting methods, Contracts may be issued
on insureds in a standard underwriting class only.
47
<PAGE>
PURCHASING A CONTRACT (REFERENCE PAGE 12)
ML of New York will not accept an initial payment for a specified face amount
that will provide a guarantee period of less than the minimum guarantee period
for which ML of New York would then issue a Contract based on the age of the
younger insured. The minimum will range from 10 to 40 years depending on the age
of the younger insured.
PLANNED PAYMENTS (REFERENCE PAGE 13)
Contract owners may change the frequency and the amount of planned payments
provided both insureds are living.
Planned payments must be received while at least one insured is living and not
more than 30 days before or 30 days after the date specified for payment.
A combination periodic plan is not available for joint insureds.
PAYMENTS WHICH ARE NOT UNDER A PERIODIC PAYMENT PLAN (REFERENCE PAGE 14).
Contract owners may make additional payments which are not under a periodic
payment plan only if both insureds are living and the attained ages of both
insureds are not over 80.
EFFECT OF A PLANNED PAYMENT AND OTHER ADDITIONAL PAYMENTS (REFERENCE PAGE 15).
If the guarantee period prior to receipt and acceptance of an additional payment
is less than for the life of the last surviving insured, the payment will first
be used to extend the guarantee period to the whole of life of the younger
insured.
CHANGING THE FACE AMOUNT
INCREASING THE FACE AMOUNT (REFERENCE PAGE 16). Contract owners may increase
the face amount of their Contracts only if both insureds are living. A change in
face amount is not permitted if the attained age of either insured is over 80.
DECREASING THE FACE AMOUNT (REFERENCE PAGE 16). Contract owners may decrease
the face amount of their Contracts if either insured is living.
Any reduction in death benefit in a Contract on joint insureds, whether by a
change in face amount or other means, will probably result in a failure to
satisfy the 7-pay test and subsequent treatment as a modified endowment
contract.
CHARGES DEDUCTED FROM THE INVESTMENT BASE
DEFERRED CONTRACT LOADING (REFERENCE PAGE 17). The deferred contract loading
equals 11% of each payment. This charge consists of a sales load, a charge for
federal taxes and a state and local premium tax charge.
The sales load, equal to 7% of each payment compensates ML of New York for sales
expenses. The sales load may be reduced if cumulative payments are sufficiently
high to reach certain break points (4% of payments in excess of $1.5 million and
2% of payments in excess of $4 million). The charge for federal taxes, equal to
2% of each payment, compensates ML of New York for a significantly higher
corporate income tax liability resulting from changes made to the Internal
Revenue Code by the Omnibus Budget Reconciliation Act of 1990. (See "ML of New
York's Income Taxes" on page 32.) The state and local premium tax charge, equal
to 2% of payments, compensates ML of New York for state and local premium taxes
that must be paid when a payment is accepted.
ML of New York deducts an amount equal to 1.1% of each payment from the
investment base on each of the ten contract anniversaries following payment.
MORTALITY COST (REFERENCE PAGE 18). For Contracts issued on joint insureds,
current cost of insurance rates are equal to the guaranteed maximum cost of
insurance rates set forth in the Contract. Those rates
48
<PAGE>
are based on the 1980 Commissioners Aggregate Mortality Table and do not
distinguish between insureds in a smoker underwriting class and insureds in a
non-smoker underwriting class. The cost of insurance rates are based on an
aggregate class which is made up of a blend of smokers and non-smokers.
GUARANTEE PERIOD
WHEN THE GUARANTEE PERIOD IS LESS THAN FOR LIFE (REFERENCE PAGE 19). If ML of
New York cancels a Contract, it may be reinstated only if neither insured has
died between the date the Contract was terminated and the effective date of the
reinstatement and the contract owner meets the other conditions listed on page
19.
NET CASH SURRENDER VALUE
CANCELLING TO RECEIVE NET CASH SURRENDER VALUE (REFERENCE PAGE 20). Contract
owners may cancel their Contracts at any time while either insured is living.
PARTIAL WITHDRAWALS (REFERENCE PAGE 21)
Partial withdrawals are not available for joint insureds.
DEATH BENEFIT PROCEEDS (REFERENCE PAGE 22)
ML of New York will pay the death benefit proceeds to the beneficiary when all
information needed to process the payment, including due proof of the last
surviving insured's death, has been received at the Service Center. Proof of
death for both insureds must be received. There is no death benefit payable at
the first death.
If one of the insureds should die within two years from the Contract's issue
date, within two years from the effective date of any increase in face amount
requested or within two years from the date an additional payment was received
and accepted, proof of the insured's death should be sent promptly to the
Service Center since ML of New York may only pay a limited benefit or contest
the Contract. (See "Incontestability" and "Payment in Case of Suicide" on page
27.)
NET SINGLE PREMIUM FACTOR (REFERENCE PAGE 23). The net single premium factors
are based on the insureds' sexes and underwriting classes and the attained ages
on the date of calculation.
PAYMENT OF DEATH BENEFIT PROCEEDS (REFERENCE PAGE 23)
If a payment is delayed, ML of New York, will add interest from the date of the
last surviving insured's death to the date of payment at an annual rate of at
least 4%.
RIGHT TO CANCEL ("FREE LOOK" PERIOD) OR EXCHANGE
EXCHANGING THE CONTRACT (REFERENCE PAGE 23). A contract owner may exchange his
or her Contract for a joint and last survivor contract with benefits that do not
vary with the investment results of a separate account.
USING THE CONTRACT
OWNERSHIP (REFERENCE PAGE 24). The contract owner is usually one of the
insureds, unless another owner has been named in the application.
The contract owner, may want to name a contingent owner in the event the
contract owner dies before the last surviving insured. The contingent owner
would then own the contract owner's interest in the Contract and have all
contract owner's rights.
NAMING BENEFICIARIES (REFERENCE PAGE 25). ML of New York pays the primary
beneficiary the proceeds of this Contract on the last surviving insured's death.
If no contingent beneficiary is living, ML of New York pays the last surviving
insured's estate.
CHANGING THE INSURED (REFERENCE PAGE 25). Not available for joint insureds.
49
<PAGE>
MATURITY PROCEEDS (REFERENCE PAGE 25). The maturity date is the contract
anniversary nearest the younger insured's 100th birthday. On the maturity date,
ML of New York will pay the net cash surrender value to the contract owner,
provided either insured is living.
OTHER CONTRACT PROVISIONS
INCONTESTABILITY (REFERENCE PAGE 27). ML of New York will not contest the
validity of a Contract after it has been in effect during the lifetime of either
insured for two years from the issue date. It will not contest any change in
face amount requested after the change has been in effect during the lifetime of
either insured for two years from the date of the change. Nor will ML of New
York contest any amount of death benefit attributable to an additional payment
which requires evidence of insurability after the death benefit has been in
effect during the lifetime of either insured for two years from the date the
payment has been received and accepted.
PAYMENT IN CASE OF SUICIDE (REFERENCE PAGE 27). If either insured commits
suicide within two years from the issue date, ML of New York will pay only a
limited benefit and terminate the Contract. The benefit will be equal to the
payments made reduced by any debt.
If either insured commits suicide within two years of the effective date of any
increase in face amount requested, the coverage attributable to the increase
will be terminated and a limited benefit will be paid. The benefit will be
limited to the amount of mortality cost deductions made for the increase.
If either insured commits suicide within two years of any date an additional
payment is received and accepted, the coverage attributable to the payments will
be terminated and only a limited benefit will be paid. The benefit will be equal
to the payment less any debt attributable to amounts borrowed during the two
years from the date the payment was received and accepted.
ESTABLISHING SURVIVORSHIP (ONLY APPLICABLE TO JOINT INSUREDS). If ML of New
York is unable to determine which of the insureds was the last survivor on the
basis of the proofs of death provided, it will consider insured No. 1 as
designated in the application to be the last surviving insured.
Within 90 days of the death of the first insured, the owner may elect to apply
the amount of the limited benefit to a single life contract on the life of the
surviving insured, subject to the following provisions:
- the new contract's issue date will be the date of death of the deceased
insured;
- the insurance age will be surviving insured's attained age on the new
contract's issue date;
- no medical examination or other evidence of insurability will be required
for the new contract;
- the face amount of the new contract will be determined by applying the
limited benefit amount as a single premium payment under the new contract.
The face amount of the new contract may not exceed the face amount of this
Contract;
- a written request for a new contract must be received at the Service
Center;
- the new contract cannot involve any other life;
- additional benefits or riders available on this Contract will be available
with the new contract only with ML of New York's consent;
- the new contract will be issued at ML of New York's then current rates for
the surviving insured's attained age, based on the underwriting class
assigned to the surviving insured when this Contract was underwritten. The
underwriting class for the new contract may differ from that of this
Contract; and
- if the amount of insurance that would be purchased under the new contract
falls below the minimum insurance amounts currently allowed, this option
will not be available.
50
<PAGE>
INCOME PLANS (REFERENCE PAGE 27)
If no plan has been chosen when the last surviving insured dies, the beneficiary
has one year to apply the death benefit proceeds either paid or payable to him
or her to one or more of the income plans.
MORE ABOUT ML LIFE INSURANCE COMPANY OF NEW YORK
DIRECTORS AND EXECUTIVE OFFICERS
ML of New York's directors and executive officers and their positions with the
Company are as follows:
<TABLE>
<CAPTION>
NAME POSITION(S) WITH THE COMPANY
- ------------------------ -----------------------------------------------
<S> <C>
Anthony J. Vespa Chairman of the Board, President, and Chief
Executive Officer
Joseph E. Crowne Director, Senior Vice President, Chief
Financial Officer, Chief Actuary, and
Treasurer
Barry G. Skolnick Director, Senior Vice President, and General
Counsel
David M. Dunford Director, Senior Vice President, and Chief
Investment Officer
John C.R. Hele Director and Senior Vice President
Frederick J.C. Butler Director
Michael P. Cogswell Director, Vice President, and Senior Counsel
Sandra K. Cox Director
Robert L. Israeloff Director
Allen N. Jones Director
Cynthia L. Kahn Director
Robert A. King Director
Irving M. Pollack Director
William A. Wilde Director
Robert J. Boucher Senior Vice President, Variable Life
Administration
</TABLE>
Each director is elected to serve until the next annual meeting of shareholders
or until his or her successor is elected and shall have qualified. Some
directors have held various executive positions with insurance company
subsidiaries of the Company's indirect parent, Merrill Lynch & Co., Inc. The
principal positions of the Company's directors and executive officers for the
past five years are listed below:
Mr. Vespa joined ML of New York in February 1994. Since February 1994, he has
held the position of Senior Vice President of Merrill Lynch, Pierce, Fenner &
Smith Incorporated. From February 1991 to February 1994, he held the position of
District Director and First Vice President of Merrill Lynch, Pierce, Fenner &
Smith Incorporated. From September 1988 to February 1991, he held the position
of Senior Resident Vice President of Merrill Lynch, Pierce, Fenner & Smith
Incorporated.
Mr. Crowne joined ML of New York in June 1991. From January 1989 to May 1991, he
was a Principal with Coopers & Lybrand.
Mr. Skolnick joined ML of New York in November 1989. He joined Merrill Lynch,
Pierce, Fenner & Smith Incorporated in July 1984. Since May 1992, he has held
the position of Assistant General Counsel of Merrill Lynch & Co., Inc. and First
Vice President of Merrill Lynch, Pierce, Fenner & Smith Incorporated. Prior to
May 1992, he held the position of Senior Counsel of Merrill Lynch & Co., Inc.
51
<PAGE>
Mr. Dunford joined ML of New York in July 1990. He joined Merrill Lynch, Pierce,
Fenner & Smith Incorporated in September 1989. Prior to September 1989, he held
the position of President of Travelers Investment Management Co.
Mr. Butler joined ML of New York in April 1991. Since November 1991, he has held
the position of Chairman of Butler, Chapman & Co., Inc. Prior to April 1991, he
served as Managing Director of the Investment Banking Division of Merrill Lynch
& Co., Inc.
Mr. Cogswell has been with ML of New York since November of 1990. Prior to
November of 1990, he was an Assistant Counsel of UNUM Life Insurance Company.
Ms. Cox joined ML of New York in February 1991. Prior to February 1991, she
served as Annuity Product Manager with Merrill Lynch Life Agency Inc.
Mr. Hele joined ML of New York in September 1990. He joined Merrill Lynch,
Pierce, Fenner & Smith Incorporated in August 1988.
Mr. Israeloff joined ML of New York in April 1991. Since 1964, he has been
Chairman and Executive Partner of Israeloff, Trattner & Co., CPAs, P.C., a
public accounting firm.
Mr. Jones joined ML of New York in June 1992. Since May 1992, he has held the
position of Senior Vice President of Merrill Lynch, Pierce, Fenner & Smith
Incorporated. From June 1992 to February 1994, he held the position of Chairman
of the Board, President, and Chief Executive Officer of ML of New York. From
January 1992 to June 1992, he held the position of First Vice President of
Merrill Lynch, Pierce, Fenner & Smith Incorporated. From January 1991 to January
1992, he held the position of District Director of Merrill Lynch, Pierce, Fenner
& Smith Incorporated. Prior to January 1991, he held the position of Senior
Resident Vice President of Merrill Lynch, Pierce, Fenner & Smith Incorporated.
Ms. Kahn joined ML of New York in November 1993. She is a partner at the law
firm of Rogers & Wells. She has been associated with Rogers & Wells since 1984.
Mr. King joined ML of New York in April 1991. Since February 1991, he has been
Vice President for Finance at Marymount College, Tarrytown, New York. From March
1973 until February 1991, he served as Managing Director of Merrill Lynch
Capital Markets.
Mr. Pollack joined ML of New York in April 1991. In 1980, he retired from the
Securities and Exchange Commission after thirty years of service, and having
served as an SEC Commissioner from 1974 to 1980. Since 1980, he has practiced
law and been a private consultant in the securities and capital markets fields.
Mr. Wilde joined ML of New York in March 1991. He joined Merrill Lynch, Pierce,
Fenner & Smith Incorporated in 1976. Since 1985, he has been a Director and
Senior Vice President of Merrill Lynch Life Agency Inc.
Mr. Boucher joined ML of New York in May 1992. Prior to May 1992, he held the
position of Vice President of Monarch Financial Services, Inc. (formerly
Monarch Resources, Inc.).
No shares of ML of New York are owned by any of its officers or directors, as it
is a wholly owned subsidiary of Merrill Lynch Insurance Group, Inc. The officers
and directors of ML of New York, both individually and as a group, own less than
one percent of the outstanding shares of common stock of Merrill Lynch & Co.,
Inc.
52
<PAGE>
SERVICES ARRANGEMENT
ML of New York and its parent, Merrill Lynch Insurance Group ("MLIG"), are
parties to a service agreement pursuant to which MLIG has agreed to provide
certain data processing, legal, actuarial, management, advertising and other
services to ML of New York, including services related to the Separate Account
and the Contracts. Expenses incurred by MLIG in relation to this service
agreement are reimbursed by ML of New York on an allocated cost basis. Charges
billed to ML of New York by MLIG pursuant to the agreement were $5.7 million
during 1993.
STATE REGULATION
ML of New York is subject to the laws of the State of New York and to the
regulations of the New York Insurance Department (the "Department"). A detailed
financial statement in the prescribed form (the "Annual Statement") is filed
with the Department each year covering ML of New York's operations for the
preceding year and its financial condition as of the end of that year.
Regulation by the Department includes periodic examination to determine contract
liabilities and reserves so that the Department may certify that these items are
correct. ML of New York's books and accounts are subject to review by the
Department at all times. A full examination of ML of New York's operations is
conducted periodically by the Department and under the auspices of the National
Association of Insurance Commissioners. ML of New York is also subject to the
insurance laws and regulations of all jurisdictions in which it is licensed to
do business.
LEGAL PROCEEDINGS
There are no legal proceedings to which the Separate Account is a party or to
which the assets of the Separate Account are subject. ML of New York and Merrill
Lynch, Pierce, Fenner & Smith Incorporated are engaged in various kinds of
routine litigation that, in the Company's judgment, is not material to ML of New
York's total assets or to Merrill Lynch, Pierce, Fenner & Smith Incorporated.
EXPERTS
The financial statements of ML of New York as of December 31, 1993 and 1992 and
for each of the three years in the period ended December 31, 1993 and of the
Separate Account as of December 31, 1993 and 1992 and for each of the periods
presented, included in this Prospectus have been audited by Deloitte & Touche,
independent auditors, as stated in their reports appearing herein, and have been
so included in reliance upon the reports of such firm given upon their authority
as experts in accounting and auditing. Other financial statements included in
the Prospectus are unaudited. Deloitte & Touche's principal business address is
1633 Broadway, New York, New York 10019-6754.
Actuarial matters included in this Prospectus have been examined by Joseph E.
Crowne, F.S.A., Chief Actuary and Chief Financial Officer of ML of New York, as
stated in his opinion filed as an exhibit to the registration statement.
LEGAL MATTERS
The organization of the Company, its authority to issue the Contract, and the
validity of the form of the Contract have been passed upon by Barry G. Skolnick,
ML of New York's Senior Vice President and General Counsel. Sutherland, Asbill &
Brennan of Washington, D.C. has provided advice on certain matters relating to
federal securities laws.
REGISTRATION STATEMENTS
Registration statements have been filed with the Securities and Exchange
Commission under the Securities Act of 1933 and the Investment Company Act of
1940 that relate to the Contract and its investment options. This Prospectus
does not contain all of the information in the registration statements as
permitted by Securities and Exchange Commission regulations. The omitted
information can be obtained from the Securities and Exchange Commission's
principal office in Washington, D.C., upon payment of a prescribed fee.
FINANCIAL STATEMENTS
The financial statements of ML of New York, included herein, should be
distinguished from the financial statements of the Separate Account and should
be considered only as bearing upon the ability of ML of New York to meet its
obligations under the Contracts.
53
To the Board of Directors of
ML Life Insurance Company of New York
We have audited the accompanying statements of net assets of
ML of New York Variable Life Separate Account II (the
Account) as of December 31, 1993 and 1992 and the related
statements of earnings and changes in net assets for the
periods presented. These financial statements are the
responsibility of the management of ML Life Insurance
Company of New York. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally
accepted auditing standards. Those standards require that
we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the
financial statements. Our procedures included confirmation
of mutual fund securities owned at December 31, 1993, by
correspondence with the funds' transfer agent. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as
evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our
opinion.
In our opinion, such financial statements present fairly, in
all material respects, the financial position of the Account
at December 31, 1993 and December 31, 1992 and the results
of its operations and the changes in its net assets for the
periods presented in conformity with generally accepted
accounting principles.
Our audits were conducted for the purpose of forming an
opinion on the basic financial statements taken as a whole.
The supplemental schedules included herein are presented for
the purpose of additional analysis and are not a required
part of the basic financial statements. These schedules are
the responsibility of the Company's management. Such
schedules have been subjected to the auditing procedures
applied in our audits of the basic financial statements and,
in our opinion, are fairly stated in all material respects
when considered in relation to the basic financial
statements taken as a whole.
/s/ Deloitte & Touche
February 16, 1994
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
STATEMENT OF NET ASSETS AT DECEMBER 31, 1993
==============================================
<TABLE>
<CAPTION>
Market
Cost Shares Value
=============== =============== ===============
<S> <C> <C> <C>
ASSETS
Investments in Merrill Lynch Series Fund, Inc. (Note B):
Money Reserve Portfolio $ 860,290 860,290 $ 860,290
Intermediate Government Bond Portfolio 18,207 1,509 18,134
Long-Term Corporate Bond Portfolio 45,431 3,638 45,797
Capital Stock Portfolio 179,053 7,574 194,888
Growth Stock Portfolio 259,334 10,944 269,761
Multiple Strategy Portfolio 567,971 31,010 615,234
High Yield Portfolio 69,733 7,390 71,537
Natural Resources Portfolio 39,995 5,158 38,836
Global Strategy Portfolio 689,299 47,894 738,525
Balanced Portfolio 159,042 10,965 160,308
--------------- ---------------
2,888,355 3,013,310
--------------- ---------------
Investment in Unit Investment Trusts (Note B):
Stripped ("Zero") U.S. Treasury Securities, Series A through J:
1995 Trust 1,750 1,895 1,759
1996 Trust 1,999 2,221 2,028
1997 Trust 2,027 2,344 2,032
1998 Trust 2,929 3,607 2,938
1999 Trust 1,029 1,350 1,034
2000 Trust 29,412 40,618 29,276
2005 Trust 1,467 2,945 1,498
2013 Trust 1,334 4,697 1,293
--------------- ---------------
41,947 41,858
--------------- ---------------
Total Assets $ 2,930,302 3,055,168
=============== ---------------
LIABILITIES
Payable to ML Series Fund, Inc. 30,353
Payable to ML Life Insurance Company of New York 75,638
---------------
Total Liabilities 105,991
---------------
Net Assets $ 2,949,177
===============
</TABLE>
See Notes to Financial Statements
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
STATEMENT OF NET ASSETS AT DECEMBER 31, 1992
=============================================
<TABLE>
<CAPTION> Market
Cost Shares Value
=============== =============== ===============
<S> <C> <C> <C>
ASSETS
Investments in Merrill Lynch Series Fund, Inc. (Note B):
Money Reserve Portfolio $ 53,675 53,675 $ 53,675
Multiple Strategy Portfolio 6,464 352 6,576
--------------- ---------------
Total Assets $ 60,139 60,251
=============== ---------------
LIABILITIES
Payable to ML Life Insurance Company of New York 53,610
---------------
Total Liabilities 53,610
---------------
Net Assets $ 6,641
===============
</TABLE>
See Notes to Financial Statements
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
STATEMENT OF EARNINGS AND CHANGES IN NET ASSETS
FOR THE YEAR ENDED DECEMBER 31, 1993 AND THE PERIOD FROM JUNE 30, 1992
(Date of Inception) TO DECEMBER 31, 1992
=====================================================================
<TABLE>
<CAPTION>
1993 1992
=============== ===============
<S> <C> <C>
Reinvested Dividends $ 32,519 $ 104
Net Gain (Loss):
Realized 3,446 0
Unrealized 124,757 112
--------------- ---------------
Investment Earnings 160,722 216
Mortality and Expense Charges (Note C) (11,042) (3)
Transaction Charges ( Note D ) (45) 0
--------------- ---------------
Net Earnings 149,635 213
Capital Shares Transactions:
Transfers of Net Premiums 2,646,293 5,882
Transfers of Policy Loading, Net 203,968 582
Transfers Due to Other Terminations (470) 0
Transfers Due to Policy Loans (2,977) 0
Transfers of Cost of Insurance (53,905) (36)
Transfers of Loan Processing Charges (8) 0
--------------- ---------------
Increase in Net Assets 2,942,536 6,641
Net Assets Beginning Balance 6,641 0
--------------- ---------------
Net Assets Ending Balance $ 2,949,177 $ 6,641
=============== ===============
</TABLE>
See Notes to Financial Statements
<PAGE>
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
Notes to Financial Statements
December 31, 1993
Note - A ML of New York Variable Life Separate Account
II ("Account"), a separate account of ML Life Insurance
Company of New York ("ML of New York") was established by a
board of directors resolution on December 4, 1991 and is
governed by New York State Insurance Law. The Account is a
registered unit investment trust under the Investment
Company Act of 1940 and consists of twenty-eight investment
divisions (twenty-nine during the year). Ten of the
divisions each invest in the securities of a single mutual
fund portfolio of Merrill Lynch Series Fund, Inc. ("Series
Fund"). The portfolios of the Series Fund have varying
investment objectives relative to growth of capital and
income. The Series Fund receives investment advice from
Merrill Lynch Asset Management, L.P. for a fee calculated at
an effective annual rate of .50% on the first $250 million
of the aggregate average daily net assets of the investment
divisions investing in the Series Fund with declining rates
to .30% of such assets over $800 million. Eighteen of the
divisions (nineteen during the year) invest in the
securities of a single trust of the Merrill Lynch Fund of
Stripped ("Zero") U.S. Treasury Securities, Series A through
J. Each trust of the Series consists of Stripped Treasury
Securities with a fixed maturity date and a Treasury Note
deposited to provide income to pay expenses of the trust.
The Account was formed by ML of New York, an
indirect wholly-owned subsidiary of Merrill Lynch & Co.,
Inc. ("Merrill") to support ML of New York's operations
respecting certain variable life insurance contracts
("Contracts"). The assets of the Account are the property
of ML of New York. The portion of the Account's assets
applicable to the Contracts are not chargeable with
liabilities arising out of any other business ML of New York
may conduct.
The change in net assets maintained in the Account
provides the basis for the periodic determination of the
amount of increased or decreased benefits under the
Contracts.
The net assets may not be less than the amount
required under New York insurance law to provide for death
benefits (without regard to the minimum death benefit
guarantee) and other Contract benefits.
Note - B The significant accounting policies of the
Account are as follows:
* Investments are made in the divisions and are
valued at the net asset values of the respective
Portfolios.
* Transactions are recorded on the trade date.
* Income from dividends is recognized as of the ex-
dividend date. All dividends are automatically
reinvested.
* Realized gains and losses on the sales of
investments are computed on the first in first
out method.
* The operations of the Account are included in the
Federal income tax return of ML of New York. Un-
der the provisions of the Contracts, ML of New
York has the right to charge the Account for any
Federal income tax attributable to the Account.
No charge is currently being made against the
Account for income taxes since, under current
tax law, ML of New York pays no tax on investment
income and capital gains reflected in variable
life insurance contract reserves. However, ML of
New York retains the right to charge for any
Federal income tax incurred which is attribut-
able to the Account if the law is changed. Con-
tract loading, however, includes a charge for a
<PAGE>
significantly higher Federal income tax liability
of ML of New York (see Note C). Charges for state
and local taxes, if any, attributable to the
Account may also be made.
Note - C ML of New York assumes mortality and expense
risks related to the operations of the Account and deducts a
daily charge from the assets of the Account to cover these
risks. The daily charges are equal to a rate of .90% (on
an annual basis) of the net assets for Contract owners.
ML of New York makes certain deductions from each
premium. For certain Contracts, the deductions are made
before the premium is allocated to the Account. For other
Contracts, the deductions are taken in equal installments on
the first through tenth contract anniversaries. The
deductions are for (1) sales load, (2) Federal taxes, and
(3) state and local premium taxes.
In addition, for certain Contracts, the cost of
providing life insurance coverage for the insureds will be
deducted from the investment base on the contract date and
all subsequent processing dates. For other Contracts, the
cost of providing life insurance coverage will be deducted
only on processing dates. This cost will vary dependent
upon the insured's underwriting class, sex, attained age of
each insured and the Contract's net amount at risk.
Note - D ML of New York pays all transaction charges to
Merrill Lynch, Pierce, Fenner & Smith Inc., sponsor of the
unit investment trusts, on the sale of Series A through J
Unit Investment Trusts units to the Account and deducts a
daily asset charge against the assets of each trust for the
reimbursement of these transaction charges. The asset
charge is equivalent to an effective annual rate of .34%
(annually at the beginning of the year) of net assets for
Contract owners.
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
SUPPLEMENTAL CONSOLIDATING SCHEDULE OF EARNINGS AND CHANGES IN NET ASSETS
FOR THE YEAR ENDED DECEMBER 31, 1993
========================================================================
<TABLE>
<CAPTION>
Divisions Investing In
=====================================================================
Intermediate Long-Term
Money Government Corporate Capital
Reserve Bond Bond Stock
Portfolio Portfolio Portfolio Portfolio
=============== =============== =============== ===============
<S> <C> <C> <C> <C>
Reinvested Dividends $ 17,196 $ 504 $ 1,936 $ 387
Net Gain (Loss):
Realized 0 8 45 295
Unrealized 0 (73) 366 15,835
--------------- --------------- --------------- ---------------
Investment Earnings (Losses) 17,196 439 2,347 16,517
Mortality and Expense Charges (Note C) (3,568) (79) (275) (638)
Transaction Charges (Note D) 0 0 0 0
--------------- --------------- --------------- ---------------
Net Earnings (Losses) 13,628 360 2,072 15,879
Capital Shares Transactions:
Transfers of Net Premiums 2,584,685 0 0 1,537
Transfers of Policy Loading, Net 200,287 6 14 (58)
Transfers Due to Terminations (362) (6) (15) 185
Transfers Due to Policy Loans (2,977) 0 0 0
Transfers of Cost of Insurance (18,610) (362) (384) (3,323)
Transfers of Loan Processing Charges (8) 0 0 0
Transfers Among Investment Divisions (1,985,375) 18,033 41,553 179,631
--------------- --------------- --------------- ---------------
Increase in Net Assets 791,268 18,031 43,240 193,851
Net Assets Beginning Balance 68 0 0 0
--------------- --------------- --------------- ---------------
Net Assets Ending Balance $ 791,336 $ 18,031 $ 43,240 $ 193,851
=============== =============== =============== ===============
</TABLE>
<TABLE>
<CAPTION>
Growth Multiple High Natural
Stock Strategy Yield Resources
Portfolio Portfolio Portfolio Portfolio
=============== =============== =============== ===============
<S> <C> <C> <C> <C>
Reinvested Dividends $ 430 $ 4,342 $ 3,007 $ 167
Net Gain (Loss):
Realized 99 352 77 46
Unrealized 10,427 47,151 1,804 (1,158)
--------------- --------------- --------------- ---------------
Investment Earnings (Losses) 10,956 51,845 4,888 (945)
Mortality and Expense Charges (Note C) (527) (2,200) (311) (158)
Transaction Charges (Note D) 0 0 0 0
--------------- --------------- --------------- ---------------
Net Earnings (Losses) 10,429 49,645 4,577 (1,103)
Capital Shares Transactions:
Transfers of Net Premiums 0 5,882 0 0
Transfers of Policy Loading, Net 84 715 22 12
Transfers Due to Terminations 160 (150) (13) (12)
Transfers Due to Policy Loans 0 0 0 0
Transfers of Cost of Insurance (3,354) (10,483) (975) (527)
Transfers of Loan Processing Charges 0 0 0 0
Transfers Among Investment Divisions 258,708 557,504 65,233 40,260
--------------- --------------- --------------- ---------------
Increase in Net Assets 266,027 603,113 68,844 38,630
Net Assets Beginning Balance 0 6,573 0 0
--------------- --------------- --------------- ---------------
Net Assets Ending Balance $ 266,027 $ 609,686 $ 68,844 $ 38,630
=============== =============== =============== ===============
</TABLE>
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
SUPPLEMENTAL CONSOLIDATING SCHEDULE OF EARNINGS AND CHANGES IN NET ASSETS
FOR THE YEAR ENDED DECEMBER 31, 1993
===============================================================================
<TABLE>
<CAPTION>
Divisions Investing In
=====================================================================
Global
Strategy Balanced 1993 1995
Portfolio Portfolio Trust Trust
=============== =============== =============== ===============
<S> <C> <C> <C> <C>
Reinvested Dividends $ 4,382 $ 168 $ 0 $ 0
Net Gain (Loss):
Realized 1,775 85 38 0
Unrealized 49,225 1,266 0 9
--------------- --------------- --------------- ---------------
Investment Earnings (Losses) 55,382 1,519 38 9
Mortality and Expense Charges (Note C) (2,690) (475) (9) (1)
Transaction Charges (Note D) 0 0 (4) 0
--------------- --------------- --------------- ---------------
Net Earnings (Losses) 52,692 1,044 25 8
Capital Shares Transactions:
Transfers of Net Premiums 1,643 0 4,775 1,671
Transfers of Policy Loading, Net 348 50 225 79
Transfers Due to Other Terminations (206) (50) 0 (1)
Transfers Due to Policy Loans 0 0 0 0
Transfers of Cost of Insurance (11,482) (3,140) (98) (30)
Transfers of Loan Processing Charges 0 0 0 0
Transfers Among Investment Divisions 685,473 161,550 (4,927) 1
--------------- --------------- --------------- ---------------
Increase in Net Assets 728,468 159,454 0 1,728
Net Assets Beginning Balance 0 0 0 0
--------------- --------------- --------------- ---------------
Net Assets Ending Balance $ 728,468 $ 159,454 $ 0 $ 1,728
=============== =============== =============== ===============
</TABLE>
<TABLE>
<CAPTION>
Divisions Investing In
=====================================================================
1996 1997 1998 1999
Trust Trust Trust Trust
=============== =============== =============== ===============
<S> <C> <C> <C> <C>
Reinvested Dividends $ 0 $ 0 $ 0 $ 0
Net Gain (Loss):
Realized 1 97 21 47
Unrealized 29 5 10 5
--------------- --------------- --------------- ---------------
Investment Earnings (Losses) 30 102 31 52
Mortality and Expense Charges (Note C) (6) (8) (8) (6)
Transaction Charges (Note D) (2) (3) (3) (2)
--------------- --------------- --------------- ---------------
Net Earnings (Losses) 22 91 20 44
Capital Shares Transactions: 0 0 0 0
Transfers of Net Premiums 1,433 5,348 3,820 2,388
Transfers of Policy Loading, Net 68 253 181 113
Transfers Due to Other Terminations 11 (1) (1) 0
Transfers Due to Policy Loans 0 0 0 0
Transfers of Cost of Insurance (55) (55) (97) (50)
Transfers of Loan Processing Charges 0 0 0 0
Transfers Among Investment Divisions 538 (3,615) (1,001) (1,466)
--------------- --------------- --------------- ---------------
Increase in Net Assets 2,017 2,021 2,922 1,029
Net Assets Beginning Balance 0 0 0 0
--------------- --------------- --------------- ---------------
Net Assets Ending Balance $ 2,017 $ 2,021 $ 2,922 $ 1,029
=============== =============== =============== ===============
</TABLE>
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
SUPPLEMENTAL CONSOLIDATING SCHEDULE OF EARNINGS AND
CHANGES IN NET ASSETS FOR THE YEAR ENDED DECEMBER 31, 1993
===============================================================
<TABLE>
<CAPTION>
Divisions Investing In
=====================================================================
2000 2005 2013
Trust Trust Trust Total
=============== =============== =============== ===============
<S> <C> <C> <C> <C>
Reinvested Dividends $ 0 $ 0 $ 0 $ 32,519
Net Gain (Loss):
Realized 458 2 0 3,446
Unrealized (135) 31 (40) 124,757
--------------- --------------- --------------- ---------------
Net Investment Earnings (Losses) 323 33 (40) 160,722
Mortality and Expense Charges (Note C) (74) (6) (3) (11,042)
Transaction Charges (Note D) (28) (2) (1) (45)
--------------- --------------- --------------- ---------------
Net Earnings (Losses) 221 25 (44) 149,635
Capital Shares Transactions:
Transfers of Net Premiums 33,111 0 0 2,646,293
Transfers of Policy Loading, Net 1,569 0 0 203,968
Transfers Due to Other Terminations (9) 0 0 (470)
Transfers Due to Policy Loans 0 0 0 (2,977)
Transfers of Cost of Insurance (814) (41) (25) (53,905)
Transfers of Loan Processing Charges 0 0 0 (8)
Transfers Among Investment Divisions (14,956) 1,502 1,354 0
--------------- --------------- --------------- ---------------
Increase in Net Assets 19,122 1,486 1,285 2,942,536
Net Assets Beginning Balance 0 0 0 6,641
--------------- --------------- --------------- ---------------
Net Assets Ending Balance $ 19,122 $ 1,486 $ 1,285 $ 2,949,177
=============== =============== =============== ===============
</TABLE>
<PAGE>
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
ML LIFE INSURANCE COMPANY OF NEW YORK
SUPPLEMENTAL CONSOLIDATING SCHEDULE OF EARNINGS AND CHANGES IN NET ASSETS
FOR THE PERIOD FROM JUNE 30, 1992 (Date of Inception) TO DECEMBER 31, 1992
==========================================================================
<TABLE>
<CAPTION>
Divisions Investing In
==================================================
Money Multiple
Reserve Strategy
Portfolio Portfolio Total
=============== =============== ===============
<S> <C> <C> <C>
Reinvested Dividends $ 104 $ 0 $ 104
Net Unrealized Gain 0 112 112
--------------- --------------- ---------------
Investment Earnings 104 112 216
Mortality and Expense Charges (Note C) (1) (2) (3)
--------------- --------------- ---------------
Net Earnings 103 110 213
Capital Shares Transactions:
Transfers of Net Premiums 5,882 0 5,882
Transfers of Policy Loading, Net 582 0 582
Transfers of Cost of Insurance (32) (4) (36)
Transfers Among Investment Divisions (6,467) 6,467 0
--------------- --------------- ---------------
Increase in Net Assets 68 6,573 6,641
Net Assets Beginning Balance 0 0 0
--------------- --------------- ---------------
Net Assets Ending Balance $ 68 $ 6,573 $ 6,641
=============== =============== ===============
</TABLE>
<PAGE>
INDEPENDENT AUDITORS' REPORT
The Board of Directors of
ML Life Insurance Company of New York:
We have audited the accompanying balance sheets of ML Life
Insurance Company of New York (the "Company"), a wholly-owned
subsidiary of Merrill Lynch Insurance Group, Inc., as of December
31, 1993 and 1992 and the related statements of earnings,
stockholder's equity and cash flows for each of the three years
in the period ended December 31, 1993. These financial
statements are the responsibility of the Company's management.
Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with generally accepted
auditing standards. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, such financial statements present fairly, in all
material respects, the financial position of the Company at
December 31, 1993 and 1992 and the results of its operations and
its cash flows for each of the three years in the period ended
December 31, 1993 in conformity with generally accepted
accounting principles.
As discussed in Note 1 to the financial statements, in 1993 the
Company changed its method of accounting for certain
investments in debt and equity securities to conform with
Statement of Financial Accounting Standards No. 115.
/s/Deloitte & Touche
February 28, 1994
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(A wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- ------------------------------------------------------------------
BALANCE SHEETS
AS OF DECEMBER 31, 1993 AND 1992
(Dollars in Thousands)
==============================================================================
<TABLE>
<CAPTION>
ASSETS 1993 1992
---- ----
<S> <C> <C>
INVESTMENTS:
Fixed maturity securities available for sale, at estimated fair value
(amortized cost: 1993 - $442,008; 1992 - $63,568) $ 458,916 $ 63,980
Fixed maturity securities to be held to maturity, at amortized cost
(estimated fair value: 1992 - $587,970) 0 570,243
Equity securities available for sale, at estimated fair value
(cost: 1993 - $8,387; 1992 - $9,080) 7,195 9,202
Mortgage loans on real estate 17,627 22,110
Policy loans on insurance contracts 73,380 66,037
------------ ------------
Total Investments 557,118 731,572
CASH AND CASH EQUIVALENTS 27,464 41,122
ACCRUED INVESTMENT INCOME 10,164 14,021
DEFERRED POLICY ACQUISITION COSTS 24,036 27,127
FEDERAL INCOME TAXES - DEFERRED 10,468 7,537
REINSURANCE RECEIVABLES 1,685 187
OTHER ASSETS 3,765 3,397
SEPARATE ACCOUNTS ASSETS 410,613 277,725
------------ ------------
TOTAL ASSETS $ 1,045,313 $ 1,102,688
============ ============
</TABLE>
See notes to financial statements.
<PAGE>
<TABLE>
<CAPTION>
LIABILITIES AND STOCKHOLDER'S EQUITY 1993 1992
---- ----
<S> <C> <C>
LIABILITIES:
POLICY LIABILITIES AND ACCRUALS:
Policyholders' account balances $ 523,382 $ 720,335
Claims and claims settlement expenses 5,614 3,340
------------ ------------
Total policy liabilities and accruals 528,996 723,675
OTHER POLICYHOLDER FUNDS 1,200 71
OTHER LIABILITIES 5,641 1,153
FEDERAL INCOME TAXES - CURRENT 864 691
PAYABLE TO AFFILIATES - NET 5,223 7,146
SEPARATE ACCOUNTS LIABILITIES 410,613 277,705
------------ ------------
Total Liabilities 952,537 1,010,441
------------ ------------
STOCKHOLDER'S EQUITY:
Common stock, $10 par value - 220,000 shares
authorized, issued and outstanding 2,200 2,200
Additional paid-in capital 83,006 83,006
Retained earnings 8,497 6,689
Net unrealized investment gain (loss) (927) 352
------------ ------------
Total Stockholder's Equity 92,776 92,247
------------ ------------
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY $ 1,045,313 $ 1,102,688
============ ============
</TABLE>
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(A wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- ------------------------------------------------------------------
STATEMENTS OF EARNINGS
FOR THE YEARS ENDED DECEMBER 31, 1993, 1992 AND 1991
(Dollars in Thousands)
==============================================================================
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
<S> <C> <C> <C>
REVENUES:
Investment revenue:
Net investment income $ 50,661 $ 65,378 $ 69,965
Net realized investment gains (losses) 6,131 (434) (9,685)
Policy charge revenue 8,387 7,683 7,162
------------ ------------ ------------
Total Revenues 65,179 72,627 67,442
------------ ------------ ------------
BENEFITS AND EXPENSES:
Interest credited to policyholders' account
balances 44,425 57,812 57,193
Market value adjustment expense 642 25 2
Policy benefits (reinsurance recoveries: 1993 - $2,192
1992 - $953; 1991 - $455) 1,729 594 839
Reinsurance premium ceded 1,182 1,070 1,179
Amortization of deferred policy acquisition costs 9,523 8,219 7,789
Insurance expenses and taxes 5,278 4,539 5,355
------------ ------------ ------------
Total Benefits and Expenses 62,779 72,259 72,357
------------ ------------ ------------
Earnings (Loss) Before Federal Income
Tax Provision (Benefit) 2,400 368 (4,915)
------------ ------------ ------------
FEDERAL INCOME TAX PROVISION (BENEFIT):
Current 2,842 2,373 6,475
Deferred (2,250) (2,196) (8,169)
------------ ------------ ------------
Total Federal Income Tax Provision (Benefit) 592 177 (1,694)
------------ ------------ ------------
NET EARNINGS (LOSS) $ 1,808 $ 191 $ (3,221)
============ ============ ============
</TABLE>
See notes to financial statements.
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(A wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- ------------------------------------------------------------------
STATEMENTS OF STOCKHOLDER'S EQUITY
FOR THE YEARS ENDED DECEMBER 31, 1993, 1992 AND 1991
(Dollars in Thousands)
==============================================================================
<TABLE>
<CAPTION>
Net
Additional unrealized Total
Common paid-in Retained investment stockholder's
stock capital earnings gain (loss) equity
------------ ------------ ------------ ------------ ------------
<S> <C> <C> <C> <C> <C>
BALANCE, JANUARY 1, 1991 $ 2,200 $ 56,289 $ 9,719 $ (799) $ 67,409
Capital contribution 26,717 26,717
Net loss (3,221) (3,221)
Net unrealized investment loss (274) (274)
------------ ------------ ------------ ------------ ------------
BALANCE, DECEMBER 31, 1991 2,200 83,006 6,498 (1,073) 90,631
Net earnings 191 191
Net unrealized investment gain 1,425 1,425
------------ ------------ ------------ ------------ ------------
BALANCE, DECEMBER 31, 1992 2,200 83,006 6,689 352 92,247
Net earnings 1,808 1,808
Net unrealized investment loss (1) (1,279) (1,279)
------------ ------------ ------------ ------------ ------------
BALANCE, DECEMBER 31, 1993 $ 2,200 $ 83,006 $ 8,497 $ ( 927) $ 92,776
============ ============ ============ ============ ============
</TABLE>
(1) Asset gains less adjustment of policyholders' account balances and
deferred policy acquisition costs (See Note 1).
See notes to financial statements.
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(A wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- ------------------------------------------------------------------
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1993, 1992 AND 1991
(Dollars in Thousands)
==============================================================================
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
<S> <C> <C> <C>
OPERATING ACTIVITIES:
Net earnings (loss) $ 1,808 $ 191 $ (3,221)
Adjustments to reconcile net earnings (loss) to net
cash and cash equivalents provided (used)
by operating activities:
Amortization of deferred policy acquisition
costs 9,523 8,219 7,789
Capitalization of policy acquisition costs (7,252) (2,539) (14,542)
Amortization of fixed maturity securities 918 366 (1,553)
Net realized investment (gains) losses (6,131) 434 9,685
Interest credited to policyholders' account balances 44,425 57,812 57,193
Provision (benefit) for deferred Federal
income tax (2,250) (2,196) (8,169)
Cash and cash equivalents provided (used) by
changes in operating assets and liabilities:
Accrued investment income 3,857 (27) (1,715)
Policy liabilities and accruals 2,273 448 7,825
Federal income taxes - current 173 873 5,381
Other policyholder funds 1,129 63 (744)
Payable/receivable from affiliates - net (1,923) 10,149 (3,844)
Policy loans (7,343) (12,342) (5,172)
Other, net 2,644 (2,501) 4,941
------------ ------------ ------------
Net cash and cash equivalents provided
by operating activities 41,851 58,950 53,854
------------ ------------ ------------
INVESTING ACTIVITIES:
Fixed maturity securities sold 166,033 177,835 312,618
Fixed maturity securities matured 280,484 195,691 54,073
Fixed maturity securities purchased (251,522) (323,172) (439,134)
Equity securities available for sale purchased (109) (665) (15,176)
Equity securities available for sale sold 2,885 11,886 0
Mortgage loans on real estate principal payments received 4,425 1,000 0
Mortgage loans on real estate acquired 0 (124) (123)
------------ ------------ ------------
Net cash and cash equivalents provided (used) by
investing activities 202,196 62,451 (87,742)
------------ ------------ ------------
</TABLE>
(Continued)
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(a wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- ------------------------------------------------------------------
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1993, 1992 AND 1991
(Concluded) (Dollars In Thousands)
==============================================================================
<TABLE>
<Caption
1993 1992 1991
---- ---- ----
<S> <C> <C> <C>
FINANCING ACTIVITIES:
Paid in capital from parent $ 0 $ 0 $ 26,717
Policyholders' account balances:
Deposits 33,953 5,985 23,374
Withdrawals (net of transfers to Separate Accounts) (291,658) (105,082) (24,503)
------------ ------------ ------------
Net cash and cash equivalents provided
(used) by financing activities (257,705) (99,097) 25,588
------------ ------------ ------------
NET INCREASE (DECREASE) IN CASH AND
CASH EQUIVALENTS (13,658) 22,304 (8,300)
CASH AND CASH EQUIVALENTS:
Beginning of year 41,122 18,818 27,118
------------ ------------ ------------
End of year $ 27,464 $ 41,122 $ 18,818
============ ============ ============
</TABLE>
See notes to financial statements.
<PAGE>
ML LIFE INSURANCE COMPANY OF NEW YORK
(A wholly-owned subsidiary of Merrill Lynch Insurance Group, Inc.)
- -----------------------------------------------------------------------
NOTES TO FINANCIAL STATEMENTS
YEARS ENDED DECEMBER 31, 1993, 1992 AND 1991
=======================================================================
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Reporting: ML Life Insurance Company of New York (the
"Company") is a wholly-owned subsidiary of Merrill Lynch
Insurance Group, Inc. ("MLIG"). The Company is an indirect
wholly-owned subsidiary of Merrill Lynch & Co., Inc. ("Merrill
Lynch & Co.").
The Company sells life insurance and annuity products which
comprise one business segment. The primary products that the
Company currently markets are immediate annuities, market value
adjusted annuities, variable life insurance and variable
annuities. The Company is licensed to sell insurance in nine
states, however, it currently limits its marketing activities
to the State of New York. The Company markets its products
solely through the Merrill Lynch & Co. retail network.
The accompanying financial statements have been prepared in
conformity with generally accepted accounting principles for
stock life insurance companies.
Revenue Recognition: Revenues for the Company's interest
sensitive life, interest sensitive annuity, variable life and
variable annuity products consist of policy charges for the
cost of insurance, deferred sales charges, policy
administration charges and/or withdrawal charges assessed
against policyholder account balances during the period.
Policyholders' Account Balances: Liabilities for the Company's
universal life type contracts, including its life insurance and
annuity products, are equal to the full accumulation value of
such contracts as of the valuation date plus deficiency
reserves for certain products. Interest crediting rates for
the Company's fixed rate products are as follows:
Interest sensitive life products 4.0% - 9.0%
Interest sensitive deferred annuities 4.0% - 9.0%
Immediate annuities 4.0% - 10.0%
These rates may be changed at the option of the Company,
subject to minimum guarantees, after initial guaranteed rates
expire.
Liabilities for unpaid claims equal the death benefit for those
claims which have been reported to the Company and an estimate
based upon prior experience for those claims which are
unreported as of the valuation date.
Reinsurance: Effective during 1992, the Company adopted
Statement of Financial Accounting Standards ("SFAS") No. 113
"Accounting and Reporting for Reinsurance of Short Duration and
Long Duration Contracts" ("SFAS No. 113") which requires that
reinsurance receivables and prepaid reinsurance premium ceded
be reported as assets. SFAS No. 113 eliminates the practice by
insurance enterprises of reporting assets and liabilities
relating to reinsured contracts net of the effects of
reinsurance. The impact of adopting SFAS No. 113 was not
material.
<PAGE>
In the normal course of business, the Company seeks to limit
its exposure to loss on any single insured life and to recover
a portion of benefits paid by ceding reinsurance to other
insurance enterprises or reinsurers under indemnity reinsurance
agreements, primarily excess coverage and coinsurance
agreements. On life insurance contracts which the Company is
currently marketing, the maximum amount of mortality risk
retained by the Company is $500,000 on a single life.
Indemnity reinsurance agreements do not relieve the Company
from its obligations to policyholders. Failure of reinsurers
to honor their obligations could result in losses to the
Company. The Company regularly evaluates the financial
condition of its reinsurers so as to minimize its exposure to
significant losses from reinsurer insolvencies. The Company
holds collateral under reinsurance agreements in the form of
letters of credit and amounts withheld totaling $230,000 that
can be drawn upon for delinquent reinsurance recoverables.
As of December 31, 1993, the Company had life insurance in-
force which was ceded to other life insurance companies of
$168,098,000.
Deferred Policy Acquisition Costs: Policy acquisition costs
for life and annuity contracts are deferred and amortized based
on the estimated future gross profits for each group of
contracts. These future gross profit estimates are subject to
periodic evaluation by the Company, with necessary revisions
applied against amortization to date.
Policy acquisition costs are principally commissions and a
portion of certain other expenses relating to policy
acquisition, underwriting and issuance, which are primarily
related to and vary with the production of new business.
Certain costs and expenses reported in the statements of
earnings are net of amounts deferred. Policy acquisition
costs can also arise from the acquisition or reinsurance of
existing in-force policies from other insurers. These costs
include ceding commissions and professional fees related to the
reinsurance assumed.
Included in deferred policy acquisition costs are those costs
related to the acquisition by assumption reinsurance of
insurance contracts from unaffiliated insurers. The deferred
costs will be amortized in proportion to the future gross
profits over the anticipated life of the acquired insurance
contracts utilizing an interest methodology.
In December 1990, the Company entered into an assumption
reinsurance agreement with a non-affiliated insurer (See Note
6). The acquisition costs relating to this agreement are being
amortized over a twenty-year period using an effective interest
rate of 9.01%. This reinsurance agreement provides for payment
of contingent ceding commissions based upon the persistency and
mortality experience of the insurance contracts assumed. Any
payments made for the contingent ceding commissions will be
capitalized and amortized using an identical methodology as
that used for the initial acquisition costs. The following is
a reconciliation of the acquisition costs for the reinsurance
transaction for the three years ended December 31,:
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Beginning balance $ 16,925 $ 18,193 $ 3,593
Capitalized amounts 843 533 16,900
Interest accrued 1,478 1,865 1,704
Amortization (3,632) (3,666) (4,004)
------------ ------------ ------------
Ending balance $ 15,614 $ 16,925 $ 18,193
============ ============ ============
</TABLE>
<PAGE>
The following table presents the expected amortization of these
deferred acquisition costs over the next five years. The
amortization may be adjusted based on periodic evaluation of
the expected gross profits on the reinsured policies.
1994 $2,268,000
1995 2,160,000
1996 1,944,000
1997 1,512,000
1998 1,075,000
Investments: Effective December 31, 1993, the Company has
adopted SFAS No. 115 "Accounting for Certain Investments in
Debt and Equity Securities" ("SFAS No. 115"). In compliance
with SFAS No. 115, the Company classifies its investments in
fixed maturity securities and equity securities in the
available for sale category. Available for sale securities
include both fixed maturity and equity securities. These
securities may be sold for the Company's general liquidity
needs, asset/liability management strategy, credit dispositions
and investment opportunities. These securities are carried at
estimated fair value with unrealized gains and losses included
in stockholder's equity (net of tax). If a decline in value of a
security is determined by management to be other than temporary,
the carrying value is adjusted to the estimated fair value at the
date of this determination and recorded in the net realized
investment gains (losses) caption of the statement of earnings.
SFAS No. 115 allows securities to be carried at amortized cost
if the Company has both the ability and intent to hold these
securities to maturity. The Company has determined that it can
not guarantee that it will not have the need or opportunity to
sell any particular security in its investment holdings. As
such, the Company did not utilize this classification as of
December 31, 1993. Additionally, SFAS No. 115 requires that
securities held for short-term sale are to be carried at fair
value with the change in fair value being recorded as a
component of the statement of earnings. The Company has no
securities at December 31, 1993 that are held for this purpose.
In compliance with a recent Securities and Exchange Commissions
("SEC") staff announcement, the Company has recorded certain
adjustments to deferred policy acquisition costs and
policyholders' account balances in conjunction with its
adoption of SFAS No. 115. The SEC requires that companies
adjust those assets and liabilities that would have been
adjusted had the unrealized investment gains or losses from
securities classified as available for sale actually been
realized with corresponding credits or charges reported
directly to shareholder's equity. Accordingly, deferred policy
acquisition costs have been decreased by $818,000 and
policyholders' account balances have been increased by
$16,327,000 as of December 31, 1993.
As of December 31, 1992, the Company classified its investments
in fixed maturity securities as either "to be held to maturity"
or "available for sale." Fixed maturity securities to be held
to maturity were stated in the balance sheets at amortized
cost. Fixed maturity securities available for sale were stated
at estimated fair value. The net unrealized gains and losses on
these securities are reflected as a component of stockholder's
equity.
For fixed maturity securities, premiums are amortized to the
earlier of the call or maturity date, discounts are accrued to
the maturity date and interest income is accrued daily.
Realized gains and losses on the sale or maturity of the
investment are determined on the basis of identified cost.
Fixed maturity securities may contain securities which are
considered high yield. The Company defines high yield fixed
maturity securities as unsecured corporate debt obligations
which do not have a rating equivalent to Standard and Poor's
(or similar rating agency) BBB or higher, and are not
guaranteed by an agency of the federal government. Probable
losses are recognized in the period that a decline in value is
determined to be other than temporary.
<PAGE>
Mortgage loans on real estate are stated at unpaid principal
balances net of valuation allowances. Such valuation
allowances are based on the decline in value expected by
management to be realized on in-substance foreclosures of
mortgage loans and on mortgage loans which management believes
may not be collectible in full. In establishing valuation
allowances management considers, among other things, the
estimated fair value of the underlying collateral.
The Company has previously made mortgage loans collateralized
by real estate. The return on and the ultimate recovery of
these loans and investments are generally dependent on the
successful operation, sale or refinancing of the real estate.
In many parts of the country, current real estate markets are
characterized by above-normal vacancy rates, a lack of ready
sources or credit for real estate financing, reduced or
declining real estate values, and similar factors.
The Company employs a system to monitor the effects of current
and expected market conditions and other factors when assessing
the collectability of mortgage loans. When, in management's
judgment, these assets are impaired, appropriate losses are
recorded. Such estimates necessarily include assumptions,
which may include anticipated improvements in selected market
conditions for real estate, which may or may not occur. The
more significant assumptions management considers involve
estimates of the following: lease, absorption and sales rates;
real estate values and rates of return; operating expenses;
inflation; and sufficiency of any collateral independent of the
real estate.
Resulting from the Company's management and valuation of its
mortgage loans on real estate, management believes that the
carrying value approximates the fair value of these
investments.
During 1993 the Financial Accounting Standards Board issued
SFAS No. 114 "Accounting by Creditors for Impairment of a Loan"
("SFAS No. 114"). SFAS No. 114 requires that for impaired
loans, the impairment shall be measured based on the present
value of expected future cash flows discounted at the loan's
effective interest rate or the fair value of the collateral.
Impairments of mortgage loans on real estate are established as
valuation allowances and recorded to net realized investment
gains (losses). SFAS No. 114 must be adopted for fiscal years
beginning after December 15, 1994. The Company has
decided not to early adopt this statement. The Company
estimates that the impact on both financial position and
earnings from adopting SFAS No. 114 would be immaterial.
Policy loans on insurance contracts are stated at unpaid
principal balances. The Company estimates the fair market
value of policy loans as equal to the book value of the loans.
Policy loans are fully collateralized by the account value of
the associated insurance contracts, and the spread between the
policy loan interest rate and the interest rate credited to the
account value held as collateral is fixed.
Fair Value of Financial Instruments: Beginning in 1992, the
Company adopted SFAS No. 107 "Disclosures about Fair Value of
Financial Instruments", which requires companies to report the
fair value of financial instruments for certain assets and
liabilities both on and off-balance sheet.
Federal Income Taxes: Effective the first quarter 1992, the
Company adopted SFAS No. 109 "Accounting for Income Taxes"
("SFAS No. 109") which requires an asset and liability method
in recording income taxes on all transactions that have been
recognized in the financial statements. SFAS No. 109 provides that
deferred taxes be adjusted to reflect tax rates at which future
tax liabilities or assets are expected to be settled or
realized. Previously, the Company accounted for income taxes
in accordance with SFAS No. 96, "Accounting for Income Taxes."
The effect of adopting SFAS No. 109 was not material.
Separate Accounts: The Separate Accounts are established in
conformity with New York insurance law, the Company's
domiciliary state, and under such law, if and to the extent
provided under the applicable insurance contracts, assets held
in the Separate Accounts equal to the reserves and other
contract liabilities with respect to the Separate Accounts may
not be chargeable with liabilities that arise
<PAGE>
from any other
business of the Company. Separate Accounts assets may be
subject to General Account claims only to the extent the value
of such assets exceeds the Separate Accounts liabilities.
Assets and liabilities of the Separate Accounts, representing
net deposits and accumulated net investment earnings less fees,
held for the benefit of policyholders, are shown as separate
captions in the balance sheets. Assets held in the Separate
Accounts are carried at quoted market value.
The carrying value for Separate Accounts assets and liabilities
approximates the estimated fair value of the underlying assets.
Postretirement Benefits Other Than Pensions: During the fourth
quarter 1992, the Company adopted SFAS No. 106, "Employer's
Accounting for Postretirement Benefits Other Than Pensions "
("SFAS No. 106"). SFAS No. 106 requires the accrual of
postretirement benefits (such as health care benefits) during
the years an employee provides service. Prior to 1992, the
cost of these benefits were expensed on a pay-as-you-go basis
when such cost was allocated from MLIG as a component of the
Company's operating expenses. The effect of adopting SFAS No.
106 was minimal.
Statements of Cash Flows: For the purpose of reporting cash
flows, cash and cash equivalents includes cash on hand and on
deposit and short-term investments with original maturities of
three months or less.
The carrying amounts approximate the estimated fair value of
cash and cash-equivalents.
Reclassifications: To facilitate comparisons with the current
year, certain amounts in the prior years have been
reclassified.
<PAGE>
NOTE 2: INVESTMENTS
The amortized cost (original cost for equity securities) less
valuation allowances and estimated fair value of investments in
fixed maturity securities and equity securities as of December
31 are:
<TABLE>
<CAPTION>
1993
----
Amortized
Cost less Gross Gross Estimated
Valuation Unrealized Unrealized Fair
Allowances Gains Losses Value
------------ ------------ ------------ ------------
(In Thousands)
<S> <C> <C> <C> <C>
Fixed maturity securities available for sale:
Corporate securities $ 284,710 $ 13,726 $ 3,204 $ 295,232
Mortgage-backed securities 149,834 6,209 216 155,827
U.S. Treasury securities and obligations of
U.S. government corporations and
agencies 3,964 349 24 4,289
Obligations of states and political
subdivisions 3,500 68 0 3,568
------------ ------------ ------------ ------------
Total fixed maturity securities
available for sale $ 442,008 $ 20,352 $ 3,444 $ 458,916
============ ============ ============ ============
Equity securities available for sale:
Common stocks $ 2,392 $ 106 $ 438 $ 2,060
Non-redeemable preferred stocks 5,995 1,002 1,862 5,135
------------ ------------ ------------ ------------
Total equity securities available for sale $ 8,387 $ 1,108 $ 2,300 $ 7,195
============ ============ ============ ============
</TABLE>
<TABLE>
<CAPTION>
1992
----
Amortized
Cost less Gross Gross Estimated
Valuation Unrealized Unrealized Fair
Allowances Gains Losses Value
------------ ------------ ------------ ------------
(In Thousands)
<S> <C> <C> <C> <C>
Fixed maturity securities to be held to
maturity:
Corporate securities $ 290,905 $ 12,328 $ 2,017 $ 301,216
Mortgage-backed securities 265,840 8,390 951 273,279
U.S. Treasury securities and obligations of
U.S. government corporations and
agencies 12,713 298 374 12,637
Obligations of states and political
subdivisions 785 53 0 838
------------ ------------ ------------ ------------
Total fixed maturity securities to be held
to maturity $ 570,243 $ 21,069 $ 3,342 $ 587,970
============ ============ ============ ============
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
1992
----
Amortized
Cost less Gross Gross Estimated
Valuation Unrealized Unrealized Fair
Allowances Gains Losses Value
------------ ------------ ------------ ------------
(In Thousands)
<S> <C> <C> <C> <C>
Fixed maturity securities available for sale:
Corporate securities $ 34,312 $ 745 $ 419 $ 34,638
Mortgage-backed securities 29,256 451 365 29,342
------------ ------------ ------------ ------------
Total fixed maturity securities
available for sale $ 63,568 $ 1,196 $ 784 $ 63,980
============ ============ ============ ============
Equity securities available for sale:
Common stocks $ 2,488 $ 40 $ 452 $ 2,076
Non-redeemable preferred stocks 6,592 1,131 597 7,126
------------ ------------ ------------ -----------
Total equity securities available for sale $ 9,080 $ 1,171 $ 1,049 $ 9,202
============ ============ ============ ============
</TABLE>
For publicly traded securities, the estimated fair value is
determined using quoted market prices. For securities without
a readily ascertainable market value, the Company has
determined an estimated fair value using a discounted cash flow
approach including provisions for credit risk, based upon the
assumption that such securities will be held to maturity. Such
estimated fair values do not necessarily represent the values
for which these securities could have been sold at the dates of
the balance sheets. At December 31, 1993 and 1992,
respectively, securities without a readily ascertainable market
value, having an amortized cost less valuation allowances of
approximately $125,783,000 and $163,829,000, had an estimated
fair value of approximately $131,917,000 and $173,057,000,
respectively.
The amortized cost less valuation allowance and estimated fair
value of fixed maturity securities available for sale at
December 31, 1993 by contractual maturity are shown below:
<TABLE>
<CAPTION>
Amortized
Cost Less Estimated
Valuation Fair
Allowances Value
----------- -----------
(In Thousands)
<S> <C> <C>
Fixed maturity securities available for sale:
Due in one year or less $ 15,935 $ 16,257
Due after one year through five years 105,084 110,813
Due after five years through ten years 134,039 136,697
Due after ten years 37,116 39,322 292,174
Mortgage-backed securities 149,834 155,827
------------ ------------
Total fixed maturity securities available
for sale $ 442,008 $ 458,916
============ ============
</TABLE>
Fixed maturity securities not due at a single maturity date
have been included in the preceding table in the year of final
maturity. Expected maturities will differ from contractual
maturities because borrowers may have the right to call or
prepay obligations with or without call or prepayment
penalties.
<PAGE>
The Company's investment in mortgage loans on real estate
consists principally of loans collateralized by commercial real
estate. The largest concentrations of commercial real estate
mortgage loans are for properties located in California
($7,474,000 or 40%) and Maryland ($7,000,000 or 38%).
Net investment income arose from the following sources for the
years ended December 31,:
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Fixed maturity securities $ 45,667 $ 59,036 $ 62,924
Equity securities available for sale 113 499 372
Mortgage loans on real estate 1,924 2,309 2,478
Policy loans 3,487 3,029 2,491
Cash equivalents 476 1,034 1,907
Other (144) 1,310 246
------------ ------------ ------------
Gross investment income 51,523 67,217 70,418
Less expenses (862) (1,839) (453)
------------ ------------ ------------
Net investment income $ 50,661 $ 65,378 $ 69,965
============ ============ ============
</TABLE>
Net realized investment gains (losses), including changes in
valuation allowances, determined by specific identification for
the years ended December 31,:
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Fixed maturity securities $ 4,108 $ 4,069 $ (7,789)
Equity securities available for sale 2,081 (2,710) (1,896)
Mortgage loans on real estate (58) (1,793) 0
------------ ------------ ------------
Net realized investment gains (losses) $ 6,131 $ ( 434) $ (9,685)
============ ============ ============
</TABLE>
Valuation allowances have been established to reflect other than
temporary declines in estimated fair value of the following
classifications of investments as of December 31,:
<TABLE>
<CAPTION>
1993 1992
---- ---
(In Thousands)
<S> <C> <C>
Fixed maturity securities to be held to maturity $ 0 $ 9,119
Fixed maturity securities available for sale 8,881 0
Equity securities available for sale 1,502 1,502
Mortgage loans on real estate 848 790
------------ ------------
$ 11,231 $ 11,411
============ ============
</TABLE>
Proceeds, gains and losses from the sale or maturity of fixed
maturity securities available for sale and held to maturity for
the years ended December 31,:
<PAGE>
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Proceeds $ 446,517 $ 373,526 $ 366,691
Realized investment gains 4,546 5,469 6,304
Realized investment losses 438 3,206 7,864
</TABLE>
The Company held investments at December 31, 1993 of $4,550,000
which have been non-income producing for the preceding twelve
months.
The Company had investment securities of $1,118,000 and
$645,000 held on deposit with insurance regulatory authorities
at December 31, 1993 and 1992, respectively.
The Company has restructured the terms of certain of its
investments in mortgage loans on real estate in 1993 and
certain of its fixed maturity securities during 1992. The
following table provides the amortized cost less valuation
allowances immediately prior to restructuring, gross interest
income that would have been earned had the loans been current
per their original terms ("Expected Income") and gross interest
income recorded during the year ("Actual Income") and equity
interests which are received in the restructuring:
<TABLE>
<CAPTION>
1993 1992
---- ----
(In Thousands)
<S> <C> <C>
Fixed maturity securities:
Amortized cost less valuation allowances $ 0 $ 3,073
Expected income 0 678
Actual income 0 117
Equity interest received 0 668
Mortgage loans on real estate:
Amortized cost less valuation allowance $ 5,475 $ 0
Expected income 442 0
Actual Income 411 0
</TABLE>
NOTE 3: FEDERAL INCOME TAXES
The Company is taxed as a life insurance company according to
the Federal Income Tax Reform Act of 1986, as amended. The
Company's tax return is not consolidated with any other entity.
The following is a reconciliation of the provision for income
taxes, computed using the Federal statutory tax rate, with the
provision for income taxes for the three years ended December
31,:
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Provision for income taxes computed at Federal
statutory rate $ 840 $ 125 $ (1,671)
Increase (decrease) in income taxes resulting from:
Federal tax rate increase (227)
Other (21) 52 (23)
------------ ------------ ------------
Federal income tax provision (benefit) $ 592 $ 177 $ (1,694)
============ ============ ============
</TABLE>
<PAGE>
The Federal statutory rate for 1993, 1992 and 1991 was 35%, 34%
and 34%, respectively.
The Company provides for deferred income taxes resulting from
temporary differences which arise from recording certain
transactions in different years for income tax reporting
purposes than for financial reporting purposes. The sources of
these differences and the tax effect of each were as follows:
<TABLE>
<CAPTION>
1993 1992 1991
---- ---- ----
(In Thousands)
<S> <C> <C> <C>
Deferred policy acquisition costs $ (1,184) $ (2,094) $ (1,604)
Policyholders' account balances (969) 1,700 (2,768)
Investment adjustments (100) (1,093) (2,055)
Other 3 (709) (1,742)
------------ ------------ ------------
Deferred Federal income tax
provision (benefit) $ (2,250) $ (2,196) $ (8,169)
============ ============ ============
</TABLE>
Deferred tax assets and liabilities as of December 31 are
determined as follows:
<TABLE>
<CAPTION>
1993 1992
---- ----
(In Thousands)
<S> <C> <C>
Deferred tax assets:
Policyholders' account balances $ 9,848 $ 8,879
Investment adjustments 5,143 5,043
------------ ------------
Total deferred tax asset 14,991 13,922
------------ ------------
Deferred tax liabilities:
Deferred policy acquisition costs 4,283 5,467
Net unrealized investment gain (loss) (500) 181
Other 740 737
------------ ------------
Total deferred tax liability 4,523 6,385
------------ ------------
Net deferred tax asset $ 10,468 $ 7,537
============ ============
</TABLE>
The Company anticipates that all deferred tax assets will be
realized, therefore no valuation allowance has been provided.
The Company paid Federal income taxes of $2,668,000, $1,500,000
and $1,095,000 in 1993, 1992 and 1991, respectively.
NOTE 4: RELATED PARTY TRANSACTIONS
The Company and MLIG are parties to a service agreement whereby
MLIG has agreed to provide certain data processing, legal,
actuarial, management, advertising and other services to the
Company. Expenses incurred by MLIG in relation to this service
agreement are reimbursed by the Company on an allocated cost
basis. Charges billed to the Company by MLIG pursuant to the
agreement were $5,688,000, $5,403,000 and $5,034,000 for the
years ended December 31, 1993, 1992 and 1991 respectively.
The Company and Merrill Lynch Asset Management, L.P. ("MLAM") are
parties to a service agreement whereby MLAM has agreed to provide
certain invested asset management services to the Company. The
<PAGE>
Company pays a fee to MLAM for these services through the MLIG
service agreement.
The Company and Merrill Lynch Trust Company ("ML Trust") are
parties to an agreement whereby the Company retains ML Trust to
hold certain invested assets upon the terms and conditions of the
agreement. ML Trust is paid a fee based on its current fee
schedule.
The Company has a general agency agreement with Merrill Lynch
Life Agency Inc. ("MLLA") whereby registered representatives of
Merrill Lynch, Pierce, Fenner and Smith, Inc. ("MLPF&S") who are
the Company's licensed insurance agents, solicit applications for
contracts to be issued by the Company. MLLA is paid commissions
for the contracts sold by such agents. Commissions paid to MLLA
were approximately $4,927,000, $1,469,000 and $864,000 for 1993,
1992 and 1991, respectively. Substantially all of these fees
were capitalized as deferred policy acquisition costs and are
being amortized in accordance with the policy discussed in Note
1.
In connection with the acquisition of a block of variable life
insurance business from Monarch Life Insurance Company ("Monarch
Life"), the Company borrowed funds from Merrill Lynch & Co. to
partially finance the transaction. As of December 31, 1993 and
1992, the outstanding balance of these loans was approximately
$5,550,000 and $7,200,000, respectively. Approximately
$1,650,000 and $4,600,000 was repaid on these loans during 1993
and 1992, respectively. Interest was calculated on these loans at
LIBOR plus 150 basis points. Intercompany interest paid on these
loans during 1993, 1992 and 1991 was approximately $328,000,
$679,000 and $942,000, respectively.
The Company has entered into certain other marketing and
administrative service agreements with affiliates in connection
with the variable life and annuity policies it sells.
During 1993, 1992 and 1991, the Company assumption reinsured
certain policies previously indemnity reinsured by the Company's
affiliate, Merrill Lynch Life Insurance Company ("MLLIC"), and
directly written by Family Life Insurance Company ("Family
Life"), a former affiliate. These transactions resulted in the
transfer of approximately $11,860,000, $2,000,000 and $19,200,000
of policy reserves during 1993, 1992 and 1991, respectively.
The fair value of the Company's payables to affiliates is
estimated at carrying value. These borrowings are payable on
demand and bear a variable interest rate based on LIBOR.
Total intercompany interest paid was $397,000, $801,000 and
$1,193,000 for 1993, 1992 and 1991, respectively.
NOTE 5: STOCKHOLDER'S EQUITY AND STATUTORY REGULATIONS
At December 31, 1993 and 1992, $30,125,000 and $56,862,000,
respectively, of retained earnings was available for distribution
to MLIG. Notice of intention to declare a dividend must be filed
with the New York Superintendent of Insurance who may disallow
the payment. No dividends were declared or paid during 1993, 1992
and 1991. Statutory capital and surplus at December 31, 1993 and
1992, was $57,333,000 and $59,062,000, respectively.
During 1991, MLIG contributed capital to the Company of
$26,717,000 to support the underwriting of additional insurance
premiums and deposits. No capital contributions were made during
1993 and 1992.
Applicable insurance department regulations require that the
Company report its accounts in accordance with statutory
accounting practices. Statutory accounting practices primarily
differ from the principles utilized in these financial statements
by charging policy acquisition costs to expense as incurred,
establishing future policy benefit reserves using different
actuarial assumptions, not providing for deferred taxes and
valuing
<PAGE>
securities on a different basis. The Company's statutory net
income for the years ended December 31, 1993, 1992 and 1991 was
$6,515,000, $10,167,000 and $5,809,000, respectively.
The National Association of Insurance Commissioners ("NAIC")
has developed and implemented, effective December 31,
1993, the Risk Based Capital ("RBC") adequacy monitoring system.
The RBC calculates the amount of adjusted capital which a life
insurance company should have based upon that company's risk
profile. The NAIC has established four different levels of
regulatory action with respect to the RBC adequacy monitoring
system. Each of these levels may be triggered if an insurer's
total adjusted capital is less than a corresponding level of RBC.
These levels are as follows:
For companies with capital levels which are below 100% of
the basic RBC level (company action level) calculated for
that company, the company must submit to the domiciliary
insurance commissioner, and implement, an approved plan to
increase adjusted capital to at least 100% of the basic
RBC.
For companies with capital levels which are below 75% of
the basic RBC level calculated for that company, an
examination of the company will be conducted by the
domiciliary insurance department and as a result of the
findings of the examination, corrective orders may be
issued.
For companies with capital levels which are below 50% of
the basic RBC level (authorized control level) calculated
for that company, the domiciliary insurance commissioner
will have the authority to place the company into
conservatorship or liquidation.
For companies with capital levels which are below 35% of
the basic RBC level calculated for that company, the
domiciliary insurance commissioner will be required to
place the company into conservatorship or liquidation.
As of December 31, 1993, based on the RBC formula, the Company's
total adjusted capital level was 245% of the basic RBC
level.
NOTE 6: REINSURANCE AGREEMENTS
On December 31, 1990, the Company and an affiliate entered into a
100% reinsurance agreement with respect to all variable life
policies issued by Monarch Life and sold through the Merrill
Lynch retail network. As a result of the indemnity provisions of
the agreement, the Company became obligated to reimburse Monarch
Life for its net amount at risk with regard to the reinsured
policies. At the date of acquisition, assets of approximately
$65,000,000 supporting general account reserves, on a statutory
accounting basis, were transferred from Monarch Life to the
Company. This agreement provides for contingent ceding
commission payments to Monarch Life dependent upon the lapse rate
during the five years ending in 1995 and mortality experience
during the ten years ending in 2000. To date, the Company has
paid approximately $24,700,000 to Monarch Life under the terms of
the agreement. As of December 31, 1993, the Company has accrued
$870,000 for such payments.
On various dates during 1992 and 1991, the Company and an
affiliate assumption reinsured substantially all such policies,
wherever permitted by appropriate regulatory authorities. Upon
assumption, the policy liabilities and the underlying assets of
approximately $261,000,000 were transferred to the ML of New York
Variable Life Separate Account ("Account"). As a result of the
assumptions, the Company became directly obligated to the
policyholders, rather than to Monarch Life. Certain contract
owners of the reinsured policies elected to remain with Monarch
Life as permitted under certain state insurance laws. Assets and
liabilities of those policies not assumption reinsured by the
Company or its affiliate have remained with Monarch Life. The
Company and its affiliate have indemnified Monarch Life against
its net amount at risk on such policies. As of December 31,
1993, approximately 23 life insurance policies with $2,820,000
life insurance in force remain under the indemnity reinsurance
agreement.
<PAGE>
During 1992, the Company, along with its affiliates, entered into
an agreement with Monarch Life for the purchase, transfer or
assignment of certain services and assets owned, licensed or
leased by Monarch Life. Additionally, the Company along with its
affiliates were allowed to actively solicit the employment of
individuals employed by Monarch Life, who are required to service
the Company's and its affiliates' variable life insurance
policies and Monarch Life's variable life insurance policies. In
consideration of this, the Company and its affiliate, MLLIC,
transferred title to Monarch Life of certain telecommunications
equipment owned by Merrill Lynch Insurance Group Services, Inc.,
an affiliate of the Company, with a net book value of $1,753,000.
The Company agreed to service Monarch Life's variable life
insurance policies for a period of five years at an annual rate
of $100 per policy. Monarch Life has an option to terminate the
service agreement upon proper notification.
NOTE 7: INTEREST RATE SWAP CONTRACTS
During 1992, the Company terminated all outstanding swap
contracts and recorded no net gains (losses) in connection with
interest rate swap activity.
NOTE 8: COMMITMENTS AND CONTINGENCIES
State insurance laws generally require that all life insurers who
are licensed to transact business within a state become members
of the state's life insurance guaranty association. These
associations have been established for the protection of
policyholders from loss (within specified limits) as a result of
the insolvency of an insurer. At the time an insolvency occurs,
the guaranty association assesses the remaining members of the
association an amount sufficient to satisfy the insolvent
insurer's policyholder obligations (within specified limits).
Based upon the public information available at this time,
management believes the Company has no material financial
obligations to state guaranty associations.
In the normal course of business, the Company is subject to
various claims and assessments. Management believes the
settlement of these matters would not have a material effect on
the financial position or results of operations of the Company.
* * * * * *
<PAGE>
UNDERTAKING TO FILE REPORTS
Subject to the terms and conditions of Section 15(d) of the Securities
Exchange Act of 1934, the undersigned Registrant hereby undertakes to file with
the Securities and Exchange Commission such supplementary and periodic
information, documents and reports as may be prescribed by any rule or
regulation of the Commission heretofore or hereafter duly adopted pursuant to
authority conferred in that section.
RULE 484 UNDERTAKING
ML Life Insurance Company of New York's By-Laws provide, in Article VII,
Section 7.1 as follows:
INDEMNIFICATION OF DIRECTORS, OFFICERS, EMPLOYEES AND INCORPORATORS. To the
extent permitted by the law of the State of New York and subject to all
applicable requirements thereof:
a) any person made or threatened to be made a party to any action or
proceeding, whether civil or criminal, by reason of the fact that he,
his testator, or intestate, is or was a director, officer, employee or
incorporator of the Company shall be indemnified by the Company;
b) any person made or threatened to be made a party to any action or
proceeding, whether civil or criminal, by reason of the fact that he,
his testator or intestate serves or served any other organization in any
capacity at the request of the Company may be indemnified by the Company;
and
c) the related expenses of any such person in any other of said
categories may be advanced by the Company.
Any persons serving as an officer, director or trustee of a corporation,
trust or other enterprise, including the Registrant, at the request of Merrill
Lynch are entitled to indemnification from Merrill Lynch, to the fullest extent
authorized or permitted by law, for liabilities with respect to actions taken or
omitted by such persons in any capacity in which such persons serve Merrill
Lynch or such other corporation, trust or other enterprise. Any action initiated
by any such person for which indemnification is provided shall be approved by
the Board of Directors of Merrill Lynch prior to such initiation.
DIRECTORS' AND OFFICERS' INSURANCE
Merrill Lynch has purchased from Corporate Officers' and Directors'
Assurance Company directors' and officers' liability insurance policies which
cover, in addition to the indemnification described above, liabilities for which
indemnification is not provided under the By-Laws. The Company will pay an
allocable portion of the insurance premium paid by Merrill Lynch with respect to
such insurance policies.
NEW YORK BUSINESS CORPORATION LAW
In addition, Sections 722, 723 and 724 of the New York Business Corporation
Law generally provide that a corporation has the power (and in some instances
the obligation) to indemnify a director or officer of the corporation, or a
person serving at the request of the corporation as a director or officer of
another corporation or other enterprise against any judgments, amounts paid in
settlement, and reasonably incurred expenses in a civil or criminal action or
proceeding if the director or officer acted in good faith in a manner he or she
reasonably believed to be in or not opposed to the best interests of the
corporation (or, in the case of a criminal action or proceeding, if he or she in
addition had no reasonable cause to believe that his or her conduct was
unlawful).
Insofar as indemnification for liability arising under the Securities Act of
1933 (the "Act") may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the
II-1
<PAGE>
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
REPRESENTATIONS PURSUANT TO RULE 6E-3(T)
This filing is made pursuant to Rule 6e-3(T) under the Investment Company
Act of 1940.
Registrant elects to be governed by Rule 6e-3(T)(b)(13)(i)(B) under the
Investment Company Act of 1940 with respect to the policies described in the
Prospectus.
Registrant makes the following representations:
(1) Section 6e-3(T)(b)(13)(iii)(F) has been relied upon.
(2) The level of the mortality and expense risk and guaranteed benefits
risk charge is within the range of industry practice for comparable
flexible or scheduled contracts.
(3) Registrant has concluded that there is a reasonable likelihood that
the distribution financing arrangement of the Separate Account will
benefit the Separate Account and policyowners and will keep and make
available to the Commission on request a memorandum setting forth the basis
for this representation.
(4) The Separate Account will invest only in management investment
companies which have undertaken to have a board of directors, a
majority of whom are not interested persons of the company, formulate and
approve any plan under Rule 12b-1 to finance distribution expenses.
The methodology used to support the representation made in paragraph (2)
above is based on an analysis of the mortality and expense risk and guaranteed
benefits risk charge contained in other variable life insurance contracts.
Registrant undertakes to keep and make available to the Commission on request
the documents used to support the representation in paragraph (2) above.
II-2
<PAGE>
CONTENTS OF REGISTRATION STATEMENT
This Registration Statement comprises the following papers and documents:
The facing sheet.
The prospectus consisting of 83 pages.
Undertaking to File Reports.
Rule 484 Undertaking.
Representations Pursuant to Rule 6e-3(T).
The signatures.
Written Consents of the Following Persons:
(a) Barry G. Skolnick, Esq.
(b) Joseph E. Crowne, F.S.A.
(c) Sutherland, Asbill & Brennan
(d) Deloitte & Touche, independent certified public accountants
The following Exhibits:
<TABLE>
<S> <C> <C> <C> <C>
1.A. (1) Resolution of the Board of Directors of ML Life Insurance Company of New York
establishing the Separate Account (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(2) Not applicable
(3) (a) Distribution Agreement between ML Life Insurance Company of New York and Merrill
Lynch, Pierce, Fenner & Smith Incorporated (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-61670 Filed April 26, 1993)
(b) Amended Sales Agreement between ML Life Insurance Company of New York and
Merrill Lynch Life Agency Inc. (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-61670 Filed April 26, 1993)
(c) Schedules of Sales Commissions. See Exhibit A(3)(b)
(4) Not applicable
(5) (a) (1) Modified Flexible Premium Variable Life Insurance Policy (Incorporated by
Reference to Registrant's Form S-6 Registration No. 33-51702 Filed September 4,
1992)
(2) Modified Flexible Premium Joint and Last Survivor Variable Life Insurance Policy
(Incorporated by Reference to Registrant's Form S-6 Registration No. 33-51702
Filed September 4, 1992)
(b) (1) Backdating Endorsement (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-51702 Filed September 4, 1992)
(2) Guarantee of Insurability Rider (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(3) Single Premium Immediate Annuity Rider (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(4) Flexible Premium Joint and Last Survivor Partial Withdrawal Rider for use with
Modified Flexible Premium Joint and Last Survivor Variable Life Insurance Policy
(Incorporated by Reference to Registrant's Form S-6 Registration No. 33-51702
Filed September 4, 1992)
(5) Flexible Premium Partial Withdrawal Rider for use with Modified Flexible Premium
Variable Life Insurance Policy (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(6) Change of Insured Rider for use with Flexible Premium Variable Life Insurance
Policy (Incorporated by Reference to Registrant's Form S-6 Registration No.
33-51702 Filed September 4, 1992)
(6) (a) Charter of ML Life Insurance Company of New York (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
</TABLE>
II-3
<PAGE>
<TABLE>
<S> <C> <C> <C> <C>
(b) By-Laws of ML Life Insurance Company of New York (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(7) Not applicable
(8) (a) Agreement between ML Life Insurance Company of New York and Merrill Lynch Funds
Distributor, Inc.
(b) Agreement between ML Life Insurance Company of New York and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-61670 Filed April 26, 1993)
(c) Participation Agreement among Merrill Lynch Life Insurance Company, ML Life
Insurance Company of New York and Monarch Life Insurance Company (Incorporated
by Reference to Registrant's Post-Effective Amendment No. 3 to Form S-6
Registration No. 33-61670 Filed April 27, 1994)
(d) Management Agreement between Royal Tandem Life Insurance Company and Merrill
Lynch Asset Management, Inc. (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-61670 Filed April 26, 1993)
(e) Form of Participation Agreement among Merrill Lynch Life Insurance Company, ML
Life Insurance Company of New York and Family Life Insurance Company
(Incorporated by Reference to Registrant's Post-Effective Amendment No. 3 to
Form S-6 Registration No. 33-55472 Filed April 27, 1994)
(9) (a) Service Agreement between Tandem Financial Group, Inc. and Royal Tandem Life
Insurance Company (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-51702 Filed September 4, 1992)
(b) Service Agreement between ML Life Insurance Company of New York and Merrill
Lynch Life Insurance Company (Incorporated by reference to Registrant's Form S-6
Registration No. 33-61670 Filed April 26, 1993)
(10) (a) Variable Life Insurance Application (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(b) Variable Life Insurance Supplemental Application 1 (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(c) Application for Additional Payment for Variable Life Insurance (Incorporated by
Reference to Registrant's Form S-6 Registration No. 33-51702 Filed September 4,
1992)
(d) Application for Reinstatement (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(11) Memorandum describing ML Life Insurance Company of New York's Issuance, Transfer
and Redemption Procedures (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-51702 Filed March
1, 1994)
2. See Exhibit 1.A.(5)
3. Opinion and Consent of Barry G. Skolnick, Esq. as to the legality of the securities being
registered
4. Not applicable
5. Not applicable
6. Opinion and Consent of Joseph E. Crowne, F.S.A. as to actuarial matters pertaining to the
securities being registered
7. (a) Power of Attorney of Frederick J.C. Butler (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(b) Power of Attorney of Michael P. Cogswell (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
</TABLE>
II-4
<PAGE>
<TABLE>
<S> <C> <C> <C> <C>
(c) Power of Attorney of Sandra K. Cox (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(d) Power of Attorney of Joseph E. Crowne (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(e) Power of Attorney of David E. Dunford (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(f) Power of Attorney of John C.R. Hele (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(g) Power of Attorney of Robert L. Israeloff (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(h) Power of Attorney of Allen N. Jones (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(i) Power of Attorney of Cynthia L. Kahn (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(j) Power of Attorney of Robert A. King (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(k) Power of Attorney of Irving M. Pollack (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(l) Power of Attorney of Barry G. Skolnick (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(m) Power of Attorney of Anthony J. Vespa (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(n) Power of Attorney of William A. Wilde (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
8. (a) Written Consent of Barry G. Skolnick, Esq. (See Exhibit 3)
(b) Written Consent of Joseph E. Crowne, F.S.A. (See Exhibit 6)
(c) Written Consent of Sutherland, Asbill & Brennan
(d) Written Consent of Deloitte & Touche, independent certified public accountants
</TABLE>
II-5
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant,
ML of New York Variable Life Separate Account II, hereby certifies that this
Post-Effective Amendment No. 3 meets all of the requirements for effectiveness
pursuant to paragraph (b) of Rule 486 under the Securities Act of 1933, and has
duly caused this Post-Effective Amendment No. 3 to the Registration Statement to
be signed on its behalf by the undersigned thereunto duly authorized, and its
seal to be hereunto affixed and attested, all in the City of Plainsboro and the
State of New Jersey, on the 27th day of April, 1994.
ML OF NEW YORK VARIABLE LIFE SEPARATE ACCOUNT II
(Registrant)
By: ML LIFE INSURANCE COMPANY OF NEW YORK
(Depositor)
<TABLE>
<S> <C>
Attest: /s/ SHELLEY K. PARKER By: /s/BARRY G. SKOLNICK
-------------------------------- -----------------------------------
Shelley K. Parker Barry G. Skolnick
Vice President Senior Vice President
</TABLE>
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 3 to the Registration Statement has been signed
below by the following persons in the capacities indicated on April 27, 1994.
<TABLE>
<CAPTION>
SIGNATURE TITLE
-------------------------------------- --------------------------------------
<S> <C>
* Chairman of the Board, President, and
-------------------------------------- Chief
Anthony J. Vespa Executive Officer
* Director, Senior Vice President, Chief
-------------------------------------- Financial Officer, Chief Actuary, and
Joseph E. Crowne Treasurer
* Director, Senior Vice President, and
-------------------------------------- Chief Investment Officer
David M. Dunford
* Director, and Senior Vice President
--------------------------------------
John C.R. Hele
* Director, Vice President, and Senior
-------------------------------------- Counsel
Michael P. Cogswell
* Director
--------------------------------------
Frederick J.C. Butler
</TABLE>
II-6
<PAGE>
<TABLE>
<CAPTION>
SIGNATURE TITLE
-------------------------------------- --------------------------------------
<S> <C>
* Director
--------------------------------------
Sandra K. Cox
* Director
--------------------------------------
Robert L. Israeloff
* Director
--------------------------------------
Allen N. Jones
* Director
--------------------------------------
Cynthia L. Kahn
* Director
--------------------------------------
Robert A. King
* Director
--------------------------------------
Irving M. Pollack
* Director
--------------------------------------
William A. Wilde
*By: /s/BARRY G. SKOLNICK In his own capacity as Director,
---------------------------------- Senior Vice President, and General
Barry G. Skolnick Counsel and as Attorney-In-Fact
</TABLE>
II-7
<PAGE>
EXHIBIT INDEX
<TABLE>
<S> <C> <C> <C> <C>
1.A. (1) Resolution of the Board of Directors of ML Life Insurance Company of New York
establishing the Separate Account (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(2) Not applicable
(3) (a) Distribution Agreement between ML Life Insurance Company of New York and Merrill
Lynch, Pierce, Fenner & Smith Incorporated (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-61670 Filed April 26, 1993)
(b) Amended Sales Agreement between ML Life Insurance Company of New York and
Merrill Lynch Life Agency Inc. (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-61670 Filed April 26, 1993)
(c) Schedules of Sales Commissions. See Exhibit A(3)(b)
(4) Not applicable
(5) (a) (1) Modified Flexible Premium Variable Life Insurance Policy (Incorporated by
Reference to Registrant's Form S-6 Registration No. 33-51702 Filed September 4,
1992)
(2) Modified Flexible Premium Joint and Last Survivor Variable Life Insurance Policy
(Incorporated by Reference to Registrant's Form S-6 Registration No. 33-51702
Filed September 4, 1992)
(b) (1) Backdating Endorsement (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-51702 Filed September 4, 1992)
(2) Guarantee of Insurability Rider (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(3) Single Premium Immediate Annuity Rider (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(4) Flexible Premium Joint and Last Survivor Partial Withdrawal Rider for use with
Modified Flexible Premium Joint and Last Survivor Variable Life Insurance Policy
(Incorporated by Reference to Registrant's Form S-6 Registration No. 33-51702
Filed September 4, 1992)
(5) Flexible Premium Partial Withdrawal Rider for use with Modified Flexible Premium
Variable Life Insurance Policy (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(6) Change of Insured Rider for use with Flexible Premium Variable Life Insurance
Policy (Incorporated by Reference to Registrant's Form S-6 Registration No.
33-51702 Filed September 4, 1992)
(6) (a) Charter of ML Life Insurance Company of New York (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(b) By-Laws of ML Life Insurance Company of New York (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(7) Not applicable
(8) (a) Agreement between ML Life Insurance Company of New York and Merrill Lynch Funds
Distributor, Inc.
(b) Agreement between ML Life Insurance Company of New York and Merrill Lynch,
Pierce, Fenner & Smith Incorporated (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-61670 Filed April 26, 1993)
(c) Participation Agreement among Merrill Lynch Life Insurance Company, ML Life
Insurance Company of New York and Monarch Life Insurance Company (Incorporated
by Reference to Registrant's Post-Effective Amendment No. 3 to Form S-6
Registration No. 33-61670 Filed April 27, 1994)
(d) Management Agreement between Royal Tandem Life Insurance Company and Merrill
Lynch Asset Management, Inc. (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-61670 Filed April 26, 1993)
</TABLE>
II-8
<PAGE>
<TABLE>
<S> <C> <C> <C> <C>
(e) Form of Participation Agreement among Merrill Lynch Life Insurance Company, ML
Life Insurance Company of New York and Family Life Insurance Company
(Incorporated by Reference to Registrant's Post-Effective Amendment No. 3 to
Form S-6 Registration No. 33-55472 Filed April 27, 1994)
(9) (a) Service Agreement between Tandem Financial Group, Inc. and Royal Tandem Life
Insurance Company (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-51702 Filed September 4, 1992)
(b) Service Agreement between ML Life Insurance Company of New York and Merrill
Lynch Life Insurance Company (Incorporated by Reference to Registrant's Form S-6
Registration No. 33-61670 Filed April 26, 1993)
(10) (a) Variable Life Insurance Application (Incorporated by Reference to Registrant's
Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(b) Variable Life Insurance Supplemental Application 1 (Incorporated by Reference to
Registrant's Form S-6 Registration No. 33-51702 Filed September 4, 1992)
(c) Application for Additional Payment for Variable Life Insurance (Incorporated by
Reference to Registrant's Form S-6 Registration No. 33-51702 Filed September 4,
1992)
(d) Application for Reinstatement (Incorporated by Reference to Registrant's Form
S-6 Registration No. 33-51702 Filed September 4, 1992)
(11) Memorandum describing ML Life Insurance Company of New York's Issuance, Transfer
and Redemption Procedures (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-51702 Filed March
1, 1994)
2. See Exhibit 1.A.(5)
3. Opinion and Consent of Barry G. Skolnick, Esq. as to the legality of the securities being
registered
4. Not applicable
5. Not applicable
6. Opinion and Consent of Joseph E. Crowne, F.S.A. as to actuarial matters pertaining to the
securities being registered
7. (a) Power of Attorney of Frederick J.C. Butler (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670) Filed March 1, 1994)
(b) Power of Attorney of Michael P. Cogswell (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(c) Power of Attorney of Sandra K. Cox (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(d) Power of Attorney of Joseph E. Crowne (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(e) Power of Attorney of David E. Dunford (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(f) Power of Attorney of John C.R. Hele (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(g) Power of Attorney of Robert L. Israeloff (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(h) Power of Attorney of Allen N. Jones (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
</TABLE>
II-9
<PAGE>
<TABLE>
<S> <C> <C> <C> <C>
(i) Power of Attorney of Cynthia L. Kahn (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(j) Power of Attorney of Robert A. King (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(k) Power of Attorney of Irving M. Pollack (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(l) Power of Attorney of Barry G. Skolnick (Incorporated by Reference to
Registrant's Post-Effective Amendment No. 2 to Form S-6 Registration No.
33-61670 Filed March 1, 1994)
(m) Power of Attorney of Anthony J. Vespa (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
(n) Power of Attorney of William A. Wilde (Incorporated by Reference to Registrant's
Post-Effective Amendment No. 2 to Form S-6 Registration No. 33-61670 Filed March
1, 1994)
8. (a) Written Consent of Barry G. Skolnick, Esq. (See Exhibit 3)
(b) Written Consent of Joseph E. Crowne, F.S.A. (See Exhibit 6)
(c) Written Consent of Sutherland, Asbill & Brennan
(d) Written Consent of Deloitte & Touche, independent certified public accountants
</TABLE>
II-10
<PAGE>
[Merrill Lynch letterhead]
April 4, 1994
Board of Directors
ML Life Insurance Company of New York
717 Fifth Avenue, 16th Floor
New York, NY 10022
To The Board of Directors:
In my capacity as General Counsel of ML Life Insurance Company of New York (the
"Company"), I have supervised the establishment of the ML of New York Variable
Life Separate Account II (the "Account"), by the Board of Directors of the
Company as a separate account for assets applicable to certain flexible premium
variable life insurance contracts (the "Contracts") issued by the Company
pursuant to the provisions of Section 4240 of the Insurance Laws of the State of
New York. Moreover, I have supervised the preparation of Post-Effective
Amendment No. 3 to the Registration Statement on Form S-6 (the "Registration
Statement") (File No. 33-51702) filed by the Company and the Account with the
Securities and Exchange Commission under the Securities Act of 1933, for the
registration of the Contracts to be issued with respect to the Account.
I have made such examination of the law and examined such corporate records and
such other documents as in my judgment are necessary and appropriate to enable
me to render the following opinion that:
1. The Company has been duly organized under the laws of the State of New York
and is a validly existing corporation.
2. The Account is duly created and validly existing as a separate account
pursuant to the aforesaid provisions of New York law.
3. The portion of the assets to be held in the Account equal to the reserves
and other liabilities under the Contracts is not chargeable with
liabilities arising out of any other business the Company may conduct.
4. The Contracts have been duly authorized by the Company and constitute
legal, validly issued and binding obligations of the Company in accordance
with their terms.
I hereby consent to the filing of this opinion as an exhibit to the Registration
Statement and to the use of my name under the caption "Legal Matters" in the
Prospectus contained in the Registration Statement.
Very truly yours,
/s/ Barry G. Skolnick
Barry G. Skolnick
Senior Vice President and General Counsel
<PAGE>
[Merrill Lynch letterhead]
April 4, 1994
Board of Directors
ML Life Insurance Company of New York
717 Fifth Avenue 16th Floor
New York, NY 10022
Re: ML of New York Variable Life Separate Account II
To The Board of Directors:
This opinion is furnished in connection with the filing of Post-Effective
Amendment No. 3 to the Registration Statement on Form S-6 (the "Registration
Statement") (File No. 33-51702) which covers premiums received under certain
flexible premium variable life insurance contracts ("Contracts" or "Contract")
issued by ML Life Insurance Company of New York (the "Company").
The Prospectus included in the Registration Statement describes Contracts which
are issued by the Company. The Contract forms were reviewed under my direction,
and I am familiar with the Registration Statement and Exhibits thereto. In my
opinion:
1. Using the interest rate and mortality tables guaranteed in the Contract,
current mortality rates cannot be established at levels such that the "sales
load," as defined in paragraph (c)(4) of Rule 6(e)-3T under the Investment
Company Act of 1940, would exceed 9% of any payment.
2. The illustrations of death benefits, investment base, cash surrender values
and accumulated premiums included in the Registration Statement for the Contract
and based on the assumptions stated in the illustrations, are consistent with
the provisions of the Contract. The rate structure of the Contract has not been
designed so as to make the relationship between premiums and benefits, as shown
in the illustrations, appear more favorable to a prospective purchaser of a
Contract for the ages and sexes shown, than to prospective purchasers of a
Contract for other ages and sex.
3. The table of illustrative net single premium factors included in the "Death
Benefit Proceeds" section is consistent with the provisions of the Contract.
4. The information with respect to the Contract contained in (i) the
illustrations of the change in face amount included in the "Additional Payments"
sections of the Examples, (ii) the illustrations of a change in Guarantee Period
included in the "Changing the Face Amount" section of the Examples and (iii) the
illustrations of the changes in face amount included in the "Partial
Withdrawals" section of the Examples, based on the assumptions specified, are
consistent with the provisions of the Contract.
I hereby consent to the use of this opinion as an exhibit to the Registration
Statement and to the use of my name relating to actuarial matters under the
heading "Experts" in the Prospectus.
Very truly yours,
/s/ Joseph E. Crowne
Joseph E. Crowne, FSA
Senior Vice President &
Chief Financial Officer
<PAGE>
Exhibit 8(c)
CONSENT OF SUTHERLAND, ASBILL & BRENNAN
We consent to the reference to our firm under the heading "Legal Matters"
in the prospectus included in Post-Effective Amendment No. 3 to the
Registration Statement on Form S-6 for certain variable life insurance
contracts issued through MLof New York Variable Life Separate Account II
of ML of New York Life Insurance Company of New York (File No. 33-51702).
In giving this consent, we do not admit that we are in the category of
persons whose consent is required under Section 7 of the Securities Act
of 1933.
/s/ Sutherland, Asbill & Brennan
SUTHERLAND, ASBILL & BRENNAN
Washington, D.C.
April 26, 1994
<PAGE>
Exhibit 8(d)
INDEPENDENT AUDITORS' CONSENT
We consent to the use in this Post-Effective Amendment No. 3 to Registration
Statement No. 33-51702 of ML of New York Variable Life Separate Account II
on Form S-6 of our reports on (i) ML Life Insurance Company of New York
dated February 28, 1994, and (ii) ML of New York Variable Life Separate
Account II dated February 16, 1994, appearing in the Prospectus, which is a
part of such Registration Statement, and to the reference to us under the
heading "Experts" in such Prospectus.
New York, New York
April 25, 1994
